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Chapter 1
Chemoenzymatic strategies 
to enantiopure piperidines
Lieke J. C. van Hemert, Stefan van Rootselaar and Floris P. J. T. Rutjes, 
Chemoenzymatic strategies to enantiopure piperidines, manuscript submitted.
“As for me, all I know is that I know nothing.”
 – Socrates
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Abstract
Nature has created excellent enzymatic catalysts, which are increasingly applied by 
organic chemists in chemoenzymatic strategies to generate enantio- and/or diastereo-
merically pure compounds. In this chapter, an overview is given of the enzymes that have 
been used in the synthesis of several types of piperidines. This is an interesting compound 
class, containing many members that either have relevant biological properties on their 
own, or have been used as a scaffold to create libraries of biologically active ompounds. 
The enzyme classes that will be discussed include hydrolases, hydroxynitrilases, hydroxy-
lases, nitrilases and in particular aldolases, which have been extensively applied in this 
thesis.
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1.1 — Introduction
Nature has created sophisticated biosynthetic systems to synthesize molecules with 
excellent control over the stereochemistry.1 A structural unit that is frequently produced, 
either on itself or as part of larger polycyclic systems, in a wide variety of organisms, is the 
piperidine moiety. As a result, piperidine structures are important targets for synthetic 
and medicinal chemistry in the search for specific therapeutic potential (Figure 1).
N
H
F
O O
O
3, Paroxetine
N
OH
OH
HO
OH
OH
2, Miglitol
N
H
1, piperidine
Figure 1 — Examples of piperidine structures.
Pathological conditions that have been treated with piperidine-derived small molecules 
include HIV,2 diabetes type 2 (Miglitol, 2),3 lysosomal storage disorders,4 autoimmune 
diseases,5 malaria,6 depression (Paroxetine, 3)7 and recently examples have been 
reported for the treatment of cancer.8 Numerous approaches have been developed to 
synthesize piperidine-containing bioactive compounds, for example via hydrogenation 
of pyridine derivatives,9 reduction of lactam derivatives10 and ring formation via reductive 
amination.11 The synthesis of piperidines was also accomplished with strategies involving 
metal catalysis such as ring closing metathesis with the Hoveyda-Grubbs catalyst,12 Pd-
catalyzed intramolecular hydroamination of unactivated alkenes,13 and gold(I)-catalyzed 
hydroamination of unactivated olefins.14 The biggest challenge in synthesizing these mol-
ecules is generally the stereoselective introduction of suitable functional groups. Mim-
icking nature in a chemoenzymatic approach to these compounds provides an excellent 
alternative to classical synthesis routes.15 For example, enzymatic resolution to synthesize 
enantiopure piperidines is nowadays a method that is frequently applied on industrial 
scale.16 Enzymatic resolution is one of the many options to construct enantiopure piperi-
dine scaffolds and nowadays enzymes have become fully accepted as powerful means to 
do so.17 This chapter provides a review of recent literature concerning chemoenzymatic 
approaches to synthesize enantiomerically pure hydroxylated piperidines, based on the 
different classes of enzymes that have been employed.
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1.2 — Hydrolases
Enzymes from the class of hydrolases have been commonly applied in the synthesis of 
chiral piperidines via enzymatic kinetic resolution. The hydrolases can be divided into 
three subclasses, being lipases, esterases and acylases based on substrate specificity.
1.2.1 — Lipases
The first subclass is represented by lipases, which often display a broad substrate range 
and are capable of hydrolyzing a variety of ester groups. In vivo they play an important 
role in the degradation of fatty acids via hydrolysis of esters of glycerol. Particularly their 
tolerance towards a large variety of reaction conditions, including organic solvents, ren-
ders them useful for application in chemoenzymatic strategies.18 Two well-investigated 
hydrolases are Candida antarctica lipase A and B (CAL A and CAL B, respectively), but 
Candida rugosa lipase (CRL), Rhizopus oryzae lipase (ROL) and Pseudomonas cepacia 
lipase (PCL) will be covered in this section as well.
Over the years CAL A has proven its use in many biotechnological applications.19 One 
of the substituted piperidines synthesized in enantiopure form through kinetic resolution 
by CAL A is (–)-paroxetine (3, Scheme 1).20 (–)-Paroxetine is used to treat major depres-
sion, obsessive-compulsive disorder, panic disorder, social anxiety, post-traumatic stress 
disorder and generalized anxiety disorder.7,21 Key step in the synthesis was a selective 
acylation of one of the trans-enantiomers of 4 by CAL A, which resulted in acetate 5 in 
good yield (48%) and excellent enantioselectivity (96% e.e.).22 It should be noted that 
this reaction involved a reversed enzymatic reaction: instead of hydrolysis synthesis took 
place. This intermediate was then transformed into paroxetine (3) in five steps.23 Unfor-
tunately, this compound, marketed as Paxil, became topic of discussion in a misleading 
advertisement24 and in 2008 severe side effects were observed, which tempered the 
interest, but nevertheless the drug is still on the market.25
N
H
F
O O
O
N
F
OH
(±)-4
N
F
OAc
3, Paroxetine
5 steps
5
Cbz Cbz
vinyl acetate (10 equiv.) 
CAL A (0.01 equiv.) 
water/toluene 10:1, 15 °C
10 h, 48%, 96% e.e.
Scheme 1 — CAL A catalyzed synthesis of paroxetine (3).
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Another well investigated lipase is Cal B, which has a wide substrate tolerance and cata-
lyzes numerous reactions with large variations in pH and temperature.19 CAL B can even 
operate in pure organic solvents, which is ideal for applications in organic synthesis.26 
CAL B was employed by the group of Gotor to gain access to enantiopure 3,4-disubsti-
tuted piperidines,27 which possess interesting inhibitory activities on β-galactosidases,28 
and xylanases.29 These disubstituted piperidines also act as gastrointestinal stimulants.30 
A particular example is ifoxetine (9, Scheme 2), which possesses antidepressant activ-
ity.31 The 3,4-disubstituted piperidine scaffold was synthesized in four steps starting from 
tetrahydropyridine 6, which was epoxidized with m-CPBA, followed by ring-opening 
with acetic anhydride and BF3·Et2O to provide the racemic trans-diacetate 7. An enzy-
matic resolution was carried out with CAL B to give almost quantitative conversion of 
only one of the enantiomers into monoacetate 8. With this strategy the synthesis of cis-
dihydroxypiperidines was also investigated, but was less successful. 27
N
H N N
OAc
OAc
OH
OAc
(±)-76 8
Cbz Cbz
1) Cbz-Cl, NaHCO3, DCM
2) m-CPBA, DCM
3) Ac2O, BF3·Et2O, AcOH
    69%, 3 steps
CAL B, H2O (5 equiv.)  
MeCN, 30 °C, 24 h
49%, >99% e.e N
H
O
OH
Me
Me
9, Ifoxetine
Scheme 2 — Synthesis of trans-3,4-dihydroxypiperidine scaffol 8.
Another lipase frequently used in biosynthetic pathways was isolated from Candida 
rugosa (formerly known as Candida cylindracea)32 and has been named accordingly Can-
dida rugosa lipase (CRL). Soon after it was discovered, the reliability of this enzyme 
was questioned due to irreproducible results, but careful analysis revealed that several 
isoenzymes of CRL were present in different sources causing these variations.33 Recent 
investigations indicated that use of this enzyme is viable even on industrial scale.33c The 
application of CRL was amongst others demonstrated in the synthesis of trihydroxylated 
azabicycles 14a and 14b,34 which are common pharmacophores (Scheme 3).35 Trans-diol 
10 was selectively desymmetrized through monoacylation with CRL.34 The first alkene 
was introduced via Swern oxidation of the primary alcohol, followed by a Wittig reaction 
and deprotection of the amine, providing alkene 12 in good yield. The second alkene was 
introduced on the amine, after which ring-closing metathesis with the Grubbs-II catalyst, 
reduction of the amide and Upjohn dihydroxylation provided the bicyclic heterocycles 
14a and 14b.34
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N OHHO N OAcHO
N OH
H
HO
HO N OH
HHO
HO
10 11
14a 14b
Cbz Cbz
                , CRL (0.004 mol%) 
[BMIM]PF6, 40 °C, 24 h, 90%
98% e.e.
OAc 1) (COCl)2, DMSO, TEA, DCM, 94%
2) Ph3PCH3Br, t-BuOK, toluene, 77%
3) KOH 1M, MeOH, 86%
N OAc
R
12   R = H
13a R =
 
13b R =
O
O
a) acryloyl chloride, Na2CO3, acetone/water, 73%
b) 3-butenoic acid, EDC, DMAP, DMF, 79%
4 steps
Scheme 3 — Synthesis of pharmacophores 14a and 14b.
The desymmetrization of 10 was also applied in the synthesis of alkaloid (+)-indolizidine 
209D (17, Scheme 4) which was isolated from dendrobatid frogs in Central America.36 
Alkaloid 17 and its epimers are highly active blockers of the nicotinic acetylcholine recep-
tors.37 Enzyme-mediated asymmetric syntheses of all four stereoisomers were developed 
by different groups.37,38 The group of Chênevert developed a method to obtain the 
alkaloid starting from piperidine 11.39 After Swern oxidation and Wittig reaction, a pig 
liver esterase (PLE) catalyzed deprotection of the acetate group and subsequent Swern 
oxidation and another Wittig reaction, resulted in piperidine 16. The final alkaloid 17 was 
obtained via hydrogenation, lactam formation and reduction of the bicyclic lactam.
NHO OAc N OAcBu
N
H
C6H13
1) H2/Pd, EtOH
2) Me3Al, benzene
3) LiAlH4, THF
1) Swern oxidation
2) Ph3P(C5H11)Br, t-BuOK
benzene
1) PLE, phosphate buffer 
    pH = 7
2) Swern
3) Ph3P=CHCO2Me, benzene
NBu CO2Et
Cbz Cbz
Cbz
11 15
16 17
10
Scheme 4 — Synthesis of (+)-indolizidine 209D (17).
The third lipase, Rhizopus oryzae lipase (ROL, formerly known as Rhizopus delemar)40 is 
known to exclusively react with primary alcohols in generally high enantioselectivity and 
is therefore able to discriminate between the different esters of glycerides in vivo.41 This 
enzyme played a crucial role in the synthesis of the β-galactosidase inhibitor42 isogalac-
tofagomine (21), in which it was used to hydrolyze one of the precursors (Scheme 5).43 
Alternative synthetic strategies started from carbohydrates43 or chiral separation of race-
Lieke BW CP v2.indd   14 12-09-12   13:33
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mates.44 The group of Bols applied ROL in their synthetic strategy to desymmetrize cis-
diester 18 providing (R)-acid 19 in excellent yield (95%) and enantioselectivity (99% e.e.). 
In the subsequent steps the acid was reduced to the corresponding alcohol and the diol 
was protected with an acetone clip (20). The synthetic route was continued via hydrolysis 
of the acid, followed by oxidative decarboxylation with concomitant replacement by 
iodine through a radical intermediate,45 resulting in a mixture of diastereoisomers that 
were separated with column purification. Nucleophilic substitution of the cis-iodide with 
silver trifluoroacetate in EtOAc proceeded smoothly with retention of configuration,46 
after which the trifluoroacetate and dioxolane were hydrolyzed with aqueous TFA to 
obtain piperidine 21.
N
OH O
OMe
O
MeO
N
20
N
OH O
OH
O
MeO
18 19
Boc
ROL (20 mol%), 
water, 48 h, pH 7.0
rt, 95%, 99% e.e.
1) BF3·THF, 0 °C, 99%
2) Me2C(OMe)2, TsOH, 93%
OOO
MeO
1) LiOH, H2O, 87%
2) PhI(OAc)2, I2, CCl4 
    hv, mixture of isomers
 
3) CF3COOAg, EtOAc, 30%
4) TFA, H2O, 100%
N
H
HO
21
OH
OH
Boc
Boc
Scheme 5 — Synthesis of isogalactofagomine (21) with ROL as desymmetrizing enzyme.
3,5-Dihydroxypiperidines form another interesting class of piperidines too, as they 
possess similar glucosidase inhibiting properties as the 3,4-disubstituted piperidines.47 
Recent studies also indicate possible treatment of Alzheimer’s disease and schizophrenia 
with this class of piperidines.48 Another application of these compounds is their use as 
chiral ligands in the enantioselective addition of diethylzinc onto aldehydes.49 Syntheses 
of both the cis- and trans-dihydroxylated piperidines 24a and b, respectively (Scheme 
6), were published earlier without using enzymes.50,51  A chemoenzymatic route to 
these enantiopure piperidine moieties was realized with Pseudomonas cepacia lipase 
(PCL),52 which was isolated from the bacterial strain Pseudomonas cepacia (also called 
Burkholderia cepacia). This lipase accepts both primary and secondary alcohols,41,53 and 
these properties were used in the synthesis of the 3,5-disubstituted piperidine derivatives 
24a and b. The group of Bäckvall started from glycinate 22, which was ring-closed in a 
Dieckmann condensation. Next, a one pot deacetylation by CAL B of the intermediate 
enolacetate and transfer hydrogenation by a ruthenium catalyst resulted in racemic diol 
23.47 Desymmetrization was carried out with PCL to yield each of the (3R)-acetylated 
diastereoisomers 24a and b in high enantioselectivities.
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N
OHHO
N
OHAcO
N
OHAcO
24a 24b
23
Bn
Bn Bn
            , PCL  
toluene, RT, 6 h 
24a : 29%, 98% e.e.
24b : 45%, 98% e.e.
O
O
EtO
O
N
O 1) t-BuOK, AcOH
2) CALB, then Ru-cat
    in iPrOH, heat
    70% over 3 steps
22
Bn
Scheme 6 — Diastereoselective acetylation to afford 21a and 21b.
1.2.2 — Esterases
Esterases, another subclass of hydrolases, are known to react with short chain acyl esters. 
A frequently used esterase is pig liver esterase (PLE), which has been applied in synthetic 
routes for several decades.54 This enzyme has also shown inconsistencies in reactivity due 
to the presence of isoenzymes.55 These problems were overcome by the development of 
a recombinant source and nowadays this enzyme shows remarkable stability and repro-
ducibility.56 It accepts a wide variety of substrates due to its in vivo function to hydrolyze 
carboxylic esters present in the pig diet.56 One of the targets synthesized in enantiopure 
form using PLE is the alkaloid (–)-Kishi lactam (28, Scheme 7), a versatile intermediate 
for the synthesis of perhydrohistrionicotoxin alkaloids (pHTX, 29). These alkaloids were 
isolated from the “arrow poison frog” Dendrobates histrionicus in South-America and have 
been used extensively as neurological probes for the acetylcholine receptor channel.57 
The synthesis of diacetal protected spiro compound 25, precursor for the synthesis of 
Kishi lactam 28, was previously reported by the same group.58 Key step in the synthesis of 
lactam 28 was the selective deprotection of 25 with PLE, which proceeded in high yields. 
Treatment of 26 with phenyl thionochloroformate and DMAP in DCM resulted in lactam 
27. Kishi lactam (28) was obtained via treatment of 27 with tri-n-butyltin hydride and 
AIBN, followed by deacylation and subsequent oxidation.
Lieke BW CP v2.indd   16 12-09-12   13:33
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N
H
OAc
OAc
O
PLE, pH 7
14 d, 87%
PhOCSCl, DMAP, DCM, 73%
N
H
OR
OAc
O
26, R = H
27, R = CSOPh
25
1) Bu3SnH, AIBN, PhMe, 95 °C, 93%
2) NaOMe, MeOH, 98%
3) (COCl)2, TEA, DMSO, DCM, 77%
N
H
O
O
28, Kishi lactam
N
H
C5H11
OH
C4H9
29, pHTX
Scheme 7 — Synthesis of Kishi lactam (28).
1.2.3 — Acylases
The last subclass of hydrolases, the acylases, catalyzes the formation and cleavage of 
N-acylamino acids and ester bonds, which is illustrated by the use of Aspergillus acylase 
1 (AA-1).59 AA-1 was isolated from Aspergillus niger and the enzyme was applied in the 
chemical synthesis of numerous compounds, such as the non-proteinogenic amino 
acid (S)-pipecolic acid (32, Scheme 8) which is present in various natural peptides60 and 
anti-inflammatory pharmaceuticals.61 Acid 32 is an intermediate formed especially in the 
mammalian central nervous system via a specific degradation pathway,62 which implies a 
role in important neurological functions.63
N
H
N OH N
R
OH
N
H
(S)-30
33 34
vinyl butyrate, AA-1 (300 U/mmol)
wet toluene, RT, 9 h
(S)-30: R = Cbz 42%, >99.9% e.e.
            R = Boc 37%, >99.6% e.e.
R
+
N
R
O Bu
O
1) CrO3, H2SO4 (aq)
    acetone, 77%
2) H2, Pd/C
    MeOH, 94%
R = Cbz
N
H
CO2H
32
30 31
Scheme 8 — Synthesis of (S)-pipecolic acid (32).
The novel route to (S)-pipecolic acid by Herradón et al. commenced with a racemic 
mixture of carbamate-protected piperidine 30, which was subjected to AA-1 to produce 
the desired (S)-enantiomer in excellent purity and good yield.64 The corresponding 
carboxylic acid 32 was obtained via Jones oxidation and carbamate deprotection. From 
pipecolic acid 32 also (S)-δ-coniceine (34) and (R)-coniine (33) were synthesized.65 
Another example of the use of AA-1 was seen in the synthesis of 2-ethylpiperidines 37 
(Scheme 9).66 Both products were obtained in high yield and purity over two steps.
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N Et
OO
OEt
AA-1 (0.01 equiv.)
H2O/MeCN 9:1 
pH 7.0, RT, 20-48 h
N Et
OO
OH
N Et
OO
OEt
(R)-36 (S)-35
N
H
Et N
H
Et
(R)-37
43%, 96% e.e.
over 2 steps
(S)-37
45%, 99% e.e.
over 2 steps
4 N HCl, reflux, 5 h35
Scheme 9 — Preparation of enantiomerically pure 2-ethylpiperidines 37.
The desymmetrization methods described in this section are elegant examples of the 
synthesis of enantiopure piperidines, leading to 100% yield of one of the enantiomers. 
The enzymatic kinetic resolutions of racemic mixtures, on the other hand, result in a 
maximum yield of 50% one of the desired enantiomer. In order to reach 100% yield in 
the latter case, a racemization method for the starting material needs to be developed, 
which then results in a dynamic kinetic resolution (DKR).15a,67
1.3 — Hydroxynitril lyases
Hydroxynitril lyases (HNLs), also referred to as oxynitrilases, catalyze in vivo the hydrolysis 
of a wide range of cyanohydrins (38) into the corresponding aldehydes or ketones (39) 
and toxic hydrogen cyanide (40, Scheme 10). Nature created this defense mechanism 
to protect the organism when it is under attack.68 For synthetic purposes the equilibrium 
can be reversed to give access to enantiopure cyanohydrins via addition of HCN onto 
prochiral carbonyl compounds 39. The first application of HNLs was published in 1908 
and its use has increased rapidly in particular over the last two decades.69
R1 R2
O
R1 R2
+ HCN
39 4038
HO CN
*
Scheme 10 — In vivo degradation of cyanohydrins 38.
The HNLs have been divided into four classes based on sequence, structure, catalytic 
mechanism,70 and enantioselectivity. The (S)-selective enzymes are derived from Hevea 
brasiliensis (HbHNL, isolated from leaves of the tropical rubber tree), Manihot esculenta 
(MeHNL, isolated from the cassava) and Sorghum bicolor (SbHNL, isolated from millet).71 
Lieke BW CP v2.indd   18 12-09-12   13:33
19
Chemoenzymatic strategies to enantiopure piperidines
The complementary (R)-selective enzymes include Linum usitatissimum (LuHNL, originat-
ing from flax), Phlebodium aureum (PhaHNL, found in fern plants), Prunus amygdalus 
(PaHNL, isolated from almonds) and other Prunus species.69,72 HbHNL and PaHNL display 
a broad substrate range, which due to the opposite selectivities provide excess to both 
enantiomeric configurations in generally excellent enantiomeric excess (>99%). The group 
of Gotor used PaHNL to synthesize various naturally occurring bioactive piperidines.11c,73 
These natural products were constructed via a transcyanation reaction starting from 
ω-bromoaldehyde 39b, cyanohydrin 38c and PaHNL to give the desired (R)-cyanohydrin 
38b, which was used as precursor for the synthesis of (S)-2-aminomethylpiperidine (42), 
(S)-pipecolic acid (32) and (R)-coniine (33, Scheme 11). Diamine 42 was subsequently ap-
plied as a ligand in asymmetric catalysis.74 The construction of piperidines 32 and 33 with 
HNL is an alternative to the acylase from the Aspergillus species mentioned previously 
(Section 1.2.3).
Br H
O Pr
Br CN
OHH
(R)-38b 
83%, e.e. 92%
(S)-38c
81%, e.e. 95%
N
H
NH2 N
H
N
H
CO2H
33 : (R)-coniine32 : (S)-pipecolic acid
CNHO
+
Pr
CNHO
+
38c39b
1) Tf2O, pyridine, DCM, 98%
2) BnNH2, DCM, -65 °C
3) Et3N, DCM, RT
    73% over 3 steps
N CN
Bn
41
42
PaHNL
H2O/DIPE 9:1
pH 5.5, RT, 24 h
Scheme 11 — Synthesis of naturally occurring piperidines with PaHNL.
PaHNL was also applied in the synthesis of the biologically active iminosugars l-altro-
1-deoxynojirimycin (45a), d-allo-1-deoxynojirimycin (45b) and d-galacto-1-deoxynojiri-
mycin (45c, Scheme 12).75 The first two iminosugars possess moderate inhibitory effects 
on the α-glucosidase enzyme of different organisms, while piperidine 45c inhibits 
multiple enzymes.76 The synthesis of these iminosugars started from crotonaldehyde 
(39d), which was treated with a crude extract from almonds containing PaHNL to give 
TBS-protected cyanohydrin 38d after silyl protection.75 Subsequent DIBAL-H reduction 
and transimination, followed by sodium borohydride reduction afforded amine 43 in 
high yield. Boc-protection of the amine and RCM with the Grubbs-I catalyst, followed 
by Upjohn dihydroxylation77 resulted in compounds 44a–c, after which deprotection 
produced iminosugars 45a–c.
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1) PaHNL, HCN
    EtOAc, 4 °C, 14 h
    pH 5.5, 
2) TBSCl, DMAP, Im
    DCM, 0 °C
    74% over 2 steps
H
O
CN
OTBS
NH
OTBDPS
OBn43
1) Boc2O
2) Grubbs I
3) K2OsO4, NMO 
    H2O, THF, RT, 48h
    84% over 2 steps
N
OH
OBn
HO
HO NH·HCl
OH
OH
HO
HO
NH2
OBn
1) DIBALH, -78 °C
2) MeOH, -90 °C
3) (R/S)-A, RT, 18 h
4) NaBH4, 0 °C, 4 h
    78-80% over 4 steps
39d 38d
Boc
1) TBAF, THF, RT, 18 h
2) H2, Pd/C, 6 M HCl
    MeOH, RT, 18 h
    81% over 2 steps
NH·HCl
OH
OH
45a
HO
HO NH·HCl
OH
OH
45b
HO
HO NH·HCl
OH
OH
45c
HO
HO
44 45
A
*
Scheme 12 — Synthesis of iminosugars 45a–c via a chemoenzymatic strategy involving HNL.
In order to reach the opposite stereochemistry, HbHNL was used extensively by Rutjes 
et al. in the synthesis of the natural products (+)-epiquinamide78 (48, Scheme 13) and 
(+)-febrifugine79 (49). Alkaloid 48 was isolated from the Ecuadorian poison frog Epipe-
dobates tricolor in 2003.80 Shortly after its isolation conflicting reports were published 
about its ability to mimic the function of nicotine.81 Further research on the activity of 
epiquinamide demonstrated that contamination with traces of the alkaloid epibatidine 
caused the actual activity.82 Alkaloid 49 was obtained in 1946 for the first time from Di-
chroa febrifuga83 and later from the more abundant Hydrangea umbellate84 and showed 
potent antimalarial activity.85 In 1999, epimers of alkaloid 49 were obtained, which led to 
the unambiguous assignment of all chiral centers.86 With this achievement the develop-
ment of other synthetic pathways was stimulated, unfortunately, side effects have ham-
pered clinical trials so far.8b,86,87 Key step in the synthesis of both natural products is the 
treatment of methyl-4-oxobutyrate (39e) under acidic conditions with HbHNL, followed 
by TBS-protection of the hydroxyl group to produce 38e in excellent yield and e.e.88 
Subsequent reduction and diazotation resulted in the formation of N,O-acetal 46. Using 
N-acyliminium ion chemistry, the allyl chain was introduced leading predominantly to 
cis-isomer 47, which served as a precursor for both alkaloids 48 and 49.
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Scheme 13 — Synthesis of alkaloids 48 and 49 with (S)-HNL.
1.4 — Hydroxylases
Hydroxylases, also known as oxygenases, constitute a class of enzymes that catalyze 
the chemo-, regio- and stereoselective oxygenation of alkanes and many other com-
pounds.89 Among them is Sphingomonas sp. HXN-200 (SPH), which was isolated with 
a trickling bed bioreactor. This enzyme is present in a parent cell line, whose activity 
was appointed to the P450 oxygenase CYP153.89 The employment of SPH allowed the 
transformation of various non-activated molecules into their corresponding hydroxyl-
ated descendants,89 among which a few piperidine derivatives.90 The first application of 
SPH was the regioselective transformation of N-protected piperidine 50 into alcohol 51 
(Scheme 14, a). Unfortunately, this approach did not result in a chiral compound. In route 
b a diastereoselective dihydroxylation was carried out with the same cell lysate, starting 
from N-protected 1,2,5,6-tetrahydropyridine 52 affording almost exclusively the (3R,4R)-
enantiomer 54 via the racemic epoxide intermediate 53.90b Scaffold 54 was also prepared 
with hydrolases as demonstrated in Section 1.2.
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Scheme 14 — Hydroxylation of N-protected piperidine derivatives 51 and 54.
1.5 — Nitrilases
Nitrilases and nitrile hydratases are enzymes that transform aromatic and aliphatic nitriles 
into the corresponding acids and amides, respectively, in a chemo- and enantioselective 
fashion.91,92 In the synthesis of piperidines, the reactivity of a nitrilase present in Rhodococ-
cus erythropolis NCIMB 1154093 was demonstrated by Rutjes et al. in an enantioselective 
synthesis of 4-hydroxypiperidone (57, Scheme 15).67 Nucleophilic attack of cyanide onto 
racemic epichlorohydrin (55) resulted in a prochiral dicyanide, which was O-protected 
with a benzyl group. Enantioselective monohydrolysis with Rhodococcus erythropolis 
NCIMB 11540 resulted in mono acid 56. Esterification and reduction finally led to enan-
tiopure lactam 57, which can be transformed into a plethora of other druglike building 
blocks via well-established chemistry.67
OBn
NC CO2H
O Cl
5755 56
N
H
OH
O
1) CH2N2, 
    EtOH, Et2O
2) CoCl2, NaBH4
    MeOH, -10 °C 
3) H2, Pd/C, MeOH
    73% over 3 steps
    75-96% e.e.
1) NaCN, MgSO4
    H2O, -10 °C, 43%
2) BnBr, NaH, THF
3) R. erythropolis NCIMB 11540
    0.1 M KH2PO4/K2HPO4
    pH 7, 30 °C
Scheme 15 — Chemoenzymatic synthesis of hydroxypiperidone 57.
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1.6 — Aldolases
Aldolases are widely abundant in many organisms and involved in the degradation of 
carbohydrates.94 For synthetic purposes, especially the synthesis of sugar-mimicking 
polyhydoxylated piperidines, aldolases are a useful tool. These so-called ‘iminosugars’ for 
are defined as cyclic sugar derivatives in which the ring oxygen atom has been replaced 
by nitrogen.95 Iminosugars are potent glucosidase and glycosyltransferase inhibitors and 
therefore may have potent pharmaceutical applications. Furthermore, they are useful 
probes in mechanistic studies of the glycosidase and glycosyltransferase pathway.96 
Aldolases facilitate the stereospecific cleavage of a carbon-carbon bond via a retro aldol 
reaction. In Nature, β-hydroxy carbonyl adducts undergo this reaction in which amino 
acids and carbohydrates are degraded to primary and secondary metabolites.97a These 
enzymes can be classified in different ways for example by analysis of the activation 
mechanism: class I aldolases form an enamine with the substrate, while class II aldolases 
activate the substrate with a Lewis acid.97 This mechanism will be discussed in more detail 
in Chapter 2. Another way to distinguish between the different aldolases is by the sub-
strate specificity. The enzymes that are most commonly used are dihydroxyacetone phos-
phate (DHAP)-dependent aldolases, dihydroxyacetone (DHA)-dependent aldolases, 
(phenyl)pyruvate-dependent aldolases, glycine-dependent threonine aldolases (ThrA) 
and acetaldehyde aldolases.97 For synthetic purposes the reactivity of these enzymes can 
be reversed by tuning the conditions resulting in the aldol adduct for synthetic purposes. 
Because these enzymes operate with high stereoselectivity, they are remarkably useful 
as catalysts in synthetic pathways towards both natural and non-natural carbohydrates 
such as iminosugars.96,97b Nature provided four complementary DHAP-aldolases named 
after the degradation (red bond) of their natural substrate: D-fructose 1,6-biphosphate 
aldolase (58, FruA), D-tagatose 1,6-biphosphate aldolase (59, TagA), L-rhamnulose 
1-phosphate aldolase (60, RhuA) and L-fuculose 1-phosphate aldolase (61, FucA, Figure 
2).
OPO32-
O
OPO32-
O
OPO32-
O
OPO32-
O
OH OH
OH
OH
OHOH
OH
OH OH
OH
OH
OH
O32-PO O32-PO
Fru aldolase
D-fructose 1,6-biphosphate, 58
Rhu aldolase
L-rhamnulose 1-phosphate, 60
Tag aldolase
D-tagatose 1,6-biphosphate, 59
Fuc aldolase
L-fuculose 1-phosphate, 61
R H
O
O
OH OPO32-
+
DHAP
Figure 2 — The four stereocomplementary DHAP-dependent aldolases and their natural substrates.
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One extensively investigated iminosugar is d-fagomine (65) and its epimers 66–68 
(Scheme 16), which was accessible via catalysis by different DHAP-dependant aldolases. 
Naturally occurring iminosugar d-fagomine (65) was isolated for the first time from seeds 
of Fagopyrum esculentum and its pharmacochemical potential is significant. D-Fagomine 
inhibits several enzymes that are important in the mammalian glucose level-regulation. 
The N-alkyl derivatives of 65 have also been synthesized and showed interesting biologi-
cal activity.98,99 Chemoenzymatic syntheses of iminosugars 65–68 started with an aldol 
condensation of N-Cbz-aminopropanal 62 and DHAP in the presence of FruA rabbit 
muscle aldolase (RAMA), which provided the stereochemistry of the natural compound 
65 and epimer 66 in a 84:16 ratio after dephosphorylation and hydrogenation.100 The 
other epimers were synthesized with RhuA and resulted in compounds 67 and 68.101
N
H
Cbz H
O
N
H
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OH
OH
O
OH
N
H
Cbz
OH
OH
O
OH
N
H
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OH
HO N
H
HO
OH
HO
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HO N
H
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65
67 68
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H2, Pd/C
MeOH
62
63
1) RAMA (12 U/mL)
    DHAP (120 mM)
    DMF/water 1:4 
    25 °C, 7 h
2) phytase, pH 4, 69%
1) RhuA (1 U/mL) 
    DHAP (100 mM) 
    
    DMF/water 1:4, 
    25 °C, 7 h
2) phytase, pH 4, 40%
H2, Pd/C
MeOH
64
76:24
86:14
Scheme 16 — Synthesis of D-fagomine and its epimers via an aldolase catalyzed reaction.
Drawback of this approach was the use of DHAP, which is an unstable and reactive 
compound.102 In 2001, d-fructose-6-phosphate aldolase (FSA) was isolated from E. coli,103 
and this enzyme was able to accept the non-phosphorylated donor DHA. This enzyme 
provided an excellent alternative to circumvent the use of DHAP in the synthesis of D-
fagomine (65). The alternative route also reduced the synthetic strategy by one step, since 
dephosphorylation was no longer required.102 Besides DHA, other donor aldehydes and 
ketones were accepted to construct a number of other biologically active molecules, for 
example nor-fucodeoxynojirimycin (71a) and its epimer 71b (Scheme 17, route a). The 
former inhibits the α-l-fucosidase enzyme at low μm levels104 and epimer 71b was isolated 
from the plant Eupatorium fortunei.105 The synthesis of both compounds consisted of an 
FSA-catalyzed aldol reaction between aldehyde 69 and donor glycoaldehyde to produce 
the desired aldol products 70, which upon hydrogenation gave iminosugars 71.106 With 
FSA syntheses of 1-deoxynojirimycin (DNJ, 73b) and its epimer 1-deoxymannojirimycin 
(DMJ, 73a) were also readily realized (route b). These iminosugars widely abundant in 
Nature have range of activities,98b,107 including inhibiting a range of glycosidases.108,109 For 
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instance iminosugar 73b is an effective inhibitor of human α-glucosidase and its N-EtOH 
derivative is commercially marketed as Miglitol (2), a drug for Gaucher’s disease, which 
will be discussed in more detail in Section 4.1.109,110 DMJ (73a) also exhibits inhibitory ef-
fects against an α-l-fucosidase in the low μm range.109 Clapés et al. developed route b 
towards iminosugar 73 via an aldol reaction of racemic aldehyde 69 and DHA in the pres-
ence of FSA. Subsequent hydrogenation and separation of both isomers resulted in the 
desired iminosugars in moderate to good yield.11d Derivatives of 73 were synthesized with 
FSA by Wong et al. using analogues of both the acceptor aldehydes 74 and donor DHA 
(route c).111 Some of these analogues showed μm range inhibition of various enzymes.111
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Scheme 17 — Synthesis of iminosugars catalyzed by FSA.
1.7 — Outline and purpose of this thesis
Being part of the policy of the Netherlands Organization for Scientific Research (NWO), 
the Integration of Biosynthesis and Organic Synthesis (IBOS) program was set up with the 
aim to create sustainable synthetic strategies that combined both organic chemistry and 
modern biochemistry. Our project focused on using enzyme catalyzed aldol reactions to 
develop novel, sustainable and industrially viable synthetic pathways to versatile enantio-
merically pure heterocyclic building blocks. This project was a collaboration between the 
University of Amsterdam (UvA), Wageningen University (WUR), Radboud University (RU) 
and the industrial partners DSM (Geleen, The Netherlands), MSD (Oss, The Netherlands) 
and Syncom (Groningen, The Netherlands). Key element in these aldol reactions was the 
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chemoenzymatic generation of DHAP, which in combination with stereocomplementary 
aldolases would provide access to all four diastereoisomers of the aldol product. Our aim 
was to establish the scope and limitations of these strategies and use the carbohydrate 
structures for the synthesis of functionalized heterocyclic building blocks.
To gain more insight in the mechanistic properties of RAMA, computational studies 
were performed, which are described in detail in Chapter 2. In Chapter 3 an alterna-
tive route to DHAP is presented, proceeding via in situ generation from glycerol in a 
cascade reaction with a total of four enzymes in one pot. Our goal was to synthesize 
industrially relevant heterocycles and Chapter 4 includes optimization of the synthesis of 
D-fagomine and DNJ, as well as derivatization of DNJ into several fluorinated analogues. 
Application of the one-pot four enzyme cascade approach towards a synthesis of the 
naturally occurring iminosugar batzellaside is discussed in detail in Chapter 5. Besides 
the synthesis of piperidines, Chapter 6 describes a chemoenzymatic synthesis of az-
epanes, seven-membered ring iminosugars. Finally, Chapter 7 provides a perspective on 
the current issues of integrating biocatalysis with organic synthesis.
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Rabbit muscle aldolase: 
computational studies and 
experimental verifi cation
Lieke J. C. van Hemert, Alexander J. J. Groenen, Luuk J. A. Wilders, Lara Babich, Ron 
Wever, Sander Nabuurs, and Floris P. J. T. Rutjes, Expanding the scope of one-pot 
four-enzyme cascade aldol reactions, manuscript in preparation.
“Life is really simple, but we insist on making it complicated.”
 -Confucius
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Abstract
Due to its excellent stereoselectivity and the acceptance of a broad range of aldehydes, 
rabbit muscle aldolase is a useful biocatalyst in the synthesis of enantiopure multifunc-
tional molecules via C-C bond formation. This study was focused on computationally 
determining the scope of aldehydes that are accepted and the structural factors that 
influence the reaction rate of RAMA catalyzed aldol reactions. The findings were verified 
in an experimental assay. From these results we concluded that the phosphate group 
in the natural substrate D-glyceraldehyde-3-phosphate contributes most to the relative 
reaction rate (Vrel). A nitro or carboxylic acid group on the phosphate position had the 
same accelerating effect. Whereas the computational studies on the α-hydroxy group in 
the natural substrate revealed that this caused steric interactions with the enzyme and 
the experimental verification demonstrated a lowered Vrel. On the other hand, a strong 
electron-withdrawing atom on the α-position of the aldehyde greatly accelerated the 
reaction.
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2.1 — Introduction
Dihydroxyacetone phosphate (DHAP)-dependent aldolases are useful enzymes for 
stereoselective carbon-carbon bond formation.1 This proceeds through a reversible aldol 
reaction, which more generally is a powerful reaction for the synthesis of enantiopure 
multifunctional molecules.1,2 In Nature, these aldolases catalyze the retro-aldol reaction 
of carbohydrates (1) into aldehydes 2 and DHAP (3, Scheme 1) as key element of the 
glycolysis.3
R
O
H
O
OPO32-
O
R
OH
OH
OH OH
aldolase
R = Me or CH2OPO32-
1 2 3
OH OPO32-
* * *
Scheme 1 — General reaction catalyzed by aldolases in vivo.
In the synthetic sense, aldolases catalyze the aldol reaction between the nucleophilic do-
nor DHAP (3) and an electrophilic aldehyde acceptor (2) and are often applied in the syn-
thesis of carbohydrate derivatives such as iminosugars.1 In 1988, Wong et al. reported the 
synthesis of 1-deoxynojirimycin (DNJ, 4), a potent glycosidase inhibitor, via an enzymatic 
aldol reaction between azidoaldehyde 2a and DHAP (3, Scheme 2).4 The stereochemistry 
of C3 and C4 of tetrahydroxyketone 1a was introduced in the aldol reaction and directed 
by the aldolase, while the C2 chirality was predetermined by the starting material. After 
the aldol reaction and dephosphorylation, the stereochemistry of C5 in the ring (4) was 
introduced via intramolecular reductive amination.
1
2 3 4
5
OH
O
OH
OH
N3
OH
1
2
3
4
5 6
6N3
O
H
OH
2a 1a 4
OH
O
OPO32-
+
3
1. RAMA, pH 6.5
    12 h, RT 
2. phytase, pH 4.8
    16 h, 38 °C
Pd/C, H2
10 h, RT N
H
OH
OHHO
OH
Scheme 2 — Synthesis of DNJ 4 via an aldolase-catalyzed aldol reaction of aldehyde 2a and DHAP 3.
As mentioned in Section 1.6, DHAP-dependent aldolases display excellent stereocontrol 
over the newly created stereocenters C3 and C4.5 Nature provides four complementary 
DHAP-dependent aldolases, which provide access to all four diastereomers (1b–e, Figure 1).
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OPO32-
O
OPO32-
O
OPO32-
O
OPO32-
O
OH OH
OH
OH
OHOH
OH
OH OH
OH
OH
OH
O32-PO O32-PO
Fru aldolase
D-fructose 1,6-biphosphate, 1b
Rhu aldolase
L-rhamnulose 1-phosphate, 1d
Tag aldolase
D-tagatose 1,6-biphosphate, 1c
Fuc aldolase
L-fuculose 1-phosphate, 1e
Figure 1 — The four stereocomplementary DHAP-dependent aldolases and their natural substrates.
These DHAP-dependent aldolases are divided into two classes, based on their catalytic 
mode of action and mechanistic properties. The class I aldolases catalyze the aldol reac-
tion via enamine formation of DHAP with a highly conserved lysine residue in the active 
site (6a, Scheme 3). D-Fructose 1,6-biphosphate aldolase (FruA), such as rabbit muscle 
aldolase (RAMA), belongs to the class I aldolases.6
OPO32-HO
O
HO OPO32-
NHEnz
R H
O
HO OPO32-
OZn
2+Enz
R H
O
R OPO3
2-
O
OH
OH
Class I aldolases
Class II aldolases
3 7
6a
6b
5
5
* *
Scheme 3 — Mechanistic properties of the catalytic center by class I (6a) and II (6b) aldolases.
L-Rhamnulose 1-phosphate- (RhuA), D-tagatose 1,6-biphosphate- (TagA) and L-fuculose 
1-phosphate aldolase (FucA) are class II aldolases and have a divalent metal cation as 
cofactor in the active site, such as Zn2+ or Co2+, which is involved in formation of the cor-
responding enolate (6b, Scheme 3).7 The research in this chapter is focused on RAMA, a 
relatively inexpensive aldolase (€ 0.10/U),8 which accepts a broad range of aldehydes9 
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Scheme 4 — Postulated mechanism of RAMA with induced fit by Tyr363.
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with excellent stereoselectivities.10 RAMA consists of 363 amino acids and has a molecu-
lar weight of approximately 60 kDa. A RAMA-catalyzed aldol reaction between DHAP (3) 
and aldehyde 5 results mainly in D-threo (3R,4S) stereochemistry. The mechanism was 
studied comprehensively and in 2007 a high resolution crystal structure with the natural 
substrate was analyzed (PDB entry 2QUU)11 from which a mechanism could be postulated 
(Scheme 4). One of the interesting results was the role of the Tyr363 at the C-terminus, 
which acted as a proton acceptor in the active site and caused a structural change in the 
active site of the enzyme (induced fi t, step e).12 Initially, DHAP (3, steps a–c) becomes 
covalently bound to the enzyme via imine formation between Lys229 and the carbonyl 
group of DHAP, assisted by Glu187, Glu189, Lys146 and two water molecules. This step is fol-
lowed by formation of the enamine through deprotonation of C3 by the C-terminal Tyr363 
phenolate (steps d–f ). D-Glyceraldehyde-3-phosphate (D-G-3-P, 2b) replaced Tyr363 and 
the enamine attacks the carbonyl of the aldehyde to form the two new chiral centers 
(steps g–h). Upon hydrolysis, D-fructose-1,6-bisphosphate (FBP, 1b) is released from the 
active site.
O
H
R
R OPO3
2-
O
OH
OH
OPO32-RHN
H
HO
H
B
RAMA
Si
Si
65
4
3
6543
5
7OH
H
R
OPO32-O
H
HO
Figure 2 — Crucial step demonstrating the formation of chiral centers C3 and C4 based on PDB 
entry 1ZAI, with DHAP (green) and 2-hydroxybutanal (orange, R = C(OH)Et). The yellow dotted lines 
indicate hydrogen bonds.
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Figure 2 demonstrates the crucial step in which the formation of two new stereocenters 
occurs (step h).13 The Si-face of C4 from the activated imine is exposed to the solvent, 
therefore the aldehyde can only approach the enamine from this direction. The aldehyde 
is only able to fit in the active site with the Si-face towards the enamine (Figure 2), while 
the carbonyl group from the aldehyde forms two hydrogen-bonds with Glu187 and Lys146 
(step h and Figure 2).12 The aldehyde is attacked by the activated enamine from the Si-face 
(C3), which results in the formation of the (3R,4S)-product. Attack on the Re-face by a 180° 
turn of the aldehyde is sterically unfavored.
RAMA is restrictive concerning the nucleophilic donor DHAP, since all functional groups 
play an important role in the mechanism and binding to RAMA.12 A few analogs of 
DHAP have been reported, but were poorly accepted (Figure 3). The first example had 
an extra methylene group on the C6 position, while also substitution of the C6 oxygen 
by sulfur or a methylene group yielded poor substrates for RAMA.9 Replacement of the 
C4 hydroxy group by a halogen resulted in inhibition of the enzyme. Recently however, 
fluorohydroxyacetone phosphate (FHAP) was used as a donor substrate for RAMA and 
aldol product formation was observed, but low yields (7%) were obtained due to poor 
acceptance.14 FHAP is missing a hydrogen bond acceptor, which supposedly is crucial for 
catalysis so that this donor showed a dramatic lowering in reaction rate (Vrel).
O
O
H H
P
O
OOHO
H H
O CH2 or S : poor substrate
NH  : unstable
PO32- H or SO3
- : no substrate
OPO32- PO3H2 : no substrate
H Me : poor substrate
H Me : no substrate
C(3)H2 NH : inhibitor
OH H, CH3, N3 or NHAc : no substrates
I, Br, Cl : inhibitor
F : poor substrate
Figure 3 — Various analogues of DHAP tested with RAMA.
In contrast to DHAP derivatives, RAMA has a broad scope for acceptor aldehydes, and 
over a hundred aldehydes have been reported as substrates for RAMA.9,15 Little is known 
about the reaction rate and the influence of the interactions of D-G-3-P with the enzyme 
(2b and Figure 4, orange). Investigation of these interactions by computational studies 
and experimental verification would reveal insight in which factors influence the Vrel in 
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the product formation catalyzed by RAMA and could lead to predicting new classes of 
acceptor aldehydes.
Figure 4 — FBP in the active site of RAMA based on PDB entry 1ZAI.
The phosphate pocket of the aldehyde is marked by a yellow oval.
In 1989 several trends in Vrel were reported by Whitesides et al.
9 The general trend ob-
served was a decrease in reaction rate with extended chain lengths. However, the natural 
substrate D-G-3-P (2b) appeared an exception to this rule. With a bulky phosphate-group 
and α-hydroxy group, it showed a Vrel comparable with the much smaller propionalde-
hyde. These predictions were based on experimental results, since no crystal structure 
was available at that time. The purpose of these computational studies was to explore 
the structure activity relationship (SAR) of D-G-3-P with RAMA based on the increase or 
decrease of Vrel with various aldehydes using computational studies and experimental 
verifi cation hereof, which would give insight in the prediction of Vrel based on the substi-
tution on the aldehyde (Figure 5).
H
OH
O
OH hydrogen bond interactions
      or steric hindrance?
NO2
O P
O
O O H
Me     alpha substitution allowed?
Cl/Cl2 effect of EWG on alpha-position?
Effect of gamma-substitution:
interactions with phosphate pocket
or induced effect over four bonds 
or hydrogen bond interactions?
Figure 5 — Structure activity relationship (SAR) of D-G-3-P (2b)
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2.2 — Results and discussion
2.2.1 — Computational studies
The computational studies were performed with PDB11 entry 1ZAI in Yasara16,17 and docking 
software MOE18 to predict the substrate specificity of RAMA. The aldehydes reported in 
the experimental results of the Whitesides group were also calculated.9 Most aldehydes 
were found to fit in the active site, except for the multiple branched α-carbons, such as 
pivaldehyde and 2,2,2-trichloroacetaldehyde (both not shown). These aldehydes caused 
too many steric interactions and thus did not fit into the active site of RAMA according to 
these calculations. Previous studies revealed that Vrel was not only influenced by the sta-
bilizing effects of functional groups, such as phosphate in the natural substrate, but also 
by the electrophilicity of the carbonyl group.19 An electron-withdrawing group (EWG) at-
tached to the α-carbon showed a dramatic increase in Vrel.
9 Similar results were reported 
for an EWG on the γ-carbon, which was explained as an inductive activating effect over 
four bonds. As shown in Figure 4, the phosphate group of the natural substrate has also 
stabilizing interactions with the enzyme. However, up till now it is not known whether 
the increase in Vrel was caused by electron-withdrawing properties or the interactions 
with the phosphate pocket and the enzyme. To gain more insight in the factors affecting 
Vrel three sets of aldehydes were studied with a model based on PDB entry 1ZAI (Figure 6, 
sets A–C).11 These aldehydes were modeled after natural substrate 2b and investigated to 
predict the effect of the substitution on the Vrel. The first set (A) gave insight in the effect 
of hydrogen bonding of the α- and γ-substituent, as well as the effect of the interactions 
of the phosphate group with the enzyme (5a–d, 2b). The substitutions with an expected 
positive effect on Vrel are shown in green and with an expected negative effect in red. 
The second set (B) was designed to predict the influence of EWGs at the β- or γ-position 
(5e–g) and to prove the existence of negatively charged interactions with the phosphate 
pocket of the enzyme. The γ-substitution of aldehydes 5e (-NO2) and 5g (-CO2
-) resemble 
the phosphate group in the natural substrate and these analogues should be able to 
interact via hydrogen bond interactions with the enzyme, whereas aldehyde 5g, being 
one carbon shorter, should not be able to form these hydrogen bonds. The last set (C) 
was designed to reveal the influence of multiple EWGs attached on the α-position (5i–h).
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Figure 6 — Sets of aldehydes based on natural substrate 2b.
To our surprise, the α-hydroxyl group of D-G-3-P (2b) did not show any hydrogen bond 
interactions with the enzyme, which led us to conclude that this group did not contribute 
in stabilizing the substrate in the active site and thus should not accelerate Vrel. On the 
other hand longer chain lengths without α-branching fitted nicely, especially aldehydes 
bearing a negatively charged group, such as a phosphate group on de γ-position. Energy 
minimization with Yasara17b showed that other reactive groups with hydrogen bond ac-
cepting properties or (partial) negative charges, such as nitro or carboxylic acid groups, 
could occupy the phosphate pocket as well. These groups showed hydrogen bonds 
with the residues of the phosphate pocket, mimicking the phosphate group of natural 
substrate 2b and hence were expected to have a positive influence on Vrel. If this effect 
would cause the relative rate to increase, a comparison between 4-oxobutanoic acid (5g) 
and 5-oxopentanoic acid (5f) should demonstrate this with a higher Vrel for 5f. In case 
of aldehyde 5f, the negatively charged oxygen was positioned at a comparable loca-
tion as the negative charge of the phosphate group in natural substrate 2b (Figure 4). 
According to the prediction based on this model, aldehyde 5g bearing a carboxylic acid 
in the β-position would not be able to access the phosphate pocket of the active site. The 
distance to both Ser35 and Ser38 was >4Å and thus this aldehyde could not form hydrogen 
bonds with the phosphate pocket. Since these calculations cannot be used to produce 
an accurate Vrel, the three sets of aldehydes were experimentally evaluated.
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2.2.2 — Experimental verification
Most aldehydes were purchased as pure compounds, in solution or protected as dimethyl 
acetal. Lactaldehyde (5c) and 4-nitrobutanal (5e) were synthesized via a straightforward 
approach by reducing the corresponding ketone and ester, respectively. The acetal-
protected aldehydes were deprotected in situ prior to the assay, to prevent degradation 
or side reactions.
HO OPO32-
O
R H
O RAMA OPO32-
O
R
OH
OH
NADH
NAD+
HO OPO32-
OH
5
7
3
8
GPDH
Scheme 5 — RAMA activity test design with NADH as reducing agent.
The DHAP consumption was analyzed by measuring the decrease of DHAP indirectly, 
using a coupled assay with glycerol-3-phosphate dehydrogenase (GPHD) and NADH 
in which DHAP was converted into glycerol-3-phosphate (8, Scheme 5).20 The reaction 
mixture contained 50 mM DHAP (3), 100 mM aldehyde 5, acetate buffer pH 6 and 1 U/mL 
RAMA and the assay mixture consisted of 1 U/mL GPDH, 0.16 mM NADH and tris/acetate 
buffer pH 7.5. Every 10 minutes (3-5 times), a diluted 10 μL sample was added to the assay 
mixture and reacted for 3 minutes, followed by the recording of absorbance at 340 nm. 
Unfortunately, this assay revealed an initial concentration of 25 mM DHAP instead of 
the added 50 mM and in addition the obtained results were remarkably irreproducible. 
Therefore a new assay was designed, based on the actual DHAP consumption, measured 
via HPLC using UV detection at 254 nm. The relative rate (Vrel) was based on the amount 
of DHAP consumed in time in a 0.5 mL reaction mixture containing 2 U/mL RAMA, 50 
mM DHAP (3) and 100 mM aldehyde 5 at pH 6 and 20 °C. The course of the reaction was 
directly analyzed by HPLC, based on the decrease of the peak area of DHAP. All tests 
were performed in triplo.
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Table 1 — Relative reactivities of aldehydes with DHAP (3)
HO
OH
OH R
OH
OH
OH
O100 mM of RCHO
500 mM glycerol, 250 mM PPi
6 U/mL RAMA, PhoN-Sf, GPO
10 U/mL catalase, 20 mM acetate
pH 6, 30 °C, 24 h2 1a-b
Entry Set Aldehyde R Vrel Vrel reported
b, 9
1 A 5a -Et 100 ± 7 100
2 A 5b -CHMe2 41 ± 4 18
3 A 5c -CH(OH)Me 30 ± 2 9.5
4 A 5d -CH(OH)CH2OH 25 ± 8 32
5 A 2b -CH(OH)CH2OPO3
2- n.d.a 95
6 B 5e -C3H7NO2 234 ± 28 162
7 B 5f -C3H7CO2
- 133 ± 21 n.d.
8 B 5g -C2H5CO2
- 0 n.d.
9 C 5h -CH2Cl n.d. 323
10 C 5i -CHCl2 24 ± 14 n.d.
aMeasurement of the reaction rate was not possible in this setup, due to overlap on HPLC. b) The 
previously reported Vrel was obtained with the indirect DHAP assay depicted in Scheme 5, which could 
explain the differences with the measured Vrel.
A logical standard for Vrel would be D-G-3-P (2b), however, this aldehyde had a similar 
retention time as DHAP and also showed absorbance at 254 nm. Fortunately, propanal 
(5a) had a reaction rate comparable with D-G-3-P9 and was set at a Vrel of 100 (Table 1, en-
try 1). Substitution on the α-position with a methyl group showed a decrease in Vrel (entry 
2), which was in accordance with the computational predictions, as this caused steric 
interference with the enzyme. This was also demonstrated by a hydroxyl group on the 
α-position (entry 3). Instead of the expected hydrogen bonding with the enzyme, which 
should result in a higher Vrel as demonstrated by the computational studies, the effect of 
steric hindrance was more dominant and caused the Vrel to drop. Computational studies 
revealed that the oxygen of the carbonyl group could form hydrogen bonds with Glu187 
and Lys146. Glu187 was also the hydrogen-donor in the aldol condensation. The α-hydroxyl 
group was not involved in direct hydrogen bonding with the enzyme and a lower Vrel 
was observed (entry 4). RAMA also did not show any stereoselectivity towards the C3-
hydroxy group so that the formation of two diastereoisomers was observed, which is in 
accordance with previously reported results.21 This outcome led us to conclude that the 
phosphate group on the γ-position causes the increase in relative rate due to stabilizing 
interactions in the phosphate pocket of the enzyme (entry 5). The twofold negatively 
charged phosphate group of D-G-3-P (2b) had electrostatic interactions with the posi-
tively charged residues Arg148 and Lys107 and also the two hydrogen bonds with Ser35 and 
Ser38 are shown in the crystal structure (Figure 3). Although no Vrel for aldehyde 2b could 
be derived with this design, based on these results and earlier work, the phosphate group 
seemed responsible for the largest share in reactivity. We envisioned that replacement of 
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the phosphate group by a nitro or carboxylic acid group might have the same accelerat-
ing effect. 4-Nitrobutanal (5e, entry 6) showed a dramatic increase of Vrel with respect to 
2b, which is in accordance with the predictions made, but could also be explained via the 
inductive effect hypothesis mentioned by Whitesides et al.9
The effect of a carboxylic acid group on the γ-position was less dramatic (entry 7) and 
surprisingly the smaller 4-oxobutanoic acid did not show any activity (5g, entry 8), indi-
cating it was not accepted by RAMA. According to the computational studies a negatively 
charged substituent on the γ-position should have a positive effect on the Vrel due to 
interactions with the phosphate pocket of the enzyme. Whereas a negatively charged 
substituent on the β-position should not show the same effect as it could not interact with 
the phosphate pocket, however we did not expect to observe a Vrel of 0. 
1H-NMR analysis 
of the aldehyde in D2O, revealed that less than 5% of the substrate was in the aldehyde 
form and that it mainly occurred in the cyclized form (9, scheme 6).
O
H
O
OH O
OH
O
5g 9
Scheme 6 — 4-oxobutanoic acid (5) in linear and ring-closed form (9).
As demonstrated by aldehydes 5b and 5c, α-branching reduced the reactivity due 
to steric hindrance, which was also demonstrated in the computational studies with 
pivaldehyde.9 On the other hand Clapés et al. showed that large N-amino protecting 
groups, such as Fmoc or Cbz, on the α-position have no reasonable effect on the conver-
sion rates.10 It was also known that 2-chloroacetaldehyde (5h), bearing an EWG at the 
α-carbon showed the highest Vrel (entry 9), but 2,2,2-trichloroacetaldehyde showed no 
reactivity due to steric hindrance. The effect of two EWGs attached to the α-carbon could 
have a positive effect on the relative rate. To verify this effect 2,2,-dichloroacetaldehyde 
(5i, entry 10) was tested as well, which demonstrated a lower Vrel, thus the steric effect had 
a stronger influence than the electron-withdrawing effect. Moreover, when the relative 
rate of aldehyde 5i was compared with 5b and 5c, the decrease was remarkably high. 
Possibly the carbonyl group of aldehyde 5i was predominantly present in the hydrate 
form, which made the aldehyde less susceptible to nucleophilic attack of DHAP and 
thus could explain the lower reaction rate. 1H-NMR analysis in D2O, however, indicated 
that >80% was in the aldehyde form, perhaps the slightly acidic reaction conditions were 
enough to cause hydration of the aldehyde. A summary of the computational studies and 
the experimental verification is shown in Figure 7.
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H
OH
O
A small EWG on the alpha position is allowed and beneficial for the Vrel.
O P
O
O O
A hydrogen bond acceptor on the gamma position 
greatly benefits the Vrel.
Generally alpha substitution lowers the Vrel.
Figure 7 — SAR conclusions based on computational studies and experimental verification of D-G-3-P (2b)
2.3 — Conclusions
We have used computational studies in order to be able to predict which parameters 
influence the relative reaction rate in the aldol reaction catalyzed by RAMA. These pre-
dictions were verified in an experimental setup. From the resulting data we concluded 
that α-branching on the aldehyde resulted in a lower Vrel, which is in accordance with 
previously reported results.9 A small EWG on the α-carbon however resulted in a higher 
Vrel due to enhancing the electrophilicity of the carbonyl group. Unfortunately double 
substitution with an EWG at the α-carbon lowered the Vrel, probably caused by steric 
hindrance or hydration of the carbonyl group. These results led us to conclude that the 
high Vrel of D-G-3-P (2b) was caused by the stabilizing effect of the phosphate group on 
the γ-position of the aldehyde with the phosphate pocket of the enzyme. This effect was 
also demonstrated by nitro- and carboxylic acid groups. According to the computational 
studies, these groups could mimic the hydrogen bond interactions with the enzyme. This 
was also demonstrated in the experimental verification as both aldehydes showed an 
increased Vrel. When designing a substrate, it is beneficial for the reaction rate to attach a 
small EWG at the α-position and a negatively charged group or hydrogen bond acceptor 
at the γ-position.
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2.5 — Experimental
2.5.1 — General
Reactions were followed using thin layer chromatography (TLC) on silica gel–coated 
plates (Merck 60 F254) with the indicated solvent mixture. Detection was performed 
with UV-light, and/or by charring at ~150 °C after dipping into a solution of KMnO4. Flash 
column chromatography was carried out using ACROS silica gel (0.035–0.070 mm, and 
ca 6 nm pore diameter). IR spectra were recorded on an ATI Mattson Genesis Series FTIR 
spectrometer or a Bruker Tensor 27 FTIR spectrometer. Optical rotations were determined 
with a Perkin Elmer 241 polarimeter.
NMR spectra were recorded on a Bruker DMX 300 (300 MHz), a Varian 400 (400 MHz) 
and a Bruker Avance III 500MHz System (500 MHz) spectrometer in CDCl3 or CD3OD 
solutions (unless otherwise reported). Chemical shifts are given in ppm with respect to tetra-
methylsilane (TMS) as internal standard. Coupling constants are reported as J–values in Hz.
High resolution mass spectra were recorded on a JEOL AccuTOF (ESI), or a MAT900 
(EI, CI, and ESI). Fast Atom Bombardment (FAB) mass spectrometry was carried out using 
a JEOL JMS SX/SX 102A four-sector mass spectrometer coupled to a JEOL MS-MP9021D/
UPD system program.
2.5.2 — Molecular modeling of the (R)-2-hydroxypropanal-RAMA complex
The molecular model of (R)-2-hydroxypropanal bound to RAMA was constructed on the 
basis of the crystal structure of a RAMA-fructose 1,6-biphosphate complex (PDB entry: 
1ZAI) solved at 1.76 Å resolution.12 This structure contained the aldol product. The interac-
tions of the carbonyl oxygen of the aldehyde before aldol condensation were not clear. 
To gain more insight into aldehyde binding in the active site, the carbohydrate product 
was manually changed into DHAP and (R)-2-hydroxypropanal using the Yasara program17 
and finally the resulting complex was minimized in energy using Yasara2 force field.17c,d
2.5.3 — Acetal deprotection
Deprotection of a 0.5 M aldehyde solution was performed in situ with 0.5 M HCl. After 
deprotection the solution was neutralized by 0.5 M NaOH to pH 6. To make a fair com-
parison, NaCl was added to all samples when a deprotection step was not necessary.
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2.5.4 — General procedure for the enzymatic reactions
RAMA-catalyzed reactions were performed at 20 °C in a total volume of 0.5 mL contain-
ing acetate buffer (50 mM, pH 6.0), NaCl (100 mM), DHAP (3, 50 mM) and aldehyde 5 
(100 mM). The reaction was initialized by adding RAMA (2 U/mL) and analyzed by HPLC 
for 15 min.
2.5.5 — HPLC analyses
Samples (20 μL) were directly drawn from the reaction mixture and analyzed on a 
Shimadzu LC 2010 analytical HPLC system equipped with a RP C18 column (Varian, 
Inertsil ODS-3, 5 μm, 150 × 4.6 mm) and eluted with a mixture of acetonitrile/water (1:99) 
containing 0.19% trifluoroacetic acid under isocratic conditions at a flow rate of 1.0 mL 
min-1. The decrease in DHAP concentration was assayed every 2.5 min by following the 
consumption of DHAP based on the peak area using HPLC. The integrals of the DHAP 
peak (at 1.75 min) in time were divided by the integral of the DHAP peak on t = 0, to 
obtain a relative reaction rate (Vrel). The UV absorption was analyzed at 254 nm. All experi-
ments were carried out in triplo.
2.5.6 — 2-Hydroxypropanal dimethyl acetal (5c)
To a solution of 1,1-dimethoxypropan-2-one (11.8 mL, 100 mmol) in 
methanol (50 mL) and THF (50 mL) was added sodium borohydride 
(3.78 g, 100 mmol) in portions over 30 min at 0 °C. The mixture was 
allowed to warm to RT and stirred for an additional 30 min. The reac-
tion mixture was then poured into aqueous saturated NH4Cl (75 mL) 
and the aqueous layer was extracted with Et2O (3 × 100 mL). The combined organic layers 
were concentrated by rotary evaporation. The residue was dissolved in DCM (150 mL), 
washed with brine (50 mL), dried with Na2SO4 and filtered. The solvent was removed 
by rotary evaporation to give diacetal protected 5c as a colorless liquid (11.1 g, 88%). Rf: 
0.38 (heptane:EtOAc 1:1); 1H NMR (400 MHz, CDCl3) δ 4.08 (d, J = 6.5 Hz, 1H), 3.76 (qd, 
J = 6.5, 3.5 Hz, 1H), 3.46 (s, 3H), 2.31 (d, J = 3.5 Hz, 1H), 1.19 (d, J = 6.5 Hz, 3H); 13C NMR (75 
MHz, CDCl3) δ 108.1, 67.6, 55.3, 55.2, 17.3; ʋmax (film) cm
-1 2933. The analytical data were in 
accordance with previously reported results.22
OH
O
O
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2.5.7 — 4-Nitrobutanal (5e)
To a solution of methyl 4-nitrobutanoate (0.40 g, 2.7 mmol) in 
anhydrous DCM (30 mL, -78 °C) was added DIBAL-H (3.0 mL, 3.0 
mmol, 1M solution in hexanes) and stirred for 1.5 hour. The tem-
perature was increased to -40 °C and 10% aqueous potassium sodium tartrate (20 mL) 
was added and stirred for 30 min and warmed to RT. The aqueous layer was extracted 
with Et2O (3 × 50 mL) and the combined organic layers were washed with water (100 mL), 
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by 
column chromatography (heptane:EtOAc 9:1→2:1) to afford 5e (204 mg, 64%) as a yellow 
liquid. Rf: 0.42 (EtOAc:heptane 1:1); 
1H NMR (500 MHz, CDCl3) δ 9.80 (s, 1H), 4.46 (t, J = 
6.6 Hz, 2H), 2.67 (t, J = 6.6 Hz, 2H), 2.31 (q, J = 6.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
199.6, 74.3, 40.0, 19.7; ʋmax (film) cm
-1 2850, 1718, 1550, 1372. The analytical data were in 
accordance with previously reported results.23
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Synthesis of non-natural 
carbohydrates in a one-pot 
four-enzyme cascade reaction
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1 Both authors equally contributed to this work.
“Nature doesn’t hurry, Yet everything is accomplished” 
– Lao Tzu
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Abstract
A simple procedure has been developed for the synthesis of enantio- and diastereomeri-
cally pure carbohydrate fragments from glycerol and a variety of aldehydes in one pot 
using a four-enzyme cascade reaction. This work demonstrates the potential value of 
using enzymes in cascade reactions to selectively form complex products that by pre-
vious traditional organic chemistry could only be obtained via repeated isolation and 
purification of intermediates.
R
OH
OH
O
OH
one-pot four-enzyme catalytic cascade aldol reaction
OH
HO OH R H
O
+
Lieke BW CP v2.indd   56 12-09-12   13:33
57
Synthesis of non-natural carbohydrates in a one-pot four-enzyme cascade reaction
3.1 — Introduction
In the search for efficient, sustainable synthetic strategies, chemists increasingly pursue 
approaches that are inspired by Nature.1 The ultimate goal is to mimic biosynthetic path-
ways and construct complex products via ingenious sequences of multiple enzymatic 
conversions in one pot, preferably proceeding with high chemo- and stereoselectivity.2 
This concept is demonstrated in the synthesis of complex carbohydrate building blocks,3 
which may serve amongst others as intermediates for iminosugars.4 Besides impressive 
achievements in the chemical synthesis of carbohydrate fragments using asymmetric 
catalysis5 and organocatalysis,6 use of aldolases could provide direct stereoselective ac-
cess to carbohydrate structures without going through protecting group manipulations.7 
In order to explore the full potential of existing aldolases in C-C–bond formation, it is 
crucial to have facile access to phosphorylated substrates.8 Dihydroxyacetone phosphate 
(DHAP) is one of the key compounds in aldol condensation using DHAP dependent 
aldolases and the research groups of Whitesides, Wong and Fessner have used several 
enzymatic procedures to arrive at the formation of DHAP starting from glycerol,9 glycer-
olphosphate10 or dihydroxyacetone (DHA).11 These methods have the disadvantage that 
kinases are needed and that regeneration of ATP is required. The group of Sheldon was 
among the first to explore the formation of a heptose sugar using a multi-enzyme system 
in which a phosphorylated intermediate was generated using cheap pyrophosphate (PPi) 
as a phosphate donor and in which the DHAP formed was coupled enzymatically to an 
aldehyde. However, a pH switch was needed to turn off the activity of one of the enzymes 
and also a very high concentration of glycerol (85%) was required.12 The group of Wever 
recently reported the efficient phosphorylation of dihydroxyacetone by the acid phos-
phatase from Shigella flexneri (PhoN-Sf) using PPi as the phosphate source. In addition, it 
was shown that this phosphorylation process could be applied in one pot in combination 
with dihydroxyacetone phosphate (DHAP)-dependent rabbit muscle aldolase (RAMA) 
to give the desired aldol product.13 Motivated by this outcome, we now report a one-pot 
synthesis of chiral carbohydrate fragments 1 by the simultaneous action of four different 
enzymes starting from inexpensive glycerol (2) and an appropriate aldehyde (Scheme 1).
1 2
R
OH
OH
O
OH
one-pot four-enzyme catalytic cascade aldol reaction
OH
HO OH R H
O
+
Scheme 1 — One-pot synthesis of carbohydrate fragments 1.
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The newly envisaged cascade was based on initial conversion of glycerol into glycerol-
1-phosphate,9,12 followed by L-glycerol-1-phosphate oxidase (GPO)-mediated oxidation 
to DHAP. Subsequent RAMA-catalyzed C-C–bond formation and dephosphorylation 
with PhoN-Sf should then give rise to target molecules 1. Having PhoN-Sf available which 
operates at pH 6, we envisioned that we should be able to carry out the glycerol–DHAP 
cascade in a single pot with all enzymes acting simultaneously.13 Furthermore, we show 
that it is possible to obtain all the stereocomplementary products by using the corre-
sponding four DHAP-dependent aldolases present in nature.
3.2 — Results and discussion
The PhoN-Sf-mediated phosphorylation of glycerol (2) with the phosphate donor PPi 
produces glycerol-3-phosphate (3) in a chemoselective manner, due to the known se-
lectivity of PhoN-Sf for primary hydroxy functions (Scheme 2).14 The L-enantiomer is then 
oxidized by GPO in the presence of oxygen to produce DHAP (4).10 The oxidation takes 
place with concomitant formation of hydrogen peroxide, which is converted into water 
and oxygen by a third enzyme, catalase. In the next step of the cascade, DHAP reacts with 
the aldehyde catalyzed by RAMA to provide the phosphorylated aldol product 5. Under 
the reaction conditions, the aldol product is ultimately dephosphorylated by PhoN-Sf 
leading to enantio- en diasteromerically pure triol 1. The resulting enzyme-bound phos-
phate may then be either transferred to water (hydrolysis) or to glycerol (transphosphory-
lation).13 Hydrolysis is generally preferred over transphosphorylation so that phosphate 
(Pi) is released. This essentially irreversible step fortuitously shifts the thermodynamic 
equilibrium of the cascade to aldol product 1 once PPi becomes exhausted.
OHHO
OH
HO OPO32-
OH
PhoN-Sf
GPO
catalase
HO OPO32-
O
R
OH
OH
O
OPO32-
R
OH
OH
O
OH
RCHO
1
2
3
4
5
PhoN-Sf
Pi
Pi
PhoN-Sf
H2O2
O2
H2O
RAMAPhoN-Sf
H2O
PPi
Scheme 2 — Four-enzyme one-pot catalytic cascade.
Lieke BW CP v2.indd   58 12-09-12   13:33
59
Synthesis of non-natural carbohydrates in a one-pot four-enzyme cascade reaction
Supposedly, PhoN-Sf-induced phosphorylation of glycerol gives rise to a racemic mixture 
of D- and L-glycerol-3-phosphate (3). Since GPO would oxidize only the L-enantiomer,10 
the D-isomer might accumulate. However, the acid phosphatase possesses strong trans-
phosphorylation activity13 and most likely PhoN-Sf will transfer the phosphate group from 
D-glycerol-3-phosphate to glycerol resulting in racemic glycerol-3-phosphate so that 
accumulation of the D-isomer will not occur.
Table 1 — Optimization of the four-enzyme cascade.
HO
OH
OH R
OH
OH
OH
O100 mM of RCHO
500 mM glycerol, 250 mM PPi
6 U/mL RAMA, PhoN-Sf, GPO
10 U/mL catalase, 20 mM acetate
pH 6, 30 °C, 24 h2 1a-b
Entry R Product PhoN-Sf
(U/mL)
GPO
(U/mL)
Conv.
(%) a
Reaction time (h)
1 Et 1a 1.5 2 42 24
2 Et 1a 1.5 5 50 24
3 Et 1a 1.5 10 58 24
4 Et 1a 1.5 50 84 24
5 Et 1a 3.0 50 87 8
6 Et 1a 3.0 50 95 b 8
7 Et 1a 3.0 50 100 b,c 8
8 i-Pr 1b 3.0 50 48 8
a) Conversions were based on the aldehyde and determined using HPLC on aliquots of the reaction 
mixture. b) Reaction was performed at 20 °C. c) Reaction was performed in a closed vessel.
The first cascade was conducted at 0.5 mL scale (Table 1, entry 1) with propanal as ac-
ceptor aldehyde.13 A solution of 500 mM glycerol, 250 mM PPi and 100 mM propanal at 
pH 6 was incubated with the four enzymes at 30 °C, resulting in 42% conversion after 24 
h. By HPLC it was possible to monitor at selected time intervals the ratio of PPi to Pi, the 
formation of phosporylated product, dephosphorylated end product, and the amount of 
aldehyde converted (Figure 1). This allowed us to study in detail the effect of changing the 
amount of activity of GPO from 2 U/ml to 50 U/ml in the cascade (entries 2-4). Optimal 
conversion was obtained with 50 U/mL GPO (entry 4).
Encouraged by these results, the effect of changing the activity of the acid phosphatase 
was also investigated. When the activity of PhoN-Sf in the cascade was doubled, within 
8 h a conversion of 87% was reached (entry 5). Changing the activity of GPO or PhoN-Sf 
had no effect on the diastereoselectivity, a d.r. of 14:1 ((3S,4R) vs. (3S,4S)) was observed in 
all cases. Lowering the temperature to 20 °C resulted in 95% conversion and increased 
diastereoselectivity (entry 6, d.r. >30:1). Performing the reaction in a closed vessel for 8 h 
without taking samples led to a conversion of 100% (entry 7). These effects are probably 
due to evaporation of the rather volatile propanal.
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A branched aldehyde was also successfully used as a substrate, albeit that the yield was 
lower compared to propanal (entry 8), which is in line with the aldehyde specificity of 
RAMA.15 The cascade reaction using propanal was also performed on 10 mL scale in the 
presence of 3 U/mL of PhoN-Sf and 50 U/mL of GPO resulting in 87% conversion and an 
isolated yield of 97 mg (65%).Chapter	3	Graphs	
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Figure 2 — Time course of the cascade reaction starting from DHA or glycerol. The reactions were 
carried out with 1.5 U/mL PhoN-Sf, 6 U/mL RAMA, 250 mM PPi, 100 mM propanal and 0.5 M 
glycerol or 0.5 M DHA.
Figure 1 — HPLC chromatograms of propanal cascade at 0 and 10 h, analyzed with RI (above) and 
UV (below).
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Figure 2 shows the time course of the reaction and a comparison between the currently 
described cascade and the previous cascade starting from DHA instead of glycerol.13 It 
is obvious that the glycerol cascade is superior as compared to the DHA one. This may 
relate to the value of Km for glycerol which is 0.7 M, while Km for DHA is 3.6 M.
13 The 
difference in Km thus may represent an important factor for the cascade reaction resulting 
in higher conversions compared to the DHA route. Furthermore, glycerol is known to sta-
bilize most enzymes. The glycerol cascade has the additional advantage that, since DHA 
is prone to oxidation and side reactions,8c significantly fewer by-products are formed.
The effect of the glycerol concentration on the rate of product formation was also 
investigated (Figure 3). A concentration of 0.5 M glycerol was optimal. At 1 M glycerol 
both the rate and the yields were lower. The lower activity at low glycerol concentrations 
probably relates to the Km value of PhoN-Sf for glycerol of about 0.7 M.
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Figure 3 — Effect of glycerol concentration on the yield. 250 mM PPi, 20 mM acetate pH 6, 100 mM 
propanal, 6 U/ml RAMA, 50 U/ml GPO, 10 U/ml catalase, 1 or 3 U/ml of PhoN-Sf.
To probe the broader applicability of the glycerol cascade, the reaction was also carried 
out with three other aldolases in combination with propanal (Table 2). Nature provided 
four stereocomplementary DHAP-dependent aldolases (Scheme 3), each with their own 
substrate specificity. These aldolases accept a broad scope of aldehyde substrates mak-
ing the one-pot four-enzyme cascade a valuable and versatile method towards a plethora 
of stereochemically different aldol products.15,16
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Scheme 3 — The four different DHAP dependent aldolases
Rhamnulose-1-phosphate aldolase (RhuA, entry 2) and fuculose-1-phosphate aldolase 
(FucA, entry 4) gave similar conversions as compared to RAMA (entry 1), although the 
d.r. in both cases was significantly lower. In all cases the enantioselectivity with respect 
to the C3 center was complete, while C4 gave a 2:1 mixture in favor of the anticipated 
diastereoisomer.17
Table 2 — Four-enzyme cascade with four different aldolases and three different aldehydes.
500 mM glycerol, 250 mM PPi
6 U/mL Aldolase, 3 U/mL PhoN-Sf 
50 U/mL GPO, 10 U/mL catalase 
pH 6, 20 °C, 24 h
HN
H
Alloc
O OH
OH
OH
O
12c
(100 mM)
HN
Alloc
13c
3
4
Entry Aldehyde Conversion (%)a Aldolase17 d.r. Configuration17
1 1a propanal 87 RAMA 14:1 (3S,4R):(3S,4S)
2 R = Et 72 RhuA 2:1 (3R,4S):(3R,4R)
3 15 TagA 8:1 (3S,4S):(3S,4R)
4 77 FucA 2:1 (3R,4R):(3R,4S)
5 1b isobutanal 61 RAMA > 20:1 (3S,4R):(3S,4S)
6 R = iPr 25 RhuA 13:1 (3R,4S):(3R,4R)
7 - TagA -
8 16 FucA > 20:1 (3R,4R):(3R,4S)
a) Conversions were based on the aldehyde and determined with HPLC on aliquots of the reaction 
mixture. The diastereoisomeric ratio was determined based upon the peak areas in the HPLC profile 
and the assignments of the stereochemistry on the reported specificity of these aldolases in literature.17
Tagatose-1,6-diphosphate aldolase (TagA) showed higher diastereoselectivity (entry 3), 
but significantly lower conversions, due to the lower activity of the aldolase (entry 3). The 
presence of an isomerase could explain the low activity of the aldolase. The isomerase 
converted DHAP (4) into glyceraldehyde-3-phosphate (6) and the latter underwent an 
aldol reaction with DHAP as well resulting in product 1c which was confirmed with HPLC 
by comparison with reference compound tagatose (1c, Scheme 4). This caused a com-
petition between propanal and glyceraldehyde-3-phosphate in favor of the latter one, 
which is the natural substrate for the enzyme.18
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Scheme 4 — Reaction with an isomerase present in cascade reaction.
3.3 — Conclusion
A convenient procedure was developed for the production of carbohydrates in a highly 
enantio- and diastereoselective manner using an efficient one-pot four-enzyme-catalytic 
cascade. This cascade starts from inexpensive reagents and proceeds without the need 
for protecting groups. The primary step is chemoenzymatic phosphorylation of glycerol 
and subsequent oxidation to the energy rich phosphate ester DHAP at the expense of 
PPi. In the same pot, the formed DHAP is coupled to a variety of aldehydes by DHAP-
dependent aldolases allowing the synthesis of all four possible stereoisomers. Dephos-
phorylation to the final aldol product occurs once PPi is fully consumed.
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3.5 — Experimental
3.5.1 — General information
The general information is described in Section 2.5.1
3.5.2 — Enzymes
RAMA, catalase from bovine liver and GPO from Aerococcus viridans were purchased 
from Sigma Aldrich. GPO from Pediococcus and other microorganisms were also com-
mercially available via Toyobo.
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Recombinant Shigella flexneri acid phosphatase (PhoN-Sf) was expressed in E. coli and 
purified as previously described.19 Recombinant rhamnulose-1-phosphate aldolase from 
the thermophilic organism T. maritima (pBAD/gIII plasmid provided by DSM) was ex-
pressed in E. coli strain TOP10 by inducing with 0.02% L-arabinose overnight at 28 °C. The 
resulting culture broth was centrifuged at 6000 rpm for 15 min at 4 °C and the cells were 
resuspended in 100 mM Bis-Tris pH 6.5, 0.1 mM ZnCl2. Cell disruption was performed by 
sonication followed by centrifugation at 14000 rpm for 30 min at 4 °C. The thermophilic 
enzyme RhuA was isolated from the cell free extract by heat-shock in a 70 °C water bath 
for 20 min, followed by centrifugation at 14000 rpm for 30 min.
Tagatose-1,6-diphosphate aldolase from E. coli (pBAD plasmid supplied by DSM) was 
expressed in E. coli TOP10 cells and induced by 0.02% L-arabinose in the presence of 
0.3 mM ZnCl2. Cells were harvested by centrifugation at 6000 rpm for 15 min and resus-
pended in 20 mM Tris/HCl pH 7.5. Cell disruption was performed by sonication. From 
the cell-free extract, TagA was recovered by 40% ammonium sulfate precipitation and 
centrifugation at 13000 rpm for 30 min. The supernatant containing TagA was dialyzed 
overnight against 20 mM Tris/HCl pH 7.5 and loaded onto HiTrap DEAE FF 1 mL FPLC 
column for further purification. TagA was eluted at 200 mM NaCl and dialyzed against 20 
mM Tris/acetate pH 7.5, 0.1 mM ZnCl2.
Recombinant fuculose-1-phosphate (FucA) aldolase from the thermophilic bacterium 
T. ethanolicus (pBAD/gIII plasmid provided by DSM) was expressed in E. coli strain TOP10 
by inducing with 0.02% L-arabinose overnight at 37 °C. The resulting culture was centri-
fuged at 7000 rpm for 15 min at 4 °C and the cells were resuspended in 100 mM Tris-HCl 
(pH 7.5), 150 mM NaCl and 0.1 mM ZnCl2. Cell disruption was performed by French Press 
followed by centrifugation at 17000 rpm for 30 min at 4 °C. The thermophilic enzyme 
was isolated from the cell free extract by heat-shock in a 70 °C water bath for 20 min, 
followed by centrifugation at 17000 rpm for 30 min at 4 °C. The supernatant containing 
FucA was loaded onto a Q-Sepharose FF FPLC column (40 mL) and eluted with a linear 
gradient of NaCl (0-1 M NaCl in 20 column volumes). The purified fractions were col-
lected and desalted using 50 mM Tris-HCl pH 7.5 and 150 mM NaCl buffer.
3.5.3 — Enzyme activity assays
Aldolase activity was assayed by measuring the decrease of DHAP concentration in a 
reaction in which the aldolase performed the aldol coupling in the presence of DHAP (50 
mM), rac-glyceraldehyde (100 mM), 0.1 mM ZnCl2, 50 mM acetate pH 6, 30 °C. The de-
crease in DHAP concentration was assayed every 5 min with a coupled-enzyme system in 
the presence of NADH-consuming glycerol-3-phosphate dehydrogenase by measuring 
the NADH concentration by UV spectroscopy. Samples of the aldolase reaction mixture 
were diluted and incubated in 100 mM Tris/acetate pH 7.5, 0.16 mM NADH, and 1 U/
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mL glycerophosphate dehydrogenase. The absorption was analyzed at 340 nm at 20 °C 
(molar absorption coefficient 6.22 mM -1 cm-1).
The Km value of PhoN-Sf for glycerol was determined with a coupled enzyme system as 
described by Bergmeyer.20 L-glycerol-3-phosphate resulting from the phosphatase reac-
tion was assayed by coupling with glycerol-3-phosphate dehydrogenase in the presence 
of hydrazine and NAD+ at pH 9.5 and 25 °C. The reaction was spectrophotometrically 
monitored at 340 nm.
3.5.4 — Analytical methods and product characterization
The time course of the cascade reaction and the conversions were determined by HPLC 
using an Alltech OA 1000 organic acid column (0.65 × 30 cm). 20 μL of the reaction 
mixture was diluted 10-fold before injection on the HPLC. Isocratic runs were performed 
using 4.5 mM H2SO4, with a flow rate of 0.4 mL min
-1. The effluent was analyzed at 215 and 
254 nm by refractive index detector.
3.5.5 — General procedure for the preparative scale one-pot four-enzyme 
cascade
To a solution of 500 mM glycerol, 250 mM PPi (3:2 Na2PPi/Na4PPi),
21 20 mM sodium acetate 
(pH 6), and 100 mM aldehyde in water, 10 U/mL catalase from bovine liver, 5 U/mL RAMA, 
and 50 U/mL GPO were added. The reactions were started by adding 3 U/mL PhoN-Sf and 
incubated at 20 °C under mild shaking until completion. Dephosphorylation to the end 
product was completed after 24 h and 4 g of silica gel was added. The reaction slurry was 
concentrated under reduced pressure, and the silica gel was poured on top of a silica gel col-
umn and eluted with EtOAc/MeOH 19:1. The pure fractions were collected and concentrated 
under reduced pressure to give product 1 as a light-yellow oil.
3.5.6 — 5,6-Dideoxy-D-threo-2-hexulose (1a)
This compound was synthesized via method 3.5.5 from propnanal (58 mg, 
1.0 mmol) and resulted in 1a (102 mg, 0.69 mmol) in 69% isolated yield. 
1H NMR (CD3OD, 300 MHz) δ 4.53 (d, J = 19.2 Hz, 1H), 4.42 (d, J = 19.2 
Hz, 1H), 4.14 (d, J = 2.4 Hz, 1H), 3.78 (dt, J = 2.4, 6.0 Hz, 1H), 1.65-1.50 
(m, 2H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ 212.0, 77.1, 73.2, 66.0, 25.3, 
8.7; [α]20D = –17.7 (c = 0.22, MeOH); ʋmax (film) cm-1 3397, 1723; LRMS (FAB) m/z calcd for C6H12O4: 
148.07, found 149.08 [M+H]+, 171.09 [M+Na]+. The analytical data were in accordance with 
previously reported results.15
OH
OH
O
OH
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3.5.7 — 5,6-Dideoxy-5-methyl-D-threo-2-hexulose (1b)
This compound was synthesized via method 3.5.5 from isobutanal (72 mg, 
1.0 mmol) and resulted in 1b (64 mg, 0.40 mmol) in 40% isolated yield.1H 
NMR (CD3OD, 300 MHz) δ 4.53 (d, J = 19.2 Hz, 1H), 4.44 (d, J = 19.2 Hz, 
1H), 4.31 (d, J = 1.8 Hz, 1H), 3.45 (dd, J = 2.0, 9.1 Hz, 1H), 1.90 (ddd, J = 2.3, 
6.7, 13.4 Hz, 1H), 1.01 (d, J = 6.7 Hz, 3H), 0.93 (d, J = 6.7 Hz, 3H); 13C NMR (CD3OD, 75 MHz) 
δ 212.6, 77.4, 75.8, 65.9, 29.8, 17.8, 17.6; [α]20D = –12.2 (c = 0.16, MeOH); ʋmax (film) cm
-1 3396, 
1723; LRMS (FAB) m/z calcd for C7H14O4: 162.08, found 163.10 [M+H]
+, 185.12 [M+Na]+.
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Synthesis of iminosugars using 
a one-pot enzymatic cascade
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“In all things of nature there is something of the marvelous.” 
― Aristoteles
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Abstract
Having developed a one-pot four-enzyme cascade for the synthesis of carbohydrate 
fragments, we envisioned that a two-step synthesis of nitrogen heterocycles would be 
feasible. This strategy was validated with the chemoenzymatic synthesis of two well-
investigated iminosugars. Thus, after optimization D-fagomine was obtained in an overall 
yield of 69%. Furthermore, deoxynojirimycin (DNJ) was obtained in a similar strategy 
in 23% yield using a minimum of protecting groups. Subsequent derivatization of DNJ 
resulted in the synthesis of C-3 (di)fluorinated iminosugars. The four-enzyme cascade 
was also applied using the complementary aldolases RhuA, TagA and FucA to synthesize 
precursor epimers of D-fagomine.
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4.1 — Introduction
Perhaps the first known therapeutic application of iminosugars dates from the 17th cen-
tury, when Haarlem Oil was recommended for the treatment of diabetes.1 Haarlem Oil 
partly consists of extracts of the leaves of Morus alba, a rich source of iminosugars. It was, 
however, not until the 1960’s that scientific interest arose in the synthesis of these sugar 
derivatives. The first iminosugars that were isolated were derived from bacteria, such as 
1-deoxynojirimycin (DNJ (1), Figure 1). This iminosugar was first synthesized by Paulsen in 
1966,2 ten years before it was also isolated from the plant Mori cortex. As mentioned in 
Section 1.6, DNJ acts as a sugar mimic and inhibits glycosidases3 and glycosyltransferases4 
by mimicking the charge and hydrolysis transition state of the enzymatic reaction. The ef-
ficacy of DNJ has also been demonstrated in multiple clinical studies.5 Glycosidases are 
involved in many biological and pathological processes, making them important targets 
for the treatment of various diseases, such as type II diabetes,6 HIV,7 Gaucher’s disease8 
and cancer.9 N-Alkylated DNJ derivatives also showed potent inhibiting properties, two of 
which have been marketed as miglustat (N-butyl, 3, Figure 1)10 and miglitol (N-C2H4OH, 4).
11
2 : D-Fagomine
N
H
OH
OH
OH
1 : 1-Deoxynojirimycin
N
H
OH
OH
HO
OH N
OH
OH
HO
OH N
OH
OH
HO
OH
OH
1
2 3 4
5 6
3 : Miglustat 4 : Miglitol
Figure 1 — Examples of iminosugars
The first iminosugar derived from a plant was D-fagomine (2), which was isolated from 
buckwheat seeds (Fagopyrum esculentum Moench) and characterized for the first time in 
1974.12 D-Fagomine has a potent antihyperglycemic effect in streptozocin-induced dia-
betic mice and is also an inhibitor of isomaltase and α- and β-galactosidases.13,14 In 1985, 
a first synthesis of D-fagomine was reported providing the iminosugar from glucose in a 
rather lengthy procedure of 14 steps in an overall yield of 20% (Scheme 1).15 The piperidine 
ring was constructed via intramolecular nucleophilic attack by nitrogen onto the primary 
tosylate of 7 to produce bicyclic intermediate 8, subsequent acetal deprotection, reduc-
tion and hydrogenation resulted in D-fagomine (2). This route also provided access to 
DNJ (1), which was isolated in 57% overall yield in 12 steps.
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Scheme 1 — Synthesis of iminosugars 1 and 2 from protected D-glucose derivative 5.
Over the years, several new pathways have been developed for the synthesis of 
iminosugars.16 A first example of a chemoenzymatic approach involving aldolases and 
dihydroxyacetone phosphate (DHAP) was published by Effenberger et al. in 1988.17 We 
envisioned that a straightforward route to these iminosugars would also be feasible us-
ing the one-pot four-enzyme cascade strategy described in Chapter 3. Thus, the aim of 
this research was to chemoenzymatically synthesize various iminosugars 9 with different 
substitution patterns. The heterocyclic systems 9 should be obtained via intramolecular 
reductive amination of aldol products 10, which should be directly accessible through 
the enzymatic cascade described in the previous chapter (Scheme 2). Different stereoiso-
mers might be obtained by using stereocomplementary aldolases, while the introduction 
of substituents on the C-1 and C-2 positions should rely on the presence of substituents 
(e.g. hydroxyl, fluoride) in the starting aldehydes 11.
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Scheme 2 — Retrosynthesis of iminosugars 9.
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4.2 — Results and discussion
4.2.1 — Synthesis of D-fagomine
D-Fagomine was synthesized starting with commercially available Cbz-protected ami-
nopropanal 12a (Scheme 3). The first attempt under the standard enzymatic cascade 
conditions resulted in a 21% isolated yield of aldol product 13a in a 6:1 (syn:anti) ratio of 
diastereoisomers.
HN
H
Cbz
O OH
OH
OH
O
500 mM glycerol
250 mM PPi
6 U/mL RAMA
3 U/mL PhoN-Sf
50 U/mL GPO
10 U/mL catalase
pH 6, 30 °C, 48 h
12a
(100 mM)
HN
Cbz 13a
Scheme 3 — First attempt to synthesize aldol product 13a.
Due to the low solubility of aldehyde 12a, the cascade was also tested in the presence 
of cosolvents using propanal (12b) as the acceptor aldehyde (Table 1). In all cases, the 
addition of cosolvents (10%) lowered the reaction rate. Both MeCN and DMSO gave rea-
sonable results (entries 3 and 6, 38 and 39%, respectively) with conversions in the range 
Table 1 — Effect of cosolvents in the enzymatic cascade
O
H
OH
OH
OH
O500 mM glycerol, 250 mM PPi
6 U/mL RAMA, 3 U/mL PhoN-Sf
50 U/mL GPO, 10 U/mL catalase 
pH 6, 30 °C, 48 h
12 13
R
R
Entry R Aldehyde Cosolvent Conversion (%)a d.r.b
1 CbzNH 12a - 21 6:1
2 H 12b - 51 14:1
3 H 12b MeCN 38 14:1
4 H 12b 1,4-dioxane 18 14:1
5 H 12b DMF 28 14:1
6 H 12b DMSO 39 14:1
7 CbzNH 12a DMSO 32 20:1
8 AllocNH 12c - 75 5:1
9 AllocNH 12c - 87c 5:1
10 AllocNH 12c - 50d 30:1
11 AllocNH 12c - 87e (69)f 11:1
a) Conversions were based on the aldehyde and determined using HPLC on aliquots of the reaction 
mixture; b) Ratio syn:anti; c) After 6 h an extra equivalent of PPi was added; d) The incubation 
temperature was 10 °C; e) The incubation temperature was 20 °C; f ) isolated yield.
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of the control experiment (entry 2, 51%). The addition of DMF to the reaction mixture 
resulted in reasonable conversions (entry 5, 28%), while the addition of 1,4-dioxane gave 
a significantly lower conversion (entry 4, 18%) and more side products as observed by 
HLPC analysis.
In a second attempt to synthesize D-fagomine, the experiment was repeated in the pres-
ence of 10% DMSO resulting in a significant increase in yield from 21 to 32% (entry 7). 
Besides, a drastic improvement in diastereomeric ratio (d.r.) was observed from 6:1 to 
20:1. This could be due to an increased difference in the rate of formation of both diaste-
reoisomers caused by solvent-induced active site perturbation of the aldolase. To further 
optimize the solubility of the aldehyde, the Cbz-protecting group was replaced by an 
Alloc-group (12c). Gratifyingly, this more water soluble aldehyde could be subjected to 
the cascade conditions without using cosolvents providing a 75% conversion into the 
desired aldol product 13c in a d.r. of 5:1 (entry 8). Addition of extra 250 mM of PPi to 
the cascade reaction after 6 h increased the conversion to 87% (entry 9). Since it was 
noticed that the temperature of incubation had an effect on the diastereoselectivity of 
the aldolase (Section 3.2), we also investigated the effect of temperature on the cascade 
with the Alloc-protected aldehyde 12c. There was a marked increase in the isomeric 
ratio from 5:1 to 30:1 when the temperature was lowered from 30 to 10 °C, while the 
conversion dropped to approximately 50% (entry 10). Optimal results in terms of isolated 
yield were obtained at 20 °C giving product 13b in 69% yield (entry 11). The subsequent 
formation of D-fagomine (2) occurred via straightforward reductive amination of aldol 
product 13a, which provided the target molecule as a single diastereoisomer in 87% 
yield (Scheme 4). Our first attempt to convert aldol product 13c proceeded with formic 
acid and a catalytic amount of Pd(PPh3)4,
18 however, degradation of the product was 
observed. Changing to milder reaction conditions replacing formic acid by ammonium 
formate also did not result in the desired product. We then resided to a publication of the 
group of McMurry who reported a Pd/C-induced catalytic transfer hydrogenation with 
triethylsilane (TES) for Alloc-deprotection,19 which allowed TES to behave as a hydrogena-
tion reagent through in situ generation of H2. With this strategy we envisioned that both 
deprotection and ring closure via reductive amination would proceed in one step. This 
led to the diastereoselective formation of D-fagomine (2) in quantitative yield, thereby 
realizing a two-step synthesis of the natural product in 69% overall yield. To prove the 
concept of in situ H2 formation, the reaction was also tested with Pd/C and H2, how-
ever, no product was observed. Probably the Alloc-deprotection proceeded via initial 
palladium-mediated formation of the π-allyl palladium intermediate, capturing of this 
complex with TES as a hydride donor and subsequent reductive amination via in situ H2 
generation. The yields we obtained are in the same range as previously reported by the 
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Clapés group for a two-step approach using DHA and D-fructose-6-phosphate aldolase 
(FSA, Section 1.6).20
OH
OH
OH
O
HN
PG
2
N
H
OH
OH
OH
13a : H2, Pd/C, MeOH, 87%
13c : TES, Pd/C, EtOH, 100%
13a : PG = Cbz
13c : PG = Alloc
Scheme 4 — Formation of D-fagomine (2).
Epimers of D-fagomine precursors were obtained by using aldehyde 12c in the enzymatic 
cascade with the complementary aldolases (Figure 2, Table 2). Using instead of RAMA 
the RhuA aldolase derived from the thermophilic organism Thermatoga maritima, 
gave a moderate conversion (45%), while the isomeric ration dropped to 2:1 (entry 2). 
Decreasing the temperature to 10 °C considerably lowered the conversion (25%), but 
the isomeric ratio remained unchanged. A similar outcome was observed for FucA: the 
conversion was slightly higher than with RhuA, but the diastereoselectivity was worse 
(entry 3). The aldolase TagA gave almost no conversion and slightly better diastereose-
lectivity, which was also observed in case of propanal (entry 4 and Section 3.2). These 
results demonstrate that the synthesis of epimers of D-fagomine precursors 13c with the 
complementary aldolases is feasible, but also strongly depend on the substrate specific-
ity and selectivity of the aldolases.
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Figure 2 — Time course of the four enzyme cascade with various aldolases and N-Alloc-
aminopropanal 12c.
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Table 2 — Aldehyde 12c with stereocomplementary alsolases
500 mM glycerol, 250 mM PPi
6 U/mL Aldolase, 3 U/mL PhoN-Sf 
50 U/mL GPO, 10 U/mL catalase 
pH 6, 20 °C, 24 h
HN
H
Alloc
O OH
OH
OH
O
12c
(100 mM)
HN
Alloc
13c
3
4
Entry Conversion (%)a Aldolase21 d.r. Configuration21
1 87 RAMA 11:1 (3S,4R):(3S,4S)
2 45 RhuA 2:1 (3R,4S):(3R,4R)
3 54 FucA 3:2 (3R,4R):(3R,4S)
4 5.3 TagA 5:2 (3S,4S):(3S,4R)
a) Conversions were based on the aldehyde and determined using HPLC on aliquots of the reaction 
mixture after 24 h.
4.2.2 — Synthesis of deoxynojirimycin
Following the same strategy DNJ (1) was also synthesized. To this end, a first attempt pro-
ceeded via aldol reaction of in situ generated DHAP and racemic azido aldehyde 18 (Scheme 
5), a known substrate for the two-enzyme cascade reaction with DHA.22 Aldehyde 18 was 
synthesized from acetal-protected acrolein 16 in two steps.23 Unfortunately, subjecting this 
aldehyde to the conditions of the enzymatic cascade reaction resulted in a rather slow forma-
tion of aldol product 19, never approaching conversions that were previously reached in the 
two-enzyme cascade with DHA.22 Multiple attempts showed decomposition of aldehyde 18 
under these conditions and concomitant inhibition of GPO.
OEt
OEt
N3
OH
17
OEt
OEt
16
HN3
O OH
OH
OH
O
500 mM glycerol
250 mM PPi
6 U/mL RAMA
1 U/mL PhoN-Sf
5 U/mL GPO
10 U/mL catalase
pH 6, 48 h
18
(100 mM)
N3
19
OH OH
1) H2O2, benzonitrile
2) NaN3
MeOH
40 °C, 50 h, 60%
0.5 N HCl
16 h
Scheme 5 — Four-enzyme cascade synthesis of DNJ precursor 19.
Therefore another strategy was pursued which previously had been successfully applied 
using FSA by Clapés et al.24 Enantiopure aldehyde 21 was prepared from the correspond-
ing alcohol 20 by Cbz-protection and subsequent IBX oxidation (Scheme 6). In our 
hands, however, aldehyde 21 was obtained as a mixture of products, in particular since 
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the IBX oxidation did not proceed in a clean manner. N-Alloc-protection of the alcohol 
and subsequent oxidation did not result in the desired aldehyde as no clean conversions 
were observed when applying the same IBX oxidation (not shown). Nevertheless, N-Cbz-
aldehyde 21 was incubated without purification with glycerol and the four enzymes at pH 
6. To enhance the solubility of the aldehyde, 10% of DMSO was added to the mixture. 
The reaction was followed by HPLC and after 48 h the salts were precipitated in methanol 
and the crude product was purified with column purification to obtain a mixture of 22 
and the ring-closed isomer 23 in a in a d.r. of 16:1 (based on HPLC peaks),24 which was 
hydrogenated to obtain DNJ (1) in 23% yield over three steps as a single diastereoisomer.
HN
H
O
OH
OH
OH
O
500 mM glycerol
250 mM PPi
6 U/mL RAMA
3 U/mL PhoN-Sf
50 U/mL GPO
10 U/mL catalase
pH 6, 48 h
21
(100 mM)
N
H
22
OH
OH
Cbz
Cbz
OHH2N
OH
1) CbzCl, NaHCO3
    H2O, DCM, 100%
2) IBX, EtOAc 
    reflux 2 h
H2, Pd/C
MeOH
23% over 3 steps
N
H
OH
HO OH
OH
1
O
HO
NHCbz
OH
OH
OH
23
20
Scheme 6 — Chemoenzymatic synthesis of DNJ (1).
4.2.3 — Synthesis of fluorinated iminosugars
The introduction of fluoride substituents on the iminosugar skeleton was also investi-
gated. A study by Andersen et al. showed that C-2 (24 and 28), C-3 (25) and C-6 (26 
and 27) monofluorination of DNJ impairs its inhibitory properties (Figure 3).25 In addition, 
geminal difluorination of DNJ at C-3 (29) created an inhibitor with tenfold higher activity 
against α-glucosidase than Miglitol (4, Figure 1) with low cellular cytotoxicity.26 Especially 
the latter results, prompted us to adapt our strategy to be able to prepare such fluorinated 
iminosugars.
N
OH
OHHO
F
N
OH
OHF
OHN
H
F
OHHO
OH N
H
F
OHHO
OH
F
27 2825 29OH OH
N
H
OH
OHF
OH
24
N
H
OH
OHHO
F
26
Figure 3 — Fluorinated derivatives of DNJ (1) and Miglitol (8).
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The introduction of fluoride substituents was initially pursued by using fluorinated 
aldehydes in the cascade reaction. Hence, we aimed to synthesize such aldehydes by 
nucleophilic substitution of the C-2–hydroxy group of acetal protected aldehyde 17 
with DAST (Scheme 7, route a).27 Formation of fluorinated product 30 was confirmed by 
TLC and IR, however, isolation was unsuccessful. An alternative route was developed 
based on organocatalyzed α-substitution of aldehydes as described by MacMillan et al. 
using Selectfluor® or N-fluorobenzenesulfonamide (NFSI) as electrophilic fluor source 
(route b).28 In case of Selectfluor®, the desired product was never observed and multiple 
products were formed. Lowering the temperature did not result in the desired product 
either. Therefore the reaction was repeated with NFSI, which is a milder reagent than 
Selectfluor®,29 but again failed to produce the desired product 31.
OEt
OEt
N3
OH
17
DAST
toluene
70 °C, 16 h
OEt
OEt
N3
F
30
a)
b) H
O
HN
1) Selectfluor®
    or
2) NFSI
    (S)-proline, MeCN
    0 °C, 4 h
H
O
HN
F
12a 31
Cbz Cbz
N
N
Cl
F
2 BF4-
Selectfluor®
Scheme 7 — Attempted synthesis of fluoro aldehydes 30 and 31.
Since this approach was unsuccessful, we decided to follow another strategy and intro-
duce the fluoride atoms after iminosugar formation via nucleophilic substitution of the 
hydroxy group on the C-3 position of the DNJ ring (Scheme 8). Despite the fact that such 
modifications have been claimed in patent literature,30 the relevance of the resulting 
products inspired us to establish reliable procedures to access these compounds and 
optimize the required pathway. The fluorinated iminosugars 32 should thus be obtained 
via selective fluorination on C-3 and subsequent deprotection of 33. To introduce fluo-
rides on C-3, the other hydroxy groups of DNJ (1) had to be orthogonally protected, as 
well as the endocyclic nitrogen atom.
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OH
N
OPGPGO
OPG
PG
R2R1
32
a) R1 = H; R2 = F (25)
b) R1 = F; R2 = H (25)
c) R1 = R2 = F (29)
33 1
N
H
OHHO
OH
R2R1
(di)fluor introductiondeprotection
N
OPGPGO
OPG
PG
34
selective protection
N
H
OH
OH
HO
OH1
2 3 4
5 6
Scheme 8 — Retrosynthesis of fluoride introduction on C-3 of DNJ.
The first step involved Cbz-protection of the nitrogen atom using CbzCl under Schotten-
Bauman conditions (Scheme 9). The C-4 and C-6 alcohols were subsequently protected 
via acetal formation with benzaldehyde dimethyl acetal under acidic conditions, pro-
ceeding in excellent overall yield.
N
H
OH
OH
HO
OH N
O
OH
O
Ph
Cbz
BzOCbzCl, NaHCO3
dioxane:water (1:1)
100%
1. Bu2SnO
    MeOH, reflux
2. BzCl, Et3N 
    DCM, 0 °C
    100%
1 34PhC(OMe)2, pTsOH
DMF, 60 °C, 45 mbar, 87%
N
OR
OH
HO
OR
35, R = H
Cbz
36, R = CHPh
Scheme 9 — Synthesis of protected DNJ 34.
Selective C-2 hydroxy protection was accomplished by treating diol 36 with dibutyltin 
oxide in refluxing methanol, affording the corresponding cyclic dibutyltin ether as a 
dimer (Scheme 10). The tin complex exists in a trigonal bipyramidal conformation, in 
which both C-2 oxygens occupy an apical position and are not involved in the Sn2O2 
parallelogram. While the C-3 oxygens were deactivated by electron donation to tin, the 
stannylene dimer complex enhanced the nucleophilicity of the apically bound C-2 oxy-
gens by electron channeling from tin resulting in activation of these atoms.31 Treating this 
complex with benzoyl chloride and triethylamine afforded solely C-2 benzoyl-protected 
alcohol 34 in quantitative yield.32
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Scheme 10 — Introduction of the benzoyl group on C-2.
To introduce a fluoride atom in the equatorial position, C-3 alcohol 34 had to be inverted 
via oxidation and subsequent reduction of the ketone (Scheme 11). First attempts under 
Swern oxidation conditions did not result in desired ketone 39, and the same negative 
result was obtained with IBX. Fortunately, oxidation using Dess-Martin periodinane 
(DMP) afforded ketone 39 in quantitative yield. It was reduced with LS-Selectride to 
obtain the axial C-3 alcohol 40 besides an equimolar amount of the C-2–C-3 benzoyl-
migrated product (40b). Apparently, the basic reduction conditions allowed migration 
of the benzoyl group over the cis-substituted vicinal diol. The reaction was repeated with 
sodium borohydride under mildly acid conditions to circumvent the migration, yielding 
the axial alcohol 40 in 60% yield. Formation of the equatorial alcohol was also observed, 
however, this product was not isolated. Treating alcohol 40 with DAST and pyridine af-
forded the equatorial fluoride 33b in 28% yield.30
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Scheme 11 — Synthesis of DNJ fluoro-derivatives 33b and c.
To synthesize the axial C-3 fluoride, alcohol 34 was treated with DAST and pyridine, but 
surprisingly, equatorial fluoride 33b was obtained, which was unequivocally confirmed 
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by 1H-NMR. Although the H-3/H-4–H-5 coupling constants (6.0 and 8.5 Hz, respec-
tively) are not in the range of normal diaxial couplings (11-13 Hz), a 2D-NOESY experiment 
showed no spatial couplings between these protons, proving their diaxial relationship. 
The first reactions were performed under anhydrous conditions affording the equatorial 
fluoride in rather poor yields (0-34%), even after adding 5 equivalents of DAST. However, 
when the DCM layer was saturated with water prior to the reaction, the yield doubled to 
62%. We postulate that the benzoyl group participated in the DAST reaction via intramo-
lecular nucleophilic attack on the activated alcohol, creating the stabilized 5-membered 
dioxycarbenium intermediate 42 (Scheme 12). Presumably, water present in the reaction 
reacted with DAST to increase the concentration of fluoride in solution driving the re-
action towards product 33b (Scheme 12, in red). Interestingly, axial C-3 alcohol 40 was 
obtained as a byproduct in yields varying between 22 and 43%. The formation of this 
byproduct could be explained by attack of water on the electrophilic tertiary carbon of 
the 5-membered ring intermediate (Scheme 12, in blue), which upon reaction with DAST 
resulted in product 33b.
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Scheme 12 — Formation of the equatorial fluoride with DAST.
The difluorinated compound was also synthesized by treating ketone 39 with excess 
DAST to afford geminal difluoride 33c in 89% yield. In the next step, the C-2 alcohol 
was saponified with sodium hydroxide and methanol in excellent yield, after which 
subsequent hydrogenation gave full conversion into the acetate salts 32 after double 
deprotection (Scheme 13). Attempts to desalt these iminosugars for analytical purposes 
via ion exchange column chromatography drastically decreased the yield to 39 and 7% 
yield for 32b and 32c, respectively.
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Scheme 13 — Deprotection of fluoro-derivatives 33.
4.3 — Conclusion
Based on the four-enzyme-catalytic cascade, a two-step strategy to yield iminosugars was 
successfully demonstrated. Upon optimization, D-fagomine was obtained in an overall 
yield of 69%. A chemoenzymatic synthesis of DNJ was also realized with this strategy and 
derivatization afterwards resulted in the corresponding C-3 (di)fluorinated iminosugars. 
The four-enzyme-catalytic cascade was also applied on the complementary aldolases 
RhuA, TagA and FucA to synthesize epimeric precursors of D-fagomine. The results, how-
ever, demonstrated that the synthesis of the four diastereoisomers is strongly dependent 
on the substrate specificity and stereoselectivity of the aldolases. Nevertheless this 
approach may lead to the simple and inexpensive synthesis of a variety of non-natural 
heterocycles that presently can only be chemically produced at high cost.
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4.5 — Experimental
4.5.1 — General information
The general information is described in Section 2.5.1
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4.5.2 — Enzymes
The general information of the enzymes is described in Section 3.5.2
4.5.2 — Analytical methods and product characterization
The time-course of the cascade reaction and the conversions were determined by HPLC 
using an Alltech OA 1000 organic acid column (0.65 × 30 cm). 20 μL of the reaction 
mixture was diluted 10-fold before injection on the HPLC. Isocratic runs were performed 
using 4.5 mM H2SO4, with a flow rate of 0.4 mL min
-1. The effluent was UV-analyzed at 215 
and 254 nm and by refractive index detector.
4.5.3 — D-Fagomine (2)
N-Alloc-aminopropanal (12c, 157 mg, 1.0 mmol) was dissolved in H2O 
(5.47 mL). Subsequently glycerol (2.00 mL, 2.5 M, 5.0 mmol) and PPi 
(591 mg, 2.5 mmol)33 were added, followed by GPO (1.00 mL, 50 U/
mL), catalase from bovine liver (20 μL, 10 U/mL) and RAMA (161 μL, 
6 U/mL). The reactions were initiated by adding PhoN-Sf (600 μL, 3 
U/mL) and incubated until completion at 20 °C under mild shaking. Silica gel (2 g) was 
added to the reaction mixture and it was concentrated under reduced pressure. The 
product was obtained by flash chromatography (EtOAc:MeOH 19:1), giving product 13c 
(170 mg, 69 mmol) in 69% yield.
(3S,4R)-6-[(Allyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose (13c, 20 mg, 0.081 mmol) 
was dissolved in EtOH (10 mL) and triethylsilane (0.16 ml, 0.97 mmol) was added, fol-
lowed by the addition of Pd/C (10 mg, 0.094 mmol). The reaction mixture was stirred 
overnight at room temperature and filtered over Celite. The filtrate was concentrated in 
vacuo and purified with solid phase extraction, giving D-fagomine (2, 12 mg, 0.082 mmol, 
100%). 1H NMR (CD3OD, 400 MHz) δ 3.87 (dd, J = 10.9, 3.1 Hz, 1H), 3.63-3.55 (m, 1H), 
3.42-3.38 (m, 1H), 3.11 (t, J = 9.0 Hz, 1H), 3.02 (ddd, J = 12.7, 4.6, 2.4 Hz, 1H), 2.66-2.58 (m, 
2H), 2.48-2.41 (m, 1H), 1.97-1.90 (m, 1H), 1.54-1.43 (m, 1H); 13C NMR (CD3OD, 75 MHz) 
δ 73.3, 73.1, 61.4, 61.2, 42.6, 32.8; [α]20D = +6.6 (c = 0.60, MeOH); LRMS (ESI) m/z calcd 
for C6H13NO3: 147.09, found 148.10 [M+H]
+. The analytical data were in accordance with 
previously reported results.15
N
H
OH
OH
OH
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4.5.4 — 3-Azido-2-hydroxypropanal diethyl acetal (17)
To a stirred suspension of KHCO3 (2.26 g, 22.5 mmol) in methanol 
(75 mL) acrolein diethyl acetal (16, 22.5 mL, 148 mmol), benzonitrile 
(15 mL) and H2O2 (16 mL, 30% solution in water, 156.5 mmol) were 
added. The solution was warmed to 40 °C, and after 4 and 20 h 
another 5 mL of the H2O2 solution was added. The solution was 
allowed to react for an additional 25 h at 40 °C, cooled to RT and stirred for 25 h. Next, 
sodium azide (24.5 g, 0.31 mol) was added and the pH was adjusted and kept at 7.5 with 
1 M H2SO4, while the reaction mixture was stirred at 30 °C for 20 h. It was concentrated 
under reduced pressure, water (80 mL) was added to the residue, and it was extracted 
with DCM (3 × 80 mL). The organic layer was washed with brine (250 mL), dried over 
Na2SO4 and evaporated under reduced pressure. Heptane (50 mL) was added to the resi-
due to precipitate the benzamide, which was filtered off and the filtrate was evaporated 
under reduced pressure. The crude product was purified with silica gel column chroma-
tography (heptane:diethyl ether 9:1) to yield 3-azido-2-hydroxypropanal diethyl acetal 
(17, 16.7 g, 88.5 mmol, 60%) as a yellow oil. 1H NMR (CD3OD, 300 MHz) δ 4.47-4.52 (m, 
1H), 3.77-3.74 (m, 3H), 3.61-3.59 (m, 2H), 3.48-3.47 (m, 1H), 3.35-3.33 (m, 1H), 2.52 (s, 1H), 
1.27-1.22 (m, 6H); 13C NMR (CD3OD, 75 MHz): δ 102.8, 71.0, 63.2, 52.2, 13.8; ʋmax (film) cm
-1 
3435, 2098. The analytical data were in accordance with previously reported results.22a
4.5.5 — Deoxynojirimycin (1)
To a solution of N-Cbz-3-amino-1,2-dihydroxypropane (20, 0.225 
g, 1.00 mmol) in EtOAc (15 mL) was added IBX (0.560 g, 2.00 
mmol) and the reaction mixture was heated to reflux for 6 h. The 
formed precipitate was filtered off and DMSO was added (1 mL). 
The reaction mixture was concentrated under reduced pressure at 
20 °C to remove EtOAc and the crude product was used without further purification. 
Subsequently glycerol (2.00 mL, 2.5 M, 5.0 mmol) and PPi (591 mg, 2.5 mmol)
33 were 
added, followed by the addition of GPO (1.00 mL, 50 U/mL), catalase from bovine liver 
(20 μL, 10 U/mL) and RAMA (161 μL, 6 U/mL). The reactions were initiated by adding 
PhoN-Sf (600 μL, 3 U/mL) and incubated until completion at 20 °C under mild shaking. 
Silica gel (2 g) was added to the reaction mixture, after which it was concentrated under 
reduced pressure. The product was purified by flash chromatography (EtOAc:MeOH 
19:1) giving aldol product 22 (41 mg) as a colorless oil. The crude product was dissolved in 
EtOH (5 mL), Pd/C (10 mg) was added and the mixture was stirred overnight under a H2 
atmosphere. The mixture was filtered over Celite, the filtrate was concentrated in vacuo, 
giving DNJ (1, 37 mg, 0.23 mmol, 23%) as a colorless oil. 1H NMR (CD3OD, 400 MHz) 4.61 
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(br s, 1H), 3.85 (dd, J = 11.0, 3.0 Hz, 1H), 3.61 (dd, J = 11.0, 6.5 Hz, 1H), 3.45-3.40 (m, 1H), 
3.24-3.15 (m, 2H), 3.11 (dd, J = 12.0, 5.0 Hz, 1H), 2.50-2.42 (m, 2H); 13C NMR (CD3OD, 75 
MHz) δ 79.3, 72.0, 71.2, 61.7, 61.5, 49.7; [α]20D = +44.3 (c = 0.23, MeOH); ʋmax (film) cm
-1 3314, 
2892; LRMS (ESI) m/z calcd for C6H13NO4: 163.08, found 164.09 [M+H]
+. The analytical 
data were in accordance with previously reported results.15
4.5.6 — N-Cbz-1-Deoxynojirimycin (35)
1-Deoxynojirimycin (1, 500 mg, 3.06 mmol) was dissolved in water 
(10 mL), dioxane (10 mL) and NaHCO3 (296 mg, 3.52 mmol) were 
added, followed by dropwise addition of CbzCl (575 mg, 3.37 
mmol). The mixture was stirred at RT for 75 min and neutralized with 
10% aqueous citric acid (8 mL). Dioxane was evaporated, the water 
phase was saturated with NaCl and extracted with EtOAc (8 × 25 mL). The combined 
organic layers were dried with Na2SO4, filtrated and concentrated to give product 35 
as a yellow oil (1.12 g, 3.06 mmol, 100%). Rf 0.44 (EtOAc:MeOH:H2O 85:10:5); 
1H NMR 
(CD3OD, 500 MHz): δ 7.40-7.26 (m, 5H), 5.11 (s, 2H), 4.20 (br s, 1H), 3.98 (br d, J = 14.0 Hz, 
1H), 3.86 (dd, J = 11.5, 6.5 Hz, 1H), 3.74 (m, 2H), 3.67 (m, 2H), 3.42 (br d, J = 14.0 Hz, 1H); 13C 
NMR (CD3OD, 125 MHz): δ 176.8, 173.4, 158.5, 138.0, 129.4, 128.9, 128.6, 74.1, 71.0, 70.1, 
68.3, 61.2, 61.1, 43.8; [α]20D –14.4 (c = 0.20, MeOH); ʋmax (film) cm
-1 3382, 2360, 2339, 1717; 
HRMS (ESI) m/z calcd for C15H19NO6 297.1212, found 298.1291 [M+H]
+. The analytical data 
were in accordance with previously reported results.30
4.5.7 — N-Cbz-4,6-O-Benzylidene-1-deoxynojirimycin (36)
To a solution of N-Cbz-1-deoxynojirimycin (35, 3.07 mmol, 913 
mg) in DMF (25 mL) were added benzaldehyde dimethyl acetal 
(606 mg, 3.98 mmol) and p-toluene sulfonic acid (56.6 mg, 11 
mol%) and the mixture was stirred under reduced pressure 
(45 mbar) at 60 °C. After 14 h, more benzaldehyde dimethyl 
acetal was added (303 mg, 1.99 mmol). The reaction was stirred overnight under reduced 
pressure, cooled to RT and poured into ice water (20 mL) containing NaHCO3 (150 mg). 
The white precipitate was filtered off, washed with cold water, redissolved in DCM, dried 
with Na2SO4, filtered and concentrated. The water filtrate was stored at 5 °C overnight 
and the precipitate was filtered off, dried and recrystallized in hot isopropanol/heptane 
(1:1). The precipitate was filtered off, washed with cold heptanes, dried in high vacuum 
overnight to give product 36 as a white powder (1.03 g, 2.67 mmol, 87%). Rf 0.69 (EtOAc/
MeOH, 9:1); 1H NMR (CD3OD, 500 MHz): δ 7.52-7.49 (m, 2H), 7.40-7.30 (m, 8H), 5.58 (s, 
1H), 5.11 (d, J = 2.0 Hz, 2H), 4.73 (dd, J = 11.5, 7.0 Hz, 1H), 4.35 (t, J = 10.5 Hz, 1H), 4.12 (dd, J 
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= 13.5, 9.5 Hz, 1H), 3.61 (dd, J = 10.0, 8.5 Hz, 1H), 3.55-3.47 (complex m, 2H), 3.48-3.29 (m, 
2H), 2.94 (dd, J = 13.5, 9.0 Hz, 1H); 13C NMR (CD3OD, 125 MHz): δ 156.7, 139.3, 137.8, 129.9, 
129.6, 129.3, 129.1, 129.0, 127.5, 102.8, 81.9, 77.5, 71.5, 70.6, 68.5, 55.9, 50.3; [α]20D  +11.4 (c 
= 0.20, DCM); ʋmax (film) cm
-1 3354, 1694, 1147, 1089, 750, 698 cm−1; HRMS (ESI) m/z calcd 
for C21H23NO6: 385.1525, found 386.1604 [M+H]
+. The analytical data were in accordance 
with previously reported results.30
4.5.8 — N-Cbz-2-O-Benzoyl-4,6-O-benzylidene-1-deoxynojirimycin (34)
A mixture of N-Cbz-4,6-O-benzylidene-1-deoxynojirimycin (36, 
1.45 g, 3.76 mmol) and dibutyltin oxide (1.03 g, 4.14 mmol) in 
methanol (60 mL) was refluxed for 2 h. The methanol was evapo-
rated under reduced pressure and toluene (2 × 50 mL) was added 
and removed under vacuum. The residue was dissolved in DCM 
(75 mL) and triethylamine (0.63 mL, 4.51 mmol) was added. The mixture was cooled to 0 
°C, and benzoyl chloride (0.480 mL, 4.14 mmol) was added. After 30 min the red colored 
mixture was allowed to warm to RT, and after 1.5 h stirring at RT the mixture was diluted 
with DCM (50 mL) and quenched with saturated aqueous Na2CO3 (25 mL). The organic 
layer was separated and the aqueous layer was extracted with DCM (3 × 50 mL). The 
combined organic layers were washed subsequently with water (100 mL), 1 N HCl (100 
mL) and water (100 mL), dried with Na2SO4, filtrated and concentrated. The product was 
recrystallized from DCM/hexanes (1:1) to give piperidine 34 as a white powder (1.89 g, 
3.76 mmol, 100%). Rf 0.54 (heptane:EtOAc 1:1); 
1H NMR (CDCl3, 500 MHz): δ 8.02-7.99 
(m, 2H), 7.61-7.56 (m, 1H), 7.52-7.48 (m, 2H), 7.46-7.41 (m, 2H), 7.40-7.28 (m, 8H), 5.61 (s, 
1H), 5.12 (d, J = 3.0 Hz, 2H), 5.12-5.08 (m, 1H), 4.87 (dd, J = 4.5, 11.5 Hz, 1H), 4.22 (t, J = 11.0 
Hz, 1H), 4.18 (dd, J = 4.0, 14.0 Hz, 1H), 4.00 (ddd, J = 2.5, 6.0, 9.0 Hz, 1H), 3.85 (dd, J = 1.0, 
9.5 Hz, 1H), 3.51 (ddd, J = 4.5, 10.0 Hz, 1H), 3.46 (dd, J = 7.5, 13.5 Hz, 1H), 2.82 (d, J = 2.5 Hz, 
1H); 13C NMR (CDCl3, 125 MHz): δ 165.9, 155.4, 137.1, 135.9, 133.4, 129.8, 129.4, 129.3, 128.6, 
128.5, 128.4, 128.3, 128.1, 126.3, 102.0, 80.1, 74.2, 73.3, 69.5, 67.7, 53.1, 45.2; [α]20D –2.0 (c 
= 0.20, DCM); ʋmax (film) cm
-1 3447, 1713, 1267, 1093, 698 cm−1; HRMS (ESI) m/z calcd for 
C28H27NO7: 489.1788, found 490.1866 [M+H]
+. The analytical data were in accordance 
with previously reported results.30
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4.5.9 — N-Cbz-2-O-Benzoyl-4,6-O-benzylidene-3-keto-1-deoxynojirimycin (39)
To a solution of N-Cbz-2-O-benzoyl-4,6-O-benzylidene-1-
deoxynojirimycin (34, 100 mg, 0.204 mmol) in DCM (10 mL) 
was added Dess-Martin periodinane (173 mg, 0.409 mmol). 
The reaction was refluxed for 16 h, after which the precipitate 
was filtered off and the organic layer was washed with saturated 
Na2S2O3/NaHCO3 (1:1, 2 × 40 mL). The organic phase was washed with brine (20 mL), 
dried (Na2SO4), filtrated and concentrated under reduced pressure to obtain product 39 
as a yellow oil in quantitative yield (99 mg). 1H NMR (CDCl3, 500 MHz): δ 8.06-8.03 (m, 
2H), 7.62-7.58 (m, 1H), 7.53-7.50 (m, 2H), 7.47-7.43 (m, 2H), 7.38-7.33 (m, 8H), 5.64 (s, 1H), 
5.51 (ddd, J = 1.0, 6.0, 15.5 Hz, 1H), 5.20 (d, J = 12.5 Hz, 1H), 5.15 (d, J = 12.0 Hz, 1H), 4.83 (dd, 
J = 4.0, 11.0 Hz, 1H), 4.64 (dd, J = 6.0, 14.0 Hz, 1H), 4.61 (dd, J = 1.0, 10.5 Hz, 1H), 4.58 (t, J 
= 10.5 Hz, 1H), 3.70 (dt, J = 10.5 Hz, 1H), 3.57 (dd, J = 9.5, 14.0 Hz, 1H); 13C NMR (CDCl3, 125 
MHz): δ 195.3, 165.1, 154.9, 136.7, 135.6, 133.8, 130.2, 129.5, 128.9, 128.9, 128.9, 128.7, 128.6, 
128.5, 128.5, 126.5, 101.9, 80.9, 72.5, 70.0, 68.4, 56.8, 48.8; [α]20D  -10.3 (c = 0.2, DCM); ʋmax 
(film) cm-1 1719, 1262, 1096, 1024, 700 cm−1; HRMS (ESI) m/z calcd for C28H25NO7: 487.1631, 
found 488.1709 [M+H]+. The analytical data were in accordance with previously reported 
results.30
4.5.10 — N-Cbz-2-O-Benzoyl-4,6-O-benzylidene-1,5-dideoxy-1,5-imino-D-
allitol (40)
Method A – A solution of N-Cbz-2-O-benzoyl-4,6-O-benzyli-
dene-3-keto-1-deoxynojirimycin (39, 100 mg, 0.205 mmol) in 
methanol (0.5 mL) and THF (4 mL) was cooled to –5 °C on an ice 
bath and acetic acid (0.012 mL, 0.205 mmol) was added followed 
by sodiumborohydride (7.76 mg, 0.205 mmol). The mixture was 
stirred for 10 min, after which another equivalent of sodiumboro hydride (7.76 mg, 0.205 
mmol) was added and stirred for an additional 1 min. The reaction was quenched with 
saturated NH4Cl (1 mL) and diluted with water to dissolve the precipitate. The solution was 
extracted with EtOAc (3 × 5 mL), the organic layers were dried over Na2SO4, filtrated and 
concentrated. A mixture of C-3 epimers was obtained, with very little benzoyl migrated 
product. The compounds were separated by flash column chromatography (DCM:EtOAc 
98:2). Product 40 was obtained after crystallization (DCM:heptane 1:1) as a white solid 
(60 mg, 0.123 mmol, 60%).
Method B - To a solution of N-Cbz-2-O-benzoyl-4,6-O-benzylidene-3-keto-1-deoxyno-
jirimycin (39, 200 mg, 0.409 mmol) in anhydrous DCM (12 mL), pyridine (0.069 mL, 
0.858 mmol) was added under an argon atmosphere. The mixture was cooled to –78 
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°C, and DAST (0.167 mL, 1.27 mmol) was added dropwise over 5 min. The mixture was 
heated to reflux for 14 h, after which another two equivalents of DAST (0.108 mL, 0.817 
mmol) were added at –78 °C. The mixture was refluxed for an additional 16 h, cooled 
to RT and quenched with saturated NaHCO3 (10 mL). The mixture was extracted with 
DCM (3 × 15 mL) and washed with 1 N HCl (20 mL), saturated aqueous NaHCO3 (20 mL) 
and brine (20 mL). The organic layer was dried with Na2SO4, filtrated and concentrated. 
The crude product was purified via flash column chromatography (heptane:EtOAc 9:1) to 
give product 40 as a white solid (84 mg, 0.172 mmol, 42%). Rf 0.58 (heptane:EtOAc 1:1); 
1H NMR (CDCl3, 500 MHz): δ 8.09-8.06 (m, 2H), 7.60-7.56 (m, 1H), 7.50-7.31 (m, 12H), 
5.66 (s, 1H), 5.16 (d, J = 12.0 Hz, 1H), 5.11 (d, J = 12.0 Hz, 1H), 5.08 (m, 1H), 4.89 (dd, J = 11.5, 
4.5 Hz, 1H), 4.57 (t, J = 11.0 Hz, 1H), 4.51 (br s, 1H), 4.31 (dd, J = 12.5, 5.0 Hz, 1H), 3.86 (dd, 
J = 10.0, 2.5 Hz, 1H), 3.78 (dt, J = 10.5, 4.5 Hz. 1H), 3.45 (dd, J = 13.0, 12.0 Hz, 1H); 13C NMR 
(CDCl 3, 125 MHz): δ 165.6, 155.0, 137.3, 136.1, 133.5, 130.0, 129.7, 129.4, 128.8, 128.6, 128.5, 
128.4, 128.3, 126.2, 101.5, 69.7, 69.1, 67.8, 67.8, 50.7, 43.7; [α]20D –14.3 (c = 0.20, DCM); ʋmax 
(film) cm-1 3453, 1713, 1270, 1211, 1107 cm−1; HRMS (ESI) m/z calcd for C28H27NO7: 489.1788, 
found 490.1870 [M+H]+. The analytical data were in accordance with previously reported 
results.30
4.5.11 — N-Cbz-2-O-Benzoyl-4,6-O-benzylidene-1,3-dideoxy-3-
fluoronojirimycin (33b)
To a solution of N-Cbz-2-O-benzoyl-4,6-O-benzylidene-1-de-
oxynojirimycin (34, 50 mg, 0.102 mmol) in DCM saturated with 
water (7 mL) in a round-bottomed flask equipped with a reflux 
condenser was added pyridine (0.017 mL, 0.214 mmol). The 
mixture was cooled to –78 °C, followed by dropwise addition of 
DAST (0.042 mL, 0.317 mmol) over 5 min. After 24 h of refluxing another amount of DAST 
(0.042 mL, 0.317 mmol) was added at –78 °C and the reaction mixture was heated to 
reflux for an additional 24 h. The mixture was diluted with EtOAc (20 mL) and quenched 
with water (25 mL), followed by the extraction of the reaction mixture with EtOAc (3 × 25 
mL). The combined organic layers were washed with saturated aqueous NaHCO3 (100 
mL), 1 N HCl (100 mL), saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The 
organic layer was dried with Na2SO4, filtrated, concentrated and purified with column 
chromatography (100% DCM). The product was recrystallized from DCM:heptane (1:1) to 
give piperidine 33b as white needles (31 mg, 0.0632 mmol, 62%). Rf 0.60 (heptane:EtOAc 
1:1); 1H NMR (CDCl3, 500 MHz): δ 8.02-7.99 (m, 2h), 7.61-7.57 (m, 1H), 7.53-7.50 (m, 2H), 
7.47-7.43 (m, 2H), 7.40-7.30 (m, 8H), 5.63 (s, 1H), 5.31 (dddd, J = 16.5, 8.0, 5.5, 4.0 Hz, 1H), 
5.09 (s, 2H), 4.89 (ddd, J = 11.0, 4.0, 2.0 Hz, 1H), 4.80 (ddd, J = 51.0, 8.5, 6.0 Hz, 1H), 4.28 (t, 
J = 11.0 Hz, 1H), 4.22 (ddd, J = 14.0, 3.5, 2.0 Hz, 1H), 4.10 (ddd, J = 19.0, 10.5, 8.5 Hz, 1H), 3.51 
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(ddd, J = 10.5, 10.0, 4.5 Hz, 1H), 3.45 (dd, J = 14.0, 8.0 Hz, 1H); 13C NMR (CDCl3, 125 MHz): 
δ 165.2, 155.4, 137.0, 135.8, 133.7, 129.9, 129.4, 129.2, 128.8, 128.7, 128.5, 128.5, 128.2, 126.3, 
101.7, 92.5 (d, JC3,F = 186.9 Hz), 78.5 (d, J = 19.5 Hz), 70.7 (d, J = 23.5 Hz), 69.7, 68.0, 52.6 
(d, JC5,F = 7.3 Hz), 45.2 (d, JC1,F = 6.0 Hz); [α]
20
D –1.2 (c = 0.2, DCM); ʋmax (film) cm
-1 1715, 1089, 
1014, 698 cm−1; HRMS (ESI) m/z calcd for C28H26FNO6: 491.1744, found 492.1829 [M+H]
+. 
The analytical data were in accordance with previously reported results.30
4.5.12 — N-Cbz-2-O-Benzoyl-4,6-O-benzylidene-1,3-dideoxy-3,3-
difluoronojirimycin (33c)
To a solution of N-Cbz-2-O-benzoyl-4,6-O-benzylidene-3-keto-
1-deoxynojirimycin (39, 100 mg, 0.205 mmol) in anhydrous 
DCM (5 mL) under argon atmosphere DAST (0.136 mL, 1.03 
mmol) was added at  78 °C. The mixture was warmed to RT and 
stirred for 30 h. DCM (10 mL) was added and the mixture was 
washed with water (10 mL). The layers were separated and the water layer was extracted 
with DCM (3 × 10 mL). The combined organic extracts were washed with saturated aque-
ous NaHCO3 (30 mL), 1 N HCl (30 mL), saturated aqueous NaHCO3 (30 mL) and brine (30 
mL). The organic layer was dried with Na2SO4, filtrated and concentrated. The product 
was redissolved in dioxane and lyophilized, affording product 33c as a white solid (93 
mg, 0.182 mmol, 89%). Rf 0.60 (heptane:EtOAc 1:1); 
1H NMR (CDCl3, 500 MHz): δ 8.11-
8.07 (m, 2H), 7.64-7.59 (m, 1H), 7.54-7.51 (m, 2H), 7.50-7.44 (m, 2H), 7.41-7.32 (m, 8H), 5.63 
(s, 1H), 5.31 (m, 1H), 5.17 (d, J = 12.0 Hz, 1H), 5.13 (d, J = 12.0 Hz, 1H), 4.86 (dd, J = 11.5, 2.5 Hz, 
1H), 4.56 (t, J = 11.0 Hz, 1H), 4.52 (ddd, J = 13.0, 5.0, 3.0 Hz, 1H), 4.03 (ddd, J = 18.0, 10.5, 
3.5 Hz, 1H), 3.61 (dt, J = 10.5, 5.0 Hz, 1H), 3.20 (dd, J = 11.5, 1.5 Hz, 1H); 13C NMR (CDCl3, 125 
MHz): δ 165.1, 154.6, 136.7, 135.7, 134.0, 130.2, 129.5, 128.9, 128.8, 128.7, 128.6, 128.5, 127.4 
(d, JC3,F = 243.75 Hz), 101.8, 77.7, 69.3, 68.2 (t, J = 19.3 Hz), 53.5 (d, JC5,F = 6.3 Hz), 45.9 (d, JC1,F 
= 5.9 Hz); 19F NMR (CDCl3, 470 MHz): δ -119.72 (d, J = 241.6 Hz), -135.20 (dt, J = 239.7, 17.4 
Hz); [α]20D –15.8 (c = 0.2, DCM); ʋmax (film) cm
-1 1713, 1264, 1103, 698 cm−1; HRMS (ESI) m/z 
calcd for C28H25F2NO6: 509.1650, found 510.1718 [M+H]
+.
4.5.13 — N-Cbz-4,6-O-Benzylidene-1,3-dideoxy-3-fluoronojirimycin (43b)
To a solution of N-Cbz-2-O-benzoyl-4,6-O-benzylidene-1,3-
dideoxy-3-fluoronojirimycin (33c, 31.9 mg, 0.0651 mmol) in ace-
tonitrile (2 mL) was added a solution of sodium hydroxide (3.1 mg, 
0.078 mmol) in methanol (2 mL) and the mixture was stirred at RT 
for 1 h. It was diluted with EtOAc (10 mL), 1 N HCl (5 mL) was added, 
which was followed by an extraction with EtOAc (3 × 10 mL). The organic layers were 
N
O
O
Ph
Cbz
BzO
F F
N
O
O
Ph
Cbz
HO
F
Lieke BW CP v2.indd   89 12-09-12   13:33
Chapter 4
90
washed with brine (30 mL), dried over Na2SO4, filtrated and concentrated. The product 
was recrystallized from DCM:heptane (1:1) to give product 43b as a white solid (19 mg, 
0.0487 mmol, 76%). Rf 0.47 (heptane:EtOAc 1:1); 
1H NMR (CDCl3, 500 MHz): δ 7.52-7.48 
(m, 2H), 7.41-7.33 (m, 8H), 5.57 (s, 1H), 5.13 (d, J = 12.0 Hz, 1H), 5.10 (d, J = 12.0 Hz, 1H), 4.83 
(ddd, J = 11.5, 4.5, 2.0 Hz, 1H), 4.55-4.38 (m, 2H), 4.32 (dt, J = 13.5, 5.0 Hz, 1H), 3.89 (m, 
2H), 3.31 (dt, J = 10.0, 4.5 Hz, 1H), 2.89 (dd, J = 13.5, 10.0 Hz, 1H), 2.32 (d, J = 3.0 Hz, 1H); 13C 
NMR (CDCl3, 125 MHz): δ 154.9, 137.1, 135.9, 129.4, 128.8, 128.6, 128.5, 128.4, 126.3, 101.5, 
96.2 (d, JC3,F = 182.5 Hz), 78.3 (d, J = 17.5 Hz), 77.7, 69.5, 69.0, 68.8, 68.0, 54.4 (d, JC5,F = 7.2 
Hz), 48.4 (d, JC1,F = 7.7 Hz); 
19F NMR (CDCl3, 470 MHz): δ -194.14; [α]
20
D +8.2 (c = 0.2, DCM); 
ʋmax (film) cm
-1 3416, 1076, 1215, 1152, 1007, 756 cm−1; HRMS (ESI) m/z calcd for C21H22FNO5: 
387.1482, found 388.1567 [M+H]+. The analytical data were in accordance with previously 
reported results.30
4.5.14 — N-Cbz-4,6-O-Benzylidene-1,3-dideoxy-3,3-difluoronojirimycin (43c)
Same procedure as for N-Cbz-4,6-O-benzylidene-1,3-dideoxy-
3-fluoronojirimycin (43b). Product 43c was obtained as a pale 
yellow solid (64 mg, 96%). Rf 0.45 (heptane:EtOAc, 1:1); 
1H NMR 
(CDCl3, 500 MHz): δ 7.53-7.49 (m, 2H), 7.42-7.34 (m, 8H), 5.59 (s, 
1H), 5.13 (d, J = 12.0 Hz, 1H), 5.10 (d, J = 12.5 Hz, 1H), 4.85 (ddd, J = 
11.5, 4.5, 2.0 Hz, 1H), 4.52 (t, J = 11.0 Hz, 1H), 4.41 (ddd, J = 14.0, 5.5, 4.0 Hz, 1H), 3.90-3.78 
(m, 2H), 3.50 (dt, J = 10.0, 4.0 Hz, 1H), 2.95 (t, J = 12.0 Hz, 1H), 2.19 (br s, 1H); 13C NMR 
(CD3OD, 125 MHz): δ 154.8, 137.4, 136.1, 128.7, 128.2, 128.0, 127.9, 127.7, 126.0, 117.7 (t, JC3,F 
= 246.9 Hz), 101.2, 76.8 (t, J = 19.1 Hz), 68.9, 67.4 (t, J = 20.1 Hz), 67.4, 53.1 (d, JC5,F = 6.3 Hz), 
48.0 (d, JC1,F = 6.3 Hz); 
19F NMR (CDCl3, 470 MHz): δ -121.45 (d, J = 235.9 Hz), -139.15 (dt, J = 
236.4, 18.3 Hz); [α]20D +7.8 (c = 0.2, DCM); ʋmax (film) cm
-1 3351, 1738, 1365, 1216 cm−1; HRMS 
(ESI) m/z calcd for C21H21FNO5: 405.1388, found 406.1479 [M+H]
+.
4.5.15 — 1,3-Dideoxy-3-fluoronojirimycin (32b)
To a solution of N-Cbz-4,6-O-benzylidene-1,3-dideoxy-3-fluo-
ronojirimycin (43b, 40 mg, 0.103 mmol) in glacial acetic acid 
(3 mL) was added Pd/C (22 mg, 0.206 mmol) and the solution 
was stirred under a hydrogen atmosphere for 78 h at RT. The 
solution was filtered over Celite, concentrated and dried on a 
vacuum pump to obtain the acetate salt. The product was dissolved in water and Serdolit 
CG-400 I (OH type) was added. The suspension was stirred overnight, filtrated over Celite 
and the filtrate was lyophilized. This procedure was repeated two times to fully desalt 
the product, which was purified by preparative TLC (CHCl3:MeOH:NH4OH 4:3:1) to give 
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product 32b as a white solid (6.6 mg, 0.0402 mmol, 39%). Rf 0.59 (CHCl3:MeOH:NH4OH 
4:3:1); 1H NMR (D2O, 500 MHz): δ 4.36 (dt, J = 53.5, 9.0 Hz, 1H), 3.88-3.80 (m, 1H), 3.76 
(dd, J = 11.5, 5.5 Hz, 1H), 3.63 (dt, J = 13.0, 10.0 Hz, 1H), 3.22-3.14 (m, 1H), 2.66 (br s, 1H), 2.57 
(t, J = 11.5 Hz, 1H); 13C NMR (D2O, 125 MHz): δ 99.0 (d, JC3,F = 178.3 Hz), 69.6 (d, J = 16.9 Hz), 
69.2 (d, J = 16.5 Hz), 60.7, 59.3 (d, JC5,F = 6.6 Hz), 47.7 (d, JC1,F = 8.0 Hz). 
19F NMR (D2O, 470 
MHz): δ -152.54.The analytical data were in accordance with previously reported results.34
4.5.16 — 1,3-Dideoxy-3,3-difluoronojirimycin (32c)
Same procedure as for 1,3-dideoxy-3-fluoronojirimycin (32b). 
Product 32c was obtained as a white solid (3 mg, 7%). Rf 0.35 
(CHCl3/MeOH/NH4OH, 4:3:1); 
1H NMR (CD3OD, 500MHz): δ 
3.76 (ddd, J = 11.0, 2.5, 1.5 Hz, 1H), 3.74-3.65 (m, 1H), 3.68 (dd, J = 
11.0, 5.0 Hz, 1H), 3.52 (ddd, J = 20.5, 10.0, 4.0 Hz, 1H), 3.10 (ddd, 
J = 12.5, 5.5, 4.0 Hz, 1H), 2.61 (m, 2H); 13C NMR (CD3OD, 125 MHz): δ 120.4 (t, JC3,F = 248.8 
Hz), 68.8 (t, J = 32.5), 68.3 (t, J = 19.4 Hz), 68.0 (d, JC5,F = 7.5 Hz), 59.6 (d, JC1,F = 6.8 Hz), 58.2, 
41.8. The analytical data were in accordance with previously reported results.26
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A chemoenzymatic strategy 
towards batzellasides A-C
Part of this work is published in Lieke J. C. van Hemert, Alexander J. J. Groenen, Luuk 
J. A. Wilders, Lara Babich, Ron Wever, Sander Nabuurs, and Floris P. J. T. Rutjes, 
Expanding the scope of one-pot four-enzyme cascade aldol reactions, manuscript in 
preparation.
“A jug fi lls drop by drop.” 
― Buddha
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Abstract
The batzellasides form a new class of C-alkylated iminosugars originally isolated from 
Batzella sponges collected off the west coast of Madagascar. These compounds showed 
interesting biological activities and therefore a synthetic route towards these compounds 
was developed.
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Key in the approach was the chemoenzymatic coupling of the aldehyde with DHAP to 
form the aldol product. This coupling involved a four-enzyme cascade reaction with 
RhuA WT and provided the hemiaminal in 51% isolated yield as a mixture of isomers at 
the 2-position. Furthermore, preliminary feasibility studies for conversion into the target 
natural product have been carried out.
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5.1 — Introduction
Since the discovery of nojirimycin (1, Figure 1), an antibiotic obtained from several Strep-
tomyces species in the 1960s, many iminosugars have been isolated from various species, 
including plant and microbial sources.
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Figure 1 — Examples of iminosugars isolated from Batzella sp.
In 2005 Crews et al. collected sponges off the coast from Madagascar from the Batzella spe-
cies, and discovered that they were the first marine species known to produce a variety of 
iminosugars (Figure 1).1 The fractions containing iminosugars were able to inhibit the growth of 
Staphylococcus epidermidis with MIC values of ≤6.3 μg/mL. Some of the active iminosugars were 
isolated, characterized and named batzellasides A, B and C (2a–c).1 These characterizations 
were conducted by NMR analysis with which most stereocenters could be determined, except 
for the hydroxyl group attached to C8.2 The absolute configuration of the latter stereocenter was 
elucidated in the beginning of 2011 by the group of Yoda through total synthesis (Scheme 1).3
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Scheme 1 — Total synthesis of batzellaside B (2b) starting from L-arabinose.
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In their approach, commercially available L-arabinose was converted in 22 steps into 
batzellaside B (2b) in an overall yield of 3.9%. Key step was the introduction of the allyl 
side chain via Lewis acid-mediated allylation (10 to 11). The absolute configuration of C8 
was determined to be S by Mosher ester analysis of a synthetic intermediate, which was 
prepared through a separate route.
Independently, we were simultaneously working on a synthesis of this molecule as 
well. It was our goal to use the newly developed enzymatic cascade to develop a chemo-
enzymatic total synthesis approach with a minimum of protecting group interconversions 
(Scheme 2).
N
H
OH
OH
O
OHN
H
OH
OH
OH
OH
PG N
H
O
PG H
2a-c 1312
indium allylation
cross metathesis
and hydrogenation
N
H
OH
OH
OH
O
11
H
enzymatic 
cascadeoxidation
reductive amination
R
Scheme 2 — Retrosynthetic approach towards batzellasides A–C (2a–c).
Batzellasides A-C might be synthesized via indium-mediated allylation of aldehyde 11, 
followed by cross-metathesis and hydrogenation to introduce the carbon chain with 
various lengths. Iminosugar 11 should be accessible via oxidative cleavage and reduc-
tive amination of trihydroxy aminoketone 12. The latter product was to be synthesized 
in the enzymatic cascade using DHAP, aldehyde 13 and RhuA, to obtain the required 
stereochemistry (Section 3.2). The RhuAs available came from Thermatoga maritima (WT) 
and Escherichia coli (WT and mutant N29D). Since little was known about the substrate 
specificity of RhuA, it was difficult to predict whether the aldehyde would be accepted 
by the enzyme. Therefore we chose to pursue a strategy for the synthesis of aldehyde 13 
that would allow us to easily vary the protecting group.
5.2 — Results and discussion
5.2.1 — Synthesis of aldehyde 13 via azonia-Cope rearrangement
A first attempt to synthesize aldehyde 13 proceeded via a method described by Kobayashi 
et al.4 In this method, the chiral center of the aldehyde was introduced in a single step 
via a camphorsulfonic acid (CSA) mediated azonia–Cope rearrangement as depicted in 
Scheme 3 (14 to 15). The auxiliary CSA moiety in combination with the chairlike transition 
state causes the rearrangement to proceed in a highly diastereomeric fashion.
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Scheme 3 — Introduction of the chiral center via an azonia–Cope rearrangement.
Such an approach would require aldehyde 17, which was prepared via mono TBS-
protection of 1,3-propanediol5 and subsequent oxidation with PCC to afford the target 
aldehyde in 39% yield over two steps (Scheme 4).
HO OH TBSO
16 17
a) NaH, THF, 0 °C, 1 h
    then TBSCl, RT, 24 h
b) PCC, DCM,
    RT, 24 h, 
39% over 2 steps
NH3, MeOH
RT, 24 h, 80%
1) (1R)-(–)-CSA, 17 
    DCE, 0 °C, 24 h
2) HONH2, AcOH 
    MeOH, 50 °C, 3 h
+
Me
Me
Me
O
NH2
20
Me
Me
Me
O
O
B O
O
18 19
H2N OTBS
21
O
H
Scheme 4 — Intended synthesis of aldehyde 13 via an azonia-cope rearrangement.
To induce a diastereoselective azonia-Cope rearrangement, (1R)-camphorquinone (18) 
was used as the chiral auxiliary. The least hindered ketone was amino-allylated with am-
monia and allylboronic acid pinacol ester (19) to give α-aminoketone 20 in good yield 
and diastereoselectivity (de >99%, 1H- and 13C-NMR analysis indicated the formation of a 
single diastereoisomer).4 After mixing amine 20 with aldehyde 17 and CSA, the azonia-
Cope rearrangement proceeded via a chair like transition state in favor of formation of the 
most substituted imine 15 (Scheme 3).4 According to mass spectrometry the formation 
of 15 was successful, which was confirmed by 1H-NMR experiments that showed disap-
pearance of the imine proton of intermediate 14. Unfortunately, subsequent release of 
21 upon quenching with HONH2 in AcOH and methanol appeared unsuccessful. These 
attempts led us to pursue an alternative strategy.
5.2.2 — Synthesis of aldehyde 13 via the Arndt-Eistert sequence
The second route towards aldehyde 13 started with commercially available (S)-allylglycine 
(22). Insertion of a methylene group using the Arndt-Eistert sequence should provide the 
desired aldehyde 13a (Scheme 5).6
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Boc2O, NaHCO3
THF, H2O, 86%H2N
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1) EtOC(O)Cl, Et3N
    THF, -15 to 0 °C
2) CH2N2, Et2O, 0 °C
AgBz, sonication, THF
75% over 3 steps
N
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Boc N
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Me
OMe
N
H
OMeMe
25
N
H
Boc H
O
13a
a) DIBAL-H, 
    hexane/toluene
    -78 to 0 °C, 1 h, 30%
or
b) LiAlH4, THF,
    -78 °C, 1 h, 80%
Scheme 5 — Synthesis of aldehyde 13a via Arndt–Eistert sequence
In the first step, (S)-allylglycine (22) was Boc-protected in 86% yield. Next, the Arndt-
Eistert sequence started with activation of the acid moiety as a mixed anhydride. 
Subsequently, diazoketone 24 was formed by careful addition of freshly distilled 
diazomethane in diethylether. Next, a Wolff rearrangement of α-diazoketone 24 in the 
presence of N-methoxymethylamine (25) resulted in formation of the Weinreb amide 26 
in an overall yield of 75% over three steps. In the final step, reduction of Weinreb amide 
26 produced the desired aldehyde 13a in moderate to good yields. The reduction with 
LiAlH4 was superior to DIBAL-H giving yields of aldehyde 13a of 80 and 30%, respectively. 
Drawback of this approach was the use of potentially explosive diazomethane, which use 
was limited to the size of the dedicated equipment and thus restricted to relatively small 
scale synthesis.7
H2N
OH
O
N
H
OMe
O
R N
H
OHR
N
H
R NN
H
R H
O
LiBH4, THF 
rt , 15 h 
29a, 63% 
29b, 55%
DIBAL-H, toluene 
-42 °C, 4 h 
13a, 54%; 13b, 51%
a) Boc2O, Et3N, H2O:THF 1:1, 15 h
b) CbzCl, Et3N, DCM, 2 h
a, R = Boc 
b, R = Cbz
22 27, R = H 29
3013
1. MsCl, DCM, Et3N 
    -23 °C, 30 min.
2. NaCN, DMF  
    50 °C, 4 h 
30a, 61%; 30b, 65% 
2 steps
SOCl2, MeOH 
reflux, 3 h, quant.
28a, 95%
28b, quant.
Scheme 6 — Synthesis of aldehyde 13a-b via cyanide substitution.
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5.2.3 — Synthesis of aldehyde 13 via cyanide substitution
In order to arrive at a scalable synthesis, the additionally required methylene was also 
introduced via cyanide substitution (Scheme 6).
In the first step, commercially available (S)-allylglycine (22) was converted into the cor-
responding methyl ester HCl salt 27 in quantitative yield. Secondly, the free amine was 
protected with a Boc or Cbz protecting group giving the corresponding carbamates 28a 
and b in 95% and 100% yield, respectively. Subsequent reduction with LiBH4 led to the 
corresponding alcohols (63% for 29a, 55% for 29b), which were converted into the cor-
responding mesylates and substituted by NaCN in 61% (30a) and 65% yield (30b) over 
two steps. The desired aldehydes 13a and 13b were obtained via reduction of nitriles 30a 
and 13b with DIBAL-H in 54% (31a) and 51% yield (31b), respectively. This resulted in an 
overall yield of 20% for the Boc- (13a) and 18% for the Cbz-protected aldehyde (13b) over 
six steps. The scalable character of this sequence was demonstrated by the synthesis of 
ca. 5 g of aldehyde 13b.
N
H
Boc N N
H
Alloc H
O
DIBAL-H 
toluene 
-42 °C, 3 h 
44%30a 13c
1. TFA:DCM 1:1, 30 min, RT
2. AllocCl, Na2CO3 
    H2O:dioxane 1:1, RT, 2 h 
    69%, 2 steps NH
NAlloc
30c
Scheme 7 — Synthesis of Alloc-protected aldehyde 13c.
The Alloc-protected aldehyde 13c was also prepared, which proceeded through depro-
tection of Boc-protected cyanide 30a with TFA, followed by standard Alloc protection 
using AllocCl (69% yield, Scheme 7). Subsequent reduction of the cyanide resulted in the 
desired aldehyde 13c in 44% yield.
5.2.4 — Initial results with DHAP or DHA/borate and RhuA
In order to obtain some initial information on the substrate scope of RhuA, Boc-protected 
aldehyde 13a was subjected to the standard conditions of the two-enzyme cascade using 
DHA, PhoN-Sf and RhuA from the thermophillic organism Thermatoga maritima on 1 and 
10 mL scale (Scheme 8).
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500 mM DHA, 250 mM PPi
6 U/mL RhuA, 3 U/ml PhoN-Sf
pH 6, 20 °C, 24 h
13a
100 mM
12a
N
H
H
O
Boc N
H
OH
Boc
OH
O
OH
Scheme 8 — Two-enzyme cascade with aldehyde 13a and RhuA.
The first attempt to synthesize 12a resulted in a 7% isolated yield using 100 mM aldehyde, 
500 mM DHA and 250 mM PPi with 6 U/mL RhuA and 3 U/mL PhoN-Sf on preparative 
scale (10 mL). These results could, however, not be reproduced despite multiple attempts 
to scale up and isolate this product. According to HPLC analysis, the phosphorylation 
of DHA proceeded smoothly, but no consumption of aldehyde 13a took place. A test 
reaction with propanal, an excellent substrate for RhuA (Section 3.2), did not result in 
the desired product either, indicating deactivation of the aldolase over time. A possible 
explanation could be leaching of zinc from the active site of the enzyme. The Clapés 
group has prepared RhuA aldolases, both wild type (WT) and mutants, from E. coli and 
replaced the zinc with cobalt, to make the enzyme more stable.8 Aldehydes 13a-c (65 
mM) were tested with RhuA from E. Coli WT and its N29D mutant in the presence of 
DHAP (100 mM) at neutral conditions (pH = 6.9), at 20 °C for 48 h. Parallel to these reac-
tions, the aldehydes were tested with DHA (100 mM) in a borate buffer (200 mM, pH = 
7). Wong et al. demonstrated that borate could mimic the phosphate ester of DHAP in 
aldolase-catalyzed reactions.9 After analysis of the HPLC spectra, the reaction with DHAP 
and RhuA WT gave the most promising results with Cbz as a protecting group, because 
it showed the highest and cleanest conversions into desired aldol product 12b (Figure 
2). HPLC analysis also indicated the formation of a second product, which might be the 
other diastereoisomer (Section 3.2) or the cyclic aldol product 32 (Scheme 9). Motivated 
by this result, the one-pot four-enzyme cascade was conducted on a larger scale with 
aldehyde 13b and RhuA WT to isolate the product for full characterization.
500 mM glycerol, 250 mM PPi
6 U/mL RhuA, 3 U/ml PhoN-Sf
50 U/mL GPO, 10 U/mL catalase
pH 6.5, 20 °C, 42 h13b
100 mM
12b
N
H
H
O
Cbz N
H
OH
Cbz
OH
O
OH
            32
51% isolated yield
N
OHOH
OH
OH
Cbz
Scheme 9 : Enzymatic cascade with aldehyde 13b and RhuA WT.
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Figure 2 — HPLC analysis of screening reactions with aldehyde 13b and DHAP or DHA/borate.1
1These reactions were analyzed on a Varian HPLC with RP C-18 Bruker-Michrom at Biotransformation and Bioactive Molecules at the 
Catalonia Institute for Advanced Chemistry.
5.2.5 — Enzymatic cascade reaction with aldehyde 13b
Cbz-protected aldehyde 13b (100 mM) was subjected to RhuA WT (6 U/mL) and in situ 
generated DHAP from glycerol (500 mM), PP i (250 mM), PhoN-Sf (3 U/mL) and GPO (50 
U/mL). Catalase (10 U/mL) was added to convert the formed hydrogen peroxide into 
water and oxygen. The reaction was performed in 1 mL at 20 °C at a pH of 6.5 over 24 
h (Scheme 9). Every two hours the reaction mixture was analyzed with HPLC (Figure 3).
Figure 3 — HPLC analysis during the enzymatic cascade reaction with RhuA WT and 12b.1
1 These measurements were conducted on a Shimadzu HPLC with a RP C-18 column from Grace, which led to different retention 
times and the peaks of 12b and 32 were not separated as compared to Figure 2.
After 42 hours, the reaction was stopped at 65% conversion, which after work-up led to 
a 51% isolated yield based on recovered aldehyde. TLC analysis of the product showed 
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multiple products, which could indicate an equilibrium between the open aldol product 
12b and the closed hemiaminal 32. 1H-NMR analysis in CD3OD solely revealed a 1:1 mix-
ture of diastereoisomers of the cyclic product (Figure 4).
Figure 4 — Relevant part of the 1H-NMR spectrum of hemiaminal 32.
All previous cascade products 1H-NMR showed a distinct AB system around 4.5 ppm 
and portrayed the protons of the methylene group stemming from DHA (C6 and Section 
3.5). The product from the cascade with aldehyde 13b, however, showed two AB systems 
at 3.96 and 3.63 ppm (J = 8.8 Hz, 2H C6-I) and 3.93 and 3.48 ppm (9.0 Hz, 2H C6-II), 
indicating the formation of two diastereoisomers in a 1:1 ratio, which suggests formation 
of hemiaminal 32.
The next steps, which would also provide further proof of the structure of 32, involved 
nitrogen deprotection and reductive amination of the hemiaminal product to furnish 
cyclic product 33 (Scheme 10). The fi rst attempt to remove the Cbz-protecting group was 
performed with 33% HBr in acetic acid, but unfortunately degradation of the product was 
observed. Therefore the reaction was repeated in the presence of catalytic Pd/C under a 
hydrogen atmosphere, however this would also hydrogenate the unsaturated side chain 
(Scheme 10). The desired product was observed with mass spectrometry ([M+H] = 190, 
33), but isolation and purifi cation of the product were unsuccessful. We postulated that 
the formation of 34 could be realized via a reductive amination with trietylsilane and 
trifl uoroacetic acid.12
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Scheme 10 : Hydrogenation of hemiaminal 32.
5.2.6 — Strategy for the final steps towards batzellasides A–C
Simultaneous to the cascade reaction, a strategy was developed for follow up chemistry 
towards the batzellasides from the projected intermediate iminosugar 34 (Scheme 11). 
After formation of the cyclic product 34, the side chain might be introduced via ozon-
olysis of the double bond (either with or without a protecting group on the nitrogen), 
followed by indium-mediated allylation13 of the resulting aldehyde to produce imino-
sugar 35. Introduction of the various side chains would occur via cross-metathesis and 
hydrogenation of the double bond. The feasibility of the latter steps was probed on 
model compound 36.
N H
O
N
H
OH
1. HBr 33%
    AcOH, RT
2. indium(0) 
    allyl bromide 
    THF:H2O 1:1, RT 
58% over 2 steps
Cbz
Grubbs II (5 mol %) 
1-octene, reflux 
TFA in DCM
66%
N
H
OH
36 39
40
N
H
OH
1. CbzCl, Et3N 
    DCM, RT
2. DMSO, TFAA 
    DIPEA, DCM
    -78 °C 
73% over 2 steps
37
Indium(0), allyl bromide 
THF:H2O 1:1, RT 
96%
N
OH
Cbz
38
C6H13
N
H
OH
OH
OH N
H
OH
OH
OH
OH
N
H
OH
OH
OHMe
OH
n
1. ozonolysis
2. indium mediated
    allylation
1. cross-metathesis
2. hydrogenation
34 35 2
Scheme 11 — Final steps towards batzellaside 2.
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Model compound 36 was synthesized via N-protection and Swern-Moffatt oxidation of 
commercially available amino alcohol 37 in 76% yield over two steps (Scheme 11). Alde-
hyde 36 was directly allylated to give allyl alcohol 38 via an indium-mediated Barbier 
type reaction with allyl bromide in excellent yield (1:1 mixture of diastereoisomers).13 An 
extra benefit of this approach is the use of water as solvent, which is favorable for the 
solubility of the highly polar iminosugars.
An ideal route would proceed without the protecting group, so that the allylation was 
also tested on the unprotected piperidine ring. Cbz-protected aminoaldehyde 36 was 
deprotected with HBr (33%) in acetic acid to obtain the deprotected amine as the HBr 
salt. Next, the indium-mediated allylation yielded allyl alcohol 39 in 58% as a 1:1 mixture 
of diastereoisomers over two steps. Finally, the side chain was introduced via cross-
metathesis in the presence of the Grubbs-II catalyst. The reaction was initially performed 
on olefin 39 under neutral conditions, but this caused the free amine to coordinate to 
the catalyst and no reaction took place. Therefore the reaction was conducted in the 
presence of 1 equivalent of TFA to provide alkene 40 in 66% yield. Due to the difficulty to 
synthesize iminosugar 34, these model reactions were not performed on the intermedi-
ate that leads to the batzellasides A–C. Nevertheless, the reactions might be applied in 
the synthesis of one of the batzellasides once iminosugar 34 becomes available.
5.3 — Conclusion
A chemoenzymatic approach to the naturally occurring batzellasides was pursued. 
The required precursor aldehyde was obtained via a straightforward synthesis starting 
from commercially available (S)-allylglycine using a cyanide substitution to introduce 
the aldehyde carbon atom in an overall yield of 18%. The four enzyme cascade reaction 
was performed on the aldehyde at pH 6.5 using RhuA WT to provide the desired aldol 
product as the corresponding cyclic hemiaminal in 51% isolated yield. Unfortunately, 
attempts to convert the hemiaminal via reductive amination into the desired iminosugar 
were unsuccessful. To probe the feasibility of the final steps, 2-piperidylacetaldehyde was 
used as a model compound, on which the side chain was introduced in excellent yields 
via indium-catalyzed allylation and subsequent cross-metathesis.
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5.5 — Experimental
5.5.1 — General information
For the general information see Section 2.5.1
5.5.2 — Enzymes
For recombinant Shigella flexneri acid phosphatase (PhoN-Sf) , catalase from bovine liver, 
L-glycerol-3-phosphate oxidase and recombinant rhamnulose-1-phosphate aldolase 
from the thermophilic organisms T. maritima is referred to Section 3.5.2.
RhuA N29D mutant was received from the Clapés group:8  the plasmids were trans-
formed into E. coli strain M-15 [pREP-4] (QIAGEN). Cells were grown at 37°C in 5L of an 
LB medium containing ampicillin (100 mgL-1) and kanamycin (25 mgL-1) up to an optical 
density of 0.6 at 600 nm.14 For protein expression, the temperature was lowered to 
30°C to avoid inclusion bodies formation and isopropyl-b-d-thiogalactoside (IPTG) 
was added to a final concentration of 50 mM. After additional 4 h cells were harvested, 
phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0 and lysed using a Cell Disrupter 
(Constant Systems). Cellular debris was removed by centrifugation at 12,000 g for 10 
min. The clear supernatant was collected and purified by affinity chromatography on an 
FPLC system (Amersham biosciences). The crude supernatant was applied to a cooled 
HR 16/40 column (GE Healthcare), containing affinity beads (50 mL) and was washed 
with start buffer (150 mL). The protein was eluted with an aqueous buffered solution (pH 
8.0) that contained disodium hydrogen phosphate (50 mM), NaCl (300 mM) and imid-
azole (300 mM), at a flow rate of 3 mLmin-1. CoCl2 (up to 1 mM) was added to the eluted 
protein, which was incubated for 15 min. Addition of (NH4)2SO4 (0.4 g per mL of liquid) 
caused protein precipitation. The resulting pellet was centrifuged at 12,000 g for 10 min, 
suspended in (NH4)2SO4 (50 mL, 0.4 gmL
-1) and centrifuged again. The pellet was finally 
suspended in (NH4)2SO4 (50 mL, 0.4 gmL
-1) and stored at 4°C.14
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5.5.3 — Analytical methods and product characterization
The time course of the cascade reaction and the conversions were determined by HPLC 
that contained an Alltech OA 1000 organic acid column (0.65 × 30 cm) or C18 RP column. 
20 μL of the reaction mixture was diluted 10-fold with MilliQ before injection on the 
HPLC. Isocratic runs were performed using 4.5 mM H2SO4, with a flow rate of 0.4 mL min
-1 
(OA 1000 organic acid column) or a gradient of 0 to 80% MeCN in MilliQ with 0.1% TFA 
(C18 RP column). The effluent was analyzed at 215 and 254 nm by UV detector and by 
refractive index detector.
5.5.4 — General procedure for the preparative scale one-pot four-enzyme 
cascade
To a solution of 500 mM glycerol, 250 mM PPi (7:4 Na2PPi/Na4PPi),
15 and 100 mM alde-
hyde in water, 10 U/mL catalase from bovine liver, 6 U/mL RuA WT, and 50 U/mL GPO 
were added. The reactions were started by adding 3 U/mL PhoN-Sf and incubated at 
20 °C under mild shaking until completion. Dephosphorylation to the end product was 
completed after 24 h and 4 g of silica gel was added. The reaction slurry was concentrated 
under reduced pressure, and the silica gel was poured on top of a silica gel column 
(EtOAc:MeOH 19:1). The pure fractions were collected and concentrated under reduced 
pressure to give product 1 as a light-yellow oil.
5.5.5 — ((tert-Butyldimethylsilyl)oxy)propanal (17)
1,3-Propanediol (16, 4.01 g, 52.0 mmol) was dissolved in THF 
(dry, 250 mL) and cooled to 0 oC before NaH (3.51 g of 60 w% 
in mineral oil, 52.1 mmol) was added. After 1 h of stirring at 0 
°C, TBSCl (7.80 g, 52.1 mmol) was added. The reaction mixture 
was stirred overnight at RT, quenched with water (150 mL) and diluted with DCM (200 
mL). The separated water layer was extracted with DCM (2 × 100 mL). The combined 
organic layers were dried (Na2SO4), filtrated and concentrated in vacuo. The product was 
purified with silica gel column chromatography (EtOAc: heptane 1:9 → 1:2) to give the 
mono-protected diol in 70% (6.91 g) yield.5
((tert-Butyldimethylsilyl)oxy)propanol (100 mg, 0.521 mmol) was dissolved in DCM (5 mL) 
and PCC (170 mg, 0.781 mmol) was added. The reaction mixture was stirred overnight, 
filtrated and the filtrate was concentrated in vacuo. The product was purified with silica 
gel column chromatography (DCM) to yield 54 mg (55%) of aldehyde 17. 1H NMR (400 
MHz, CDCl3): δ 9.80 (t, J = 2.1 Hz, 1H), 3.99 (t, J = 6 Hz, 2H), 2.60 (dt, J = 6.0 Hz, 2.1 Hz, 
TBSO
O
H
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2H), 0.81 (s, 9H), 0.07 (s, 6H); ʋmax(neat) cm
-1 2953, 2928, 2856, 1714, 1470, 1254, 1103. The 
analytical data were in accordance with previously reported results.16
 5.5.6 — (1R,3R,4S)-3-Allyl-3-amino-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one 
(20)
To a solution of (1R)-(–)-camphorquinone (18, 1.33 g, 8.01 mmol) in 
methanolic ammonia (ca. 7.0 M, 12 mL), allylboronic acid pinacol es-
ter (19, 2.02 g, 12.0 mmol) was added dropwise at room temperature 
and stirred for 24 hours. 3.0 M aqueous HCl was added slowly to 
adjust the pH to 1. After stirring for 30 min, the aqueous layer was 
washed with DCM (3 x 50 mL), made alkaline with 6.0 M NaOH (pH ca. 10), and extracted 
with DCM (3 × 50 mL). The combined organic layers were dried (Na2SO4), filtrated and 
concentrated under reduced pressure. The crude residue was purified by silica gel col-
umn chromatography (heptane:EtOAc 3:1) to yield amine 15 (1.32 g, 80%). [α] 20D = +66.8, 
ʋmax(neat) cm
-1 3386, 2973, 1741, 1637, 1454, 919, 883, 675; 1H NMR (400 MHz, CDCl3) δ 
ppm 5.85 (ddd, J = 14.2 Hz, 7.2 Hz, 3.9 Hz, 1H), 5.24-5.12 (m, 2H), 2.21-2.30 (m, 1H), 2.12 (dd, 
J = 14.6 Hz, 7.9 Hz, 1H), 1.96-1.83 (m, 2H), 1.71-1.65 (m, 2H), 1.51-1.45 (m, 2H), 1.09 (s, 3H), 
1.02 (s, 3H), 0.93 (s, 3H); 13C NMR (75 MHz, CDCl3) δ ppm 222.8, 132.8, 118.8, 61.4, 57.9, 
52.1, 46.2, 42.0, 30.4, 22.8, 22.5, 20.4, 9.3. The analytical data were in accordance with 
previously reported results.4
5.5.7 — (S)-2-(N-Boc-amino)-4-pentenoic acid (23)
To a solution of (S)-2-amino-4-pentenoic acid (22, 2.00 g, 17.4 
mmol) in a mixture of THF/H2O (1:1, 100 mL), NaHCO3 (4.43 g, 52.7 
mmol) and Boc2O (4.60 g, 21.1 mmol) were added successively at 0 
°C. After 30 min, the reaction mixture was warmed to RT and stirred 
overnight. The solution was extracted with Et2O (300 mL) and the 
aqueous layer was acidified to pH 4 by careful addition of half saturated citric acid at 0 
°C, followed by extraction with EtOAc (3 × 100mL). The combined organic fractions were 
dried and concentrated in vacuo to yield (S)-2-(N-Boc-amino)-4-pentenoic acid (23, 3.44 
g, 15.2 mmol, 86%) as a colorless oil. [α]20D = +12.1 (c = 1.0, MeOH); 
1H NMR (CDCl3, 300 
MHz) δ 11.56 (br s, 1H), 6.23 (br s, 1H), 5.90-5.70 (m, 1H), 5.19-5.06 (m, 3H), 4.45-4.35 (m, 
1H), 2.70-2.45 (m, 2H), 1.45 (s, 9H); 176.1, 155.0, 131.6, 118.9, 65.4, 52.3, 35.9, 27.8; ʋmax(neat) 
cm-1 3398, 2977, 1697; HRMS (ESI) m/z calcd for C11H20NO4: 229.1392, found 230.1387 
[M+H]+. The analytical data were in accordance with previously reported results.17
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5.5.8 — (S)-3-(N-Boc-amino)-N-methoxy-N-methyl-5-hexenamide (26)
The compound was prepared according to the method described by 
Briand et al.18 Solution A: a solution of N,O-dimethylhydroxyl-
amine (25, 0.45 g, 4.61 mmol) and Et3N (0.62 g, 6.14 mmol) in 
THF (30 mL) was stirred overnight and filtrated, followed by the 
addition of Et3N (0.642 mL, 4.61 mmol).
Solution B: to a solution of pentenoic acid 23 (0.331 g, 1.54 mmol) in THF (12 mL) were 
added Et3N (0.214 mL, 1.54 mmol) and ethyl chloroformate (0.222 mL, 1.70 mmol) at -15 
°C. After 15 min, the solution was allowed to warm to RT.
To a solution of Diazald (1.65 g, 7.68 mmol) in Et2O (30 mL), a solution of KOH (0.31 g, 
5.53 mmol) in EtOH (10 mL) was added slowly at 0 °C. After 5 min, diazomethane in Et2O 
was distilled off at 0 °C, followed by the addition of solution B. The solution was stirred 
at RT until a homogeneous mixture was formed. Upon completion, it was quenched with 
H2O (20 mL), and the organic phase was successively washed with saturated aqueous 
NaHCO3 (70 mL), saturated aqueous NH4Cl (70 mL) and brine (70 mL), dried (Na2SO4) 
and concentrated under reduced pressure. Solution A was added to the residue, fol-
lowed by the addition of silver benzoate (0.17 g, 0.75 mmol). The mixture was placed 
in a sonication bath for 30 min. The resulting mixture was concentrated and purified via 
column chromatography (EtOAc:heptane 1:1) to yield Weinreb amide 26 (0.25 g, 0.92 
mmol, 60%) as a yellow oil. 1H NMR (CDCl3, 300 MHz) δ 5.78 (ddt, J = 17.2, 10.2, 7.1 Hz, 
1H), 5.41 (d, J = 4.0 Hz, 1H), 5.16-4.96 (m, 2H), 4.12 (q, J = 7.1 Hz, 1H), 4.00 (tdd, J = 6.9, 6.4, 
3.7 Hz, 1H), 3.67 (s, 3H), 3.17 (s, 3H), 2.70-2.58 (m, 1H), 2.48-2.32 (m, 1H), 1.74-1.58 (m, 1H), 
1.43 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ 172.0, 154.9, 134.3, 117.1, 60.7, 46.7, 38.4, 34.9, 
31.4, 27.9, 25.9; [α]D = -8.3 (c = 1.0, CH3OH); ʋmax(neat)cm
-1 3343, 2974, 1708; LRMS (ESI) 
m/z calcd for C13H24N2O4: 272.17, found 273.1 [M+H]
+, 295.2 [M+Na]+
5.5.9 — N-Boc-(S)-3-amino-5-hexenal (13a)
Compound 13a was prepared according to the method described by 
Silverman et al.19
 To a solution of Weinreb amide 26 (0.25 g, 0.91 mmol) in THF 
(dry, 20 mL), was added LiAlH4 (0.038 g, 0.96 mmol) at -78 °C 
under an inert atmosphere while stirring vigorously. The dry-ice 
bath was removed after 30 min and the reaction mixture was stirred an additional 30 min 
at RT. It was quenched subsequently with 38 μL water, 38 μL 15 % aqueous NaOH and 90 
μL water. The reaction mixture was dried (MgSO4), filtered and concentrated in vacuo. 
The resulting residue was dissolved in EtOAc (50 mL) and washed successively with cold 
aqueous HCl (1 M, 3 × 10 mL), saturated aqueous NaHCO3 (2 × 50 mL) and brine (50 mL). 
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The organic phase was dried (Na2SO4) and concentrated under reduced pressure to yield 
aldehyde 13a (0.15 g, 0.66 mmol, 73%) as a colorless oil. Rf 0.50 (EtOAc:heptane 1:1); [α]
20
D = -8.4 (c = 1.00, DCM), 
1H NMR (300 MHz, CDCl3) δ ppm 9.76 (m, 1H), 5.75 (m, 1H), 
5.02-5.19 (m, 2H), 4.71 (s, 1H), 4.12 (m, 1H), 2.62 (m, 2H), 2.32 (t, J = 6.9 Hz, 2H), 1.44 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ ppm 200.4, 154.7, 133.2, 118.0, 47.6, 45.5, 38.6, 27.9; ʋmax (film) 
cm-1: 3334, 2984, 1683, 1493, 1363, 1251, 1164, 1043, 1000, 914, 767. HRMS (ESI) m/z calcd 
for C11H20NO3: 213.1443, found 214.1431 [M+H]
+.
5.5.10 — Methyl (S)-2-amino-4-pentenoate (27)
To a solution of (S)-2-amino-4-pentenoic acid (22, 5.02 g, 43.6 mmol) 
in methanol (125 mL) was added dropwise thionyl chloride (4 mL, 
54.8 mmol) over a period of 5 minutes at 0 °C. The reaction mixture 
was heated to reflux for 3 hours and concentrated in vacuo to obtain 
(S)-methyl-2-amino-4-pentenoate 27 in quantitative yield (7.66 g, 
43.6 mmol) as a white solid (HCl salt) after co-evaporation with toluene (50 mL). Rf 0.44 
(MeOH:DCM 1:9); 1H NMR (CD3OD, 300 MHz) δ 8.82 (s, 2H), 5.86-5.72 (m, 1H), 5.33-5.26 
(m, 2H), 4.17 (t, J = 6.3 Hz, 1H), 3.84 (s, 3H), 2.77-2.64 (m, 2H); 13C NMR (CD3OD, 75 MHz) 
δ 170.3, 131.6, 121.6, 53.6, 53.5, 35.7; [α]20D = +28.4 (c = 0.10, CHCl3); ʋmax (film) cm
-1 2999, 
2857, 1739; HRMS (ESI) m/z calcd for C6H12NO2: 129.0868, found 130.0883 [M+H]
+. The 
analytical data were in accordance with previously reported results.20
5.5.11 — Methyl N-Boc-(S)-2-amino-4-pentenoate (28a)
To a solution of 27 (560 mg, 4.34 mmol) in THF/H2O (25 mL, 1:1) 
was added NaHCO3 (1.10 g, 13.1 mmol) and di-tert-butyl dicarbon-
ate (1.14 g, 5.22 mmol) consecutively at 0 °C. After 30 minutes the 
ice bath was removed and the reaction was stirred overnight at 
RT. The solution was extracted with EtOAc (3 × 25 mL). The organic 
layers were combined, dried (Na2SO4) and concentrated in vacuo to afford 28a (835 mg, 
84%) as a colorless oil. Rf 0.84 (MeOH:DCM 1:9); 
1H NMR (CD3OD, 300 MHz) δ 5.84-5.70 
(m, 1H), 5.15-5.09 (m, 2H), 4.20-4.15 (m, 1H), 3.71 (s, 3H), 2.56-2.47 (m, 1H), 2.45-2.35 (m, 
1H), 1.44 (s, 9H); 13C NMR (CD3OD, 75 MHz) δ 174.2, 157.9, 134.5, 118.6, 80.6, 54.9, 52.6, 
37.1, 28.7. [α]20D = -9.1 (c 1.0, CH3OH); ʋmax (film) cm
-1 3385, 2980, 2359, 1715, 1065, 777; 
HRMS (ESI) m/z calcd for C11H20NO4: 229.1392, found 230.1387 [M+H]
+. The analytical data 
were in accordance with previously reported results.21
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5.5.12 — Methyl N-Cbz-(S)-2-amino-4-pentenoate (28b)
To a solution of (S)-methyl-2-amino-4-pentenoate (41, 4.42 g, 26.7 
mmol) in 200 mL THF/H2O (1:1) were added successively sodium 
bicarbonate (8.78 g, 105 mmol) and CbzCl (4.19 mL, 29.4 mmol) 
at 0 °C. After 30 min the ice bath was removed and the reaction 
was stirred for 16 hours at RT. The reaction was quenched with 
aqueous HCl (1 M, 30 mL) and extracted with DCM (3 × 20 mL). The combined organic 
layers were dried and concentrated in vacuo to afford ester 28b in quantitative yield (7.44 
g, 26.7 mmol) as a colorless oil. Rf 0.75 (EtOAc:heptane 1:1); 
1H NMR (CDCl3, 300 MHz) 
δ 7.35 (m, 5H), 5.68 (m, 1H), 5.15-5.09 (m, 4H), 4.45 (q, 1H), 3.74 (s, 3H), 2.55 (m, 2H); 13C 
NMR (CDCl3, 75 MHz) δ 172.3, 155.8, 129.5, 129.0, 129.0, 128.7, 128.3, 128.2, 119.5, 67.0, 
53.4, 36.9; [α]20D = +9.1 (c = 1.0, DCM); ʋmax (film) cm
-1 3341, 2952, 2359, 1718; HRMS (ESI) 
m/z calcd for C14H17NO4: 163.1236, found: 164.1244 [M+H]
+. The analytical data were in 
accordance with previously reported results.22
5.5.13 — N-Boc-(S)-2-amino-4-pentenol (29a)
To a solution of ester 28a (10.5 g, 45.6 mmol) in THF (250 mL) 
was added LiBH4 (2.49 g, 114 mmol) portion wise at –5 °C. The 
mixture was allowed to warm to RT and stirred overnight. After 
completion, the reaction mixture was cooled to 0 °C and carefully 
quenched with aqueous saturated KHCO3. The organic phase was 
washed with aqueous saturated Na2SO4 (2 × 100 mL), brine (100 mL). And subsequently 
dried with Na2SO4 and concentrated in vacuo to yield alcohol 29a (6.08 g, 30.2 mmol, 63 
%) as a colorless oil. Rf 0.21 (EtOAc:heptane 1:2); 
1H NMR (CDCl3, 300 MHz) δ 5.73 (ddt, 
J = 17.2, 10.1, 7.1 Hz, 1H), 5.08 (dd, J = 3.3, 1.4 Hz, 2H), 5.06-4.99 (m, 1H), 4.93 (d, J = 7.4 
Hz, 1H), 3.72-3.47 (m, 3H), 3.40 (s, 1H), 2.39-2.05 (m, 2H), 1.41 (s, 9H); 13C NMR (CDCl3, 75 
MHz) δ 155.8, 133.8, 117.3, 79.1, 64.1, 51.6, 35.4, 27.9; [α]20D = +3.7 (c = 1.0, MeOH); ʋmax (film) 
cm-1 3344, 1685; LRMS (ESI) m/z calcd for C10H19NO3: 201.14, found 202.0 [M+H]
+, 224.1 
[M+Na]+. The analytical data were in accordance with previously reported results.21, 23
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5.5.14 — N-Cbz-(S)-2-amino-4-pentenol (29b)
 This compound was synthesized via method 5.5.13 from 28b (7.44 g, 
28.3 mmol) and resulted in 29b (4.20 g, 17.85 mmol) in 63% isolated 
yield. Rf 0.40 (EtOAc:heptane 1:1); 
1H NMR (CDCl3, 300 MHz) δ 
7.41-7.32 (m, 5H), 5.80 (ddt, J = 17.4, 10.2, 7.2 Hz, 1H), 5.14 (ddd, J 
= 9.5, 3.6, 1.4 Hz, 4H), 4.96 (s, 1H), 3.87-3.59 (m, 3H), 2.33 (td, J = 
14.1, 7.0 Hz, 3H), 1.64 (s, 1H).; 13C NMR (CDCl3, 75 MHz) δ 134.0, 128.7, 128.4, 128.3, 118.6, 
67.0, 65.2, 52.7, 35.9; [α]20D = +24.0 (c = 1.0, DCM); ʋmax (film) cm
-1 3400, 2359, 1696; HRMS 
(ESI) m/z calcd for C6H11NO2: 235.1208, found 236.1301 [M+H]
+. The characterization was 
in accordance with previously reported results.21
5.5.15 — N-Cbz-(S)-3-amino-5-hexenenitrile (30b)
The compound was prepared according to the method described by 
Beyermann et al.24  To a solution of N-Cbz-(S)-2-amino-4-pentenol 
(29b, 3.87 g, 16.5 mmol) in dry DCM (150 mL) was added triethyl-
amine (3.80 mL, 27.3 mmol) and methanesulfonyl chloride (1.70 
mL, 21.8 mmol) at 50 °C. After one hour the reaction mixture 
was warmed to RT and diluted with heptane (100 mL), and successively washed with 
saturated aqueous KHCO3 (100 mL), brine (100 mL), dried (Na2SO4) and concentrated 
in vacuo to yield the mesylate as an off-white solid. This was dissolved in DMF (150 mL) 
and NaCN (0.95 g, 19.4 mmol) was added. The mixture was heated for 4 hours at 50 °C. 
After completion water (250 mL) was added to the mixture and the organic phase was 
extracted with Et2O (2 × 250 mL). The combined organic layers were washed with water 
(250 mL), brine (250 mL), dried (Na2SO4) and concentrated in vacuo to yield N-Cbz-(S)-
3-amino-5-hexenenitrile (30b, 2.07 g, 8.46 mmol, 51% yield) in two steps as a colorless 
oil. Rf 0.70 (EtOAc:heptane 1:1); 
1H NMR (CDCl3, 300 MHz) δ 7.41-7.30 (m, 5H), 5.26-5.17 
(m, 2H), 5.11 (s, 2H), 4.92 (s, 1H), 3.95 (dd, J = 11.9, 5.4 Hz, 1H), 2.69 (ddd, J = 20.9, 16.8, 4.9 
Hz, 2H), 2.42 (t, J = 7.1 Hz, 2H).; 13C NMR (CDCl3, 75 MHz) δ 136.1, 132.3, 128.8, 128.5, 128.3, 
120.1, 117.1, 67.3, 47.3, 37.77, 23.08; [α]20D = -10.3 (c = 1.0, DCM); ʋmax (film) cm
-1, 2857, 2240, 
1739; HRMS (ESI) m/z calcd for C14H16N2O2: 244.1297 found 245.1290 [M+H]
+.
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5.5.16 — N-Boc-(S)-3-amino-5-hexenenitrile (30a)
 This compound was synthesized via method 5.5.15 from 29a (6.08g, 
30.2mmol) and resulted in 30a (1.96g, 9.33mmol) in 30% isolated 
yield. Rf 0.54 (EtOAc:heptane 1:1); 
1H NMR (300 MHz) δ 5.76-5.70 
(m, 1 H), 5.25-5.19 (m, 2 H), 4.67 (s, 1 H), 3.89 (s, 1 H), 2.78-2.70 (m, 
1 H), 2.57 (dd, J = 4.2 Hz, 1H), 2.40 (t, J = 7.1 Hz, 1H), 1.45 (s, 9 H); 13C 
NMR (CDCl3, 75 MHz) δ 155.1, 132.6, 119.8, 117.3, 80.4, 46.8, 37.9, 28.4, 23.1; [α]
20
D = -20.2 (c 
= 1.1, DCM); ʋmax (film) cm
-1, 3364, 2242, 1678; LRMS (ESI) m/z calcd for C11H18N2O2: 210.14 
found 211.1 [M+H]+, 233.1 [M+Na]+.
5.5.17 — N-Cbz-(S)-3-amino-5-hexenal (13b)
The compound was prepared according to the method described by 
Ibuka et al.25
 To a solution of N-Cbz-(S)-3-amino-5-hexenenitrile (30b, 391 
mg, 1.60 mmol) in dry toluene (50 mL) was added DIBAL-H (2 
mL, 2.00 mmol) at -42 °C over a period of 3 hours. After full 
conversion, saturated aqueous citric acid (10 mL) was added dropwise over a period of 
20 minutes and the reaction mixture was allowed to warm up to RT and subsequently ex-
tracted with Et2O (3 × 30 mL). The water layer was neutralized with saturated NaHCO3 and 
extracted with Et2O (3 × 30 mL). The organic layer was washed with saturated NaHCO3 (1 × 
40 mL), dried with Na2SO4, filtrated and concentrated in vacuo. After column purification 
N-Cbz-(S)-3-amino-5-hexenenitrile (12b, 215 mg, 0.869 mmol) was obtained in 54% yield 
as a white solid. Rf 0.60 (EtOAc:heptane 1:1); 
1H NMR (CDCl3, 300 MHz) δ 9.75 (s, 1H), 
7.45-7.26 (m, 5H), 5.87-5.62 (m, 1H), 5.21-5.02 (m, 2H), 4.96 (s, 1H), 2.83-2.65 (m, 2H), 2.35 
(t, J = 4.6 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ 200.9, 155.9, 133.6, 128.7, 128.3, 128.2, 119.3, 
67.0, 47.9, 46.6, 39.1; [α]20D = -24.5 (c = 0.75, DCM); ʋmax (film) cm
-1 2938, 2361, 1747; HRMS 
(ESI) m/z calcd for C14H17NO3: 247.12867, found 248.12846 [M+H]
+.
N-Boc-(S)-3-amino-5-hexenal (13a) was obtained in the same fashion from N-Boc-(S)-3-
amino-5-hexenenitrile (30a, 0.250 mg, 1.19 mmol) and resulted in the desired product in 54% 
yield (138 mg, 0.649 mmol).
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5.5.18 — N-Alloc-(S)-3-amino-5-hexenenitrile (30c)
To a solution of N-Boc-(S)-3-amino-5-hexenenitrile (30a, 268 mg, 
1.28 mmol) in DCM (10 mL), was added dropwise TFA (10 mL, 1.28 
mmol) at 0 °C. The reaction mixture was warmed to RT after 30 
minutes and stirred for 2 h and was subsequently concentrated in 
vacuo to yield (S)-3-amino-5-hexenenitrile TFA salt (290 mg, 1.30 
mmol, 100%) as a white solid.
 (S)-3-Amino-5-hexenenitrile TFA salt (150 mg, 0.670 mmol) was dissolved in water (30 
mL) and sodium carbonate (355 mg, 3.35 mmol) was added while stirring. The resulting 
solution was cooled to 5 °C and allyl chloroformate (0.143 mL, 1.34 mmol) was added 
slowly as a cooled solution in 1,4-dioxane (30 mL). The resulting mixture was stirred at 0 
°C for 1.5 h and allowed to warm to RT. Water (50 mL) was added and the aqueous layer 
was extracted with EtOAc (2 × 50 mL). The organic layer was washed with saturated aque-
ous sodium bicarbonate (2 × 75 mL). The combined aqueous layers were acidified to pH 1 
with 2 M aqueous HCl and extracted with EtOAc (3 × 75 mL). The combined organic layers 
were dried (Na2SO4) and concentrated in vacuo. The resulting oil was purified with col-
umn chromatography (EtOAc:heptane 1:1) to obtain N-Alloc-(S)-3-amino-5-hexenenitrile 
(30c, 90 mg, 69%). Rf 0.45 (EtOAc:heptane 1:1); 
1H NMR (300 MHz, CDCl3) δ ppm 5.91 (m, 
1 H), 5.72 (m, 1 H) , 5.25 (m, 4 H), 4.88 (m, 1 H), 4.57 (d, J = 5.5 Hz, 2H), 3.94 (m, 1 H), 2.77 
(dd, J = 5.0, 16.3 Hz, 1H), 2.59 (dd, J = 4.3, 16.8 Hz, 1H), 2.42 (t, 2 H).
5.5.19 — N-Alloc-(S)-3-amino-5-hexenenitrile (13c)
 This compound was synthesized via method 5.5.17 from 30c (80.0 
mg, 0.412 mmol) and resulted in 13a (35.1 mg, 0.181 mmol) in 44% 
isolated yield. Rf 0.40 (EtOAc:heptane, 1:1); 
1H NMR (400 MHz, 
CDCl3) δ ppm 9.76 (s, 1 H), 5.95-5.89 (m, 1 H), 5.81-5.72 (m, 1 H), 
5.30-5.15 (m, 4 H), 4.99-4.85 (m, 1 H), 4.54 (d, J = 4.9 Hz, 2H), 
4.20-4.12 (m, 1 H), 2.72-2.63 (m, 2 H), 2.42-2.29 (m, 2H).
5.5.20 — N-Cbz-(3R,4S,6S)-6-allyl-2-(hydroxymethyl)piperidine-2,3,4-triol (32)
To a solution of glycerol (1.00 mL, 500 mM), PPi (296 mg, 250 mM, 
3:2 Na2PPi/Na4PPi) was added 1M aqueous NaOH solution until 
pH 6.5. Then aldehyde 13b (192 mg, 500 μL, 1 M) in DMSO was 
added after which catalase (20 μL, 10 U/mL) from bovine liver, 
RhuA (2892 μL, 6 U/mL) and GPO (884 μL, 50 U/mL) were added. 
The total volume of the reaction was set with MilliQ to 4.43 mL and PhoN-Sf (667 μL, 3 
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U/mL) was added, after which the reaction mixture was incubated at 20 °C for 25 h while 
the reaction mixture was gently shaken. The reaction mixture was analyzed with HPLC 
every 2 h and after 25 h it was precipitated in MeOH (50 mL), filtered and the filtrate was 
concentrated in vacuo. The crude product was purified using column chromatography 
(EtOAc:MeOH 19:1). A conversion of 65% was obtained, based on recovered starting 
material. 85.1 mg of product 32 was isolated (multiple spots on TLC (EtOAc:DCM 1:2), 
which is 51% yield based on product mass). Rf 0.5-0.6 (EtOAc:MeOH 19:1); 
1H NMR (400 
MHz, CD3OD) δ ppm 7.30 (m, 5 H), 5.74 (m, 1 H), 5.22-4.95 (m, 4 H), 4.47 (m, 1 H), 3.74 
(m, 1 H), 3.96 and 3.63 (J = 8.75 Hz, 2 H C6-I), 3.93 and 3.48 ppm (9.02 Hz, 2 H C6-II), 3.47 
(m, 1 H), 2.22 (m, 2 H), 1.71 (m, 2 H); 13C NMR (75 MHz, CDCl3) δ ppm 157.5, 156.89, 138.4, 
138.2, 129.4, 129.3, 129.3, 128.7, 128.6, 128.5, 122.1, 117.9, 117.6, 115.3, 97.8, 96.6, 75.3, 72.5, 
70.9, 66.9, 66.6, 65.8. ʋmax (film) cm
-1 3329, 3069, 2927, 2359, 2330, 1695, 1534, 1262, 1233, 
1056, 698. LRMS (ESI) m/z calcd for C17H23NO6: 337.15 found 338.16.
5.5.21 — 2-(N-Cbz-2-piperidinyl)ethanol (37)
2-(2-Piperidinyl)ethanol (10.1 g, 78.0 mmol) was dissolved in DCM 
(250 mL) and triethylamine (10.8 mL, 78 mmol) was added, followed 
by the dropwise addition of CbzCl (1.55 mL, 109 mmol) over a period 
of 20 min at 0 °C. The reaction mixture was stirred overnight at RT 
and washed subsequently with aqueous saturated NaHCO3 (500 mL) 
water (250 mL) and brine (250 mL). The organic layer was dried (Na2SO4) and concentrated 
in vacuo. The crude product was purified using flash chromatography (EtOAc:heptane 1:2 
+ 1% NEt3) to afford 2-(N-Cbz-2-piperidinyl)ethanol (37, 18.2 g, 69.1 mmol, 89% yield) as 
an oil. Rf 0.45 (EtOAc:heptane 1:2 + 1% NEt3); 
1H NMR (300 MHz, CDCl3) δ ppm 7.42-7.30 
(m, 5 H), 5.15 (br s, 2 H), 4.55-4.41 (m, 1 H), 4.20-4.01 (m, 1 H), 3.56-3.39 (m, 3 H), 2.77 (t, 
J = 12.7 Hz, 1 H), 1.97-1.46 (m, 8 H); 13C NMR (75 MHz, CDCl3) δ ppm 156.9, 136.6, 128.7, 
128.2, 128.0, 67.5, 58.6, 47.0, 39.4, 32.5, 29.3, 25.6, 19.2; ʋmax (film) cm
-1: 3383, 3062, 3030, 
2935, 2862, 1690, 1423, 1263, 1051, 697. HRMS (ESI) m/z calcd for C15H22NO3: 263.3321, 
found 264.3373 [M+H]+. The characterization was in accordance with previously reported 
results.26
5.5.22 — 2-(N-Cbz-2-piperidinyl)acetaldehyde (36)
To a cooled solution (–78 °C) of DMSO (3 mL, 42.2 mmol) in DCM (100 
mL) was added slowly a solution of 2,2,2-trifluoroacetic anhydride 
(3.5 mL, 24.8 mmol) in DCM (100 mL). After 10 minutes a solution of 
2-(N-Cbz-2-piperidinyl) ethanol (37, 2.04 g, 7.74 mmol) in DCM (50 
mL) was added over 15 minutes. The reaction was quenched with DIPEA (11.0 mL, 63.0 
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mmol) in DCM (50 mL). After 10 minutes, the reaction temperature was allowed to warm 
up to RT. The reaction mixture was washed with water (100 mL), aqueous HCl (100 mL, 0.1 
M), saturated aqueous NaHCO3 (100 mL) water (100 mL) and brine (100 mL). The organic 
layer was dried and concentrated in vacuo to afford 2-(N-Cbz-2-piperidinyl) acetalde-
hyde (36, 1.65 g, 6.31 mmol, 82% yield) after column chromatography as an oil. Rf 0.50 
(EtOAc:heptane 1:1); 1H NMR (300 MHz, CDCl3) δ ppm 9.73 (s, 1H), 7.42-7.29 (m, 5 H), 5.14 
(s, 2 H), 5.05-4.89 (m, 1 H), 4.09 (d, J = 13.5 Hz, 1 H), 2.87 (t, J = 13.4 Hz, 1 H), 2.85-2.57 (m, 
2 H), 1.82-1.36 (m, 6 H); 13C NMR (75 MHz, CDCl3) δ ppm 200.3, 155.2, 136.8, 128.7, 128.2, 
128.0, 67.0, 46.3, 44.7, 39.5, 28.6, 25.3, 19.0; ʋmax (film) cm
-1: 3380, 2935, 2861, 1687, 1421, 
1259, 1173 cm–1. HRMS (ESI) m/z calcd for C15H20NO3: 261.14432, found 262.14331 [M+H]
+. 
The characterization was in accordance with previously reported results.26
5.5.23 — 1-(N-Cbz-2-piperidinyl)-4-penten-2-ol (38)
To a suspension of indium powder (28, 201 mg, 1.75 mmol) in 
ethanol:water 1:1 (30 mL) was added 3-bromoprop-1-ene (0.144 
mL, 1.66 mmol). The solution was stirred for 30 min at RT followed 
by the addition of 2-(N-Cbz-2-piperidinyl) acetaldehyde (36, 146 
mg, 0.561 mmol. The reaction was stirred overnight and the solid indium was filtered 
off. Ethanol was evaporated in vacuo and the residue was dissolved in DCM (50 mL). 
The organic layer was washed with brine (50 mL), dried over Na2SO4 and evaporated to 
dryness. The resulting oil was purified using column chromatography to obtain 1-(N-Cbz-
2-piperidinyl)-4-penten-2-ol (38) as a 1:1 mixture of diastereoisomers: A (79.2 mg, 0.260 
mmol, 46%) and B (88.0 mg, 0.290 mmol, 52%).
A: Rf 0.45 (EtOAc:heptane 1:3); 
1H NMR (300 MHz, CDCl3) δ ppm 7.45-7.29 (m, 5 H), 
5.88-5.76 (m, 1 H), 5.23-5.05 (m, 2 H), 5.12-5.02 (m, 2 H), 4.59-4.46 (m, 1 H), 4.10-3.98 
(m, 1 H), 3.55-3.39 (m, 1 H), 2.86 (t, J = 13.7 Hz, 1H), 2.30-2.18 (m, 2 H), 2.11-1.99 (m, 1 H), 
1.81-1.51 (m, 7 H); 13C NMR (75 MHz, CDCl3) δ ppm 157.0, 138.2, 135.2, 129.5, 129.3, 129.0, 
125.1, 117.4, 69.5, 68.1, 49.9, 37.5, 30.1, 29.8, 29.5, 19.6; ʋmax (film) cm
-1: 3372, 2932, 2855, 
1666, 1425, 1259, 1173.
B: Rf 0.30 (EtOAc:heptane 1:3); 
1H NMR (300 MHz, CDCl3) δ ppm 7.43-7.31 (m, 5 H), 
5.89-5.78 (m, 1 H), 5.15-5.09 (m, 2 H), 5.07-4.99 (m, 2 H), 4.55-4.47 (m, 1 H), 4.07-4.02 
(m, 1 H), 3.65-3.51 (m, 1H), 2.96 (t, J = 13.7 Hz, 1H), 2.27-2.20 (m, 2 H), 1.86-1.51 (m, 8 H); 13C 
NMR (75 MHz, CDCl3) δ ppm 157.1, 138.2, 136.2, 129.5, 129.0, 128.8, 117.4, 69.5, 68.1, 49.7, 
42.8, 40.7, 37.4, 29.2, 26.7, 19.8; ʋmax (film) cm
-1: 3385, 2927, 2855, 1671, 1423, 1260, 1170. 
The characterization was in accordance with previously reported results.27
N
OH
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5.5.24 — 1-(2-Piperidinyl)-4-penten-2-ol (39)
1-(N-Cbz-2-piperidinyl)-4-penten-2-ol (38, 300 mg, 1.15 mmol) 
was added to a stirred solution of HBr in acetic acid (33%, 30 
mL). After 1 hour the solution was concentrated in vacuo and 
co-evaporated with toluene (3 × 30 mL). To a suspension of 
indium powder (245 mg, 2.13 mmol) in ethanol:water (1:1, 30 mL) was added 3-bromo-
1-propene (0.200 mL, 2.32 mmol). The solution was stirred for 30 min at RT, followed 
by the addition of 2-(2-piperidineyl)acetaldehyde HBr salt (148 mg, 0.711 mmol). The 
reaction was stirred for 16 h and the solid indium was filtered off. Ethanol was evaporated 
in vacuo, followed by subsequent addition of aqueous saturated NaHCO3 until pH 7 and 
extraction with EtOAc (4 × 20 mL). The combined organic layers were dried (Na2SO4) 
and evaporated to dryness. The resulting oil was purified using a sulfonic acid column to 
obtain 1-(2-piperidinyl)-4-penten-2-ol (39, 66.8 mg, 0.404 mmol, 55% over 2 steps). Rf 
0.60 (DCM:MeOH, 9:1 + 1% NEt3); 
1H NMR (300 MHz, CD3OH) δ ppm 5.95-5.79 (m, 1 H), 
5.14-5.06 (m, 2 H), 3.94-3.65 (m, 2 H), 2.97-2.88 (m, 2 H), 2.28-2.20 (m, 2 H), 1.95-1.69 (m, 
8 H); 13C NMR (75 MHz, CDCl3) δ ppm 135.8, 118.3, 70.0, 68.2, 59.4, 57.2, 46.2, 46.1, 43.7, 
43.1, 40.3, 30.2, 30.0, 23.3, 23.4; ʋmax (film) cm
-1: 3512, 2920, 2855, 1412, 1164; HRMS (ESI) 
m/z calcd for C10H20NO: 169.27190, found: 170.27967 [M+H]
+.
5.5.25 — (E)-1-(2-Piperidinyl)-4-undecen-2-ol (40)
To a stirred solution of 1-octene (1.00 mL, 6.42 mmol) in 
DCM (10 mL) was added Grubbs-II (20 mg, 0.024 mmol) and 
1-(2-piperidinyl)-4-penten-2-ol (39, 50.4 mg, 0.295 mmol). The 
reaction mixture was heated to refluc and TFA (0.025 mL, 0.324 mmol) in DCM (2 mL) was 
added dropwise over a period of 1 hour, after which the reaction mixture was refluxed 
for an additional 16 h. After cooling to RT, aqueous saturated NaHCO3 was added to the 
reaction mixture until pH 7 and subsequently the aqueous mixture was extracted with 
EtOAc (4 × 10 mL). The organic layers were dried with Na2SO4 and concentrated in vacuo 
to obtain (E)-1-(2-piperidinyl)-4-undecen-2-ol (40, 49.7 mg, 0.197 mmol, 66%) as a color-
less oil after solid phase extraction with a sulfonic acid column. Rf 0.90 (DCM:MeOH, 
9:1 + 1% NEt3); 
1H NMR (300 MHz, CD3OH) δ ppm 5.55-5.47 (m, 2 H), 3.90-3.63 (m, 2 H), 
2.92-2.84 (m, 2 H), 2.32-2.17(m, 4 H), 1.81-1.43 (m, 16 H), 0.88-0.81 (m, 3 H); LRMS (ESI) m/z 
calcd for C16H31NO: 253.24 found 254.5 [M+H]
+.
N
H
OH
N
H
OH
C6H13
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Chemoenzymatic 
synthesis of azepanes
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“If we knew what it was we were doing, it would not be called research, would it?” 
― Albert Einstein
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Abstract
This chapter describes the application of the four-enzyme cascade in the synthesis of 
azepane derivatives. Trihydroxysubstituted azepanes were obtained in a four- to six-step 
synthesis via intramolecular reductive amination of the aldol product, which in turn was 
obtained in the enzymatic cascade reaction. Starting materials were aminoaldehydes, of 
which the nitrogen atom was typically protected as an azido- or nitro-functional group.
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6.1 — Introduction
Research so far in the area of iminosugars has been mainly focused on the synthesis of 
five- and six-membered ring analogues that resembled the transition state of known 
glycosidase inhibitors.1 In addition, some efforts have been directed at seven-membered 
ring iminosugars. For example, Wong et al. showed that seven-membered polyhy-
droxyiminocyclitols, in particular C2-symmetrical tetrahydroxyiminocyclitol (1), can be 
used as common scaffold for the development of glycosidase and HIV/FIV inhibitors 
(Figure 1).1a
N
H
HO
OHHO
OH
1
Figure 1 — C2-symmetrical tetrahydroxyiminocyclitol.
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Scheme 1 — Examples of synthetic routes to azepanes.
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Polyhydroxyazepanes (seven-membered ring nitrogen heterocycles) display more flex-
ibility as compared to their five- and six-membered analogues. They may adopt a pseudo-
chair conformation that mimics the transition state of the enzymatic glycosidic cleavage. 
This could result in an improved binding to the active site of the glycosidase enzyme.1a 
Throughout the years, different polyhydroxyazepane derivatives have been synthesized 
and evaluated for their biological activity (Scheme 1). Synthetic routes have been devel-
oped based on enzymatic aldol reactions (a),1a synthesis starting from sugar derivatives 
(b and c),2 epoxide openings (d and e),3 and ring-closing metathesis (f ).4 Drawbacks of 
these generally elegant approaches include lengthy synthetic procedures, use of organic 
solvents and production of relatively large amounts of waste. These drawbacks are largely 
due to the fact that multiple protecting group interconversions are required to obtain 
azepane analogues with the desired functionality and stereochemistry.
The synthetic route described in example f results in the 7-membered analogue 9 of 
D-fagomine (Section 4.2.1). We envisioned that a synthetic route to the latter analogue 
may also proceed via the previously described two- and four-enzyme cascade reactions, 
requiring a minimum of protecting group manipulation. More generally, azepanes of 
type 10 might be obtained via reductive amination of the corresponding aldol precursor 
11 (Scheme 2). This aldol product might be derived from protected aminoaldehyde 12 
using the enzymatic cascade reaction that was previously described (Section 3.2).
enzymatic cascade
10 11 12
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Scheme 2 — Retrosynthetic analysis of hydroxylated azepane 10
Clearly, the nucleophilic character of the amine in aldehyde 12 is not compatible with the 
aldehyde function.5 Therefore, the amine had to be masked as an azide or nitro moiety, 
which can be reduced prior to the reductive amination to liberate the required amine 
functional group.
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6.2 — Results and discussion
6.2.1 — Synthesis of aldehyde derivatives
We initially restricted ourselves to the synthesis of 4-nitrobutanal (14) and 4-azidobutanal 
(16) (Scheme 3). Nitro aldehyde 14 was obtained through DIBAL-H reduction of the cor-
responding commercially available methyl ester 13, which proceeded smoothly in 64% 
isolated yield.
O2N
OMe
O
O2N
H
O
DIBAL-H
DCM, -78 °C, 1 h
64%
Br OH N3
H
O
1) NaN3, DMF, 40 °C, 3 d
2) DMSO, (COCl)2, Et3N
    DCM, -78 °C
13 14
15 16
Scheme 3 — Synthesis of 4-nitro- and 4-azidobutanal.
The synthesis of 4-azidobutanal (16) appeared more challenging. A first attempt involved 
nucleophilic substitution of bromide 15 with sodium azide.6 Subsequently, the azido 
alcohol was oxidized to the corresponding aldehyde 16 under Swern conditions. TLC 
analysis indicated a clear spot-to-spot conversion, however no aldehyde was obtained 
after work-up. An alternative route proceeded via ozonolysis of 6-bromohexene, but also 
did not result in the desired aldehyde. To circumvent the problem of isolation and pos-
sible degradation, commercially available chloro acetal 17 was used as the starting point. 
On the one hand, substitution with sodium azide provided acetal 18, which could be 
hydrolyzed in situ to aldehyde 16 without further work-up and isolation (Scheme 4). On 
the other hand, this strategy also provided 4-chlorobutanal (19), which may additionally 
serve as a substrate for the enzymatic cascade.
Cl
O
O NaN3
DMF, 35 °C, 4 d
94%
N3
O
0.1 M HCl
RT, 1 d
Cl
N3
O
O
0.1 M HCl
RT, 1 d
17 18
19 16
O
H H
Scheme 4 — Synthesis of azido aldehyde 16.
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2-(2-Nitrophenyl)acetaldehyde (21) and 2-(2-azidophenyl)acetaldehyde (25) were also 
synthesized (Scheme 5). We anticipated that the conformational restriction introduced 
by the aryl moiety should enhance seven-membered ring formation during the reduc-
tive amination. 2-(2-Nitrophenyl)acetaldehyde (21) was synthesized via Dess-Martin 
periodinane (DMP) oxidation of commercially available alcohol 20 in a moderate yield 
of 55% (Scheme 5). Azido analogue 25 was synthesized from the same starting material 
20 in a four-step procedure.7 First, alcohol 20 was protected with a tert-butyldimethylsilyl 
(TBDMS) group in 80% yield, followed by subsequent reduction of the nitro-group and 
diazotization with isoamyl nitrite to afford 2-(2-azidophenyl)ethanol (24) in 85% yield 
over two steps. Finally, DMP was used as a mild oxidative agent to oxidize the primary 
alcohol into the corresponding aldehyde, thereby providing the targeted aldehyde 25 in 
an overall yield of 50% over four steps.
NO2
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NO2
O
H
20
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OTBDMS
NO2
OTBDMS
NH2
TBDMSCl, pyridine
0 °C, 36 h, 84%
Pd/C, H2
MeOH 
16 h, 80%
OH
N3
O
N3
2. NaN3, EtOH 
    0 °C, 2 h, 85%
DMP
EtOH, RT 
1 d, 87%
H
DMP, DCM 
40 °C, 2 d
55%
22 23
25 24
1. isoamylnitrite, HCl 
    (conc.), EtOH 
    0 °C, 45 min
Scheme 5 — Synthesis of phenacetaldehydes 21 and 25
6.2.2 — Two-step synthesis of azepanes via the catalytic cascade
The four aldehydes were subjected to the conditions of the enzymatic cascade reactions 
(Chapter 3). First, these aldehydes were tested in the two-enzyme cascade with DHA to 
investigate the substrate acceptance by RAMA on analytical scale (0.5 mL). When prod-
uct formation was observed by HPLC, the reaction was repeated with the four-enzyme 
cascade and glycerol on analytical scale and eventually on preparative scale (10 mL) so 
that the products could be isolated and characterized.
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Scheme 6 — Two-step azepane synthesis via enzymatic cascade reactions.
Aliphatic aldehydes 16 and 19 were tested fi rst (Scheme 6). A 0.5 mL solution of 500 
mM DHA, 250 mM PPi and 100 mM aldehyde at pH 6 was incubated with RAMA (6 U/
mL) and PhoN-Sf (3 U/mL) at 20 °C. It was possible to analyze the reaction by HPLC at 
selected time intervals to determine the ratio of PPi to Pi, the formation of phosporylated 
product, dephosphorylated end product, and the amount of aldehyde converted. Figure 
2 clearly indicates that aldehyde 16 was accepted by RAMA, and similar chromatograms 
were obtained for aldehyde 19. Then the reaction was repeated with glycerol (500 mM), 
RAMA (6 U/mL), PhoN-Sf (3 U/mL), GPO (50 U/mL) and catalase (20 U/mL), which also 
proceeded smoothly according to HPLC analysis. The reaction was repeated at prepara-
tive scale (10 mL) and after 48 h, the aldol products were obtained in a d.r. of 15.6:1 and 
isolated via silica gel purifi cation and obtained in 13 (26) and 35% (27) isolated yield.
Figure 2 — Time course on HPLC, aliquots of 20 μL were 10 times diluted and measured.
These yields were surprisingly low compared to the conversions measured by HPLC. 
Conversions were estimated at 75-85% for the azido (26) and 85-95% for the chloro aldol 
product (27), based on the NMR analysis and calibration curves of the isolated products. 
Multiple products, however, were observed on TLC after work-up, indicating degradation 
of the isolated products that led to the relatively low isolated yields upon purifi cation.
Nevertheless, aldol product 26 was submitted to the reductive amination conditions 
(Pd/C, H2) in MeOH at room temperature, resulting in full conversion overnight to afford 
azepane 28 in quantitative yield. The reductive amination occurred without selectivity at 
the C-2 position, providing a 1:1 ratio of the corresponding diastereoisomers. Separation 
of the diastereoisomers has hitherto not been successful. This enzymatic route produced 
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the azepane in four steps, while the route described in literature required ten steps.4 
Unfortunately, chlorinated aldol product 27 degraded over time, therefore the synthesis 
of the corresponding azepane was no longer pursued.
O
H
O2N
OH
O
OH
500 mM glycerol or DHA,
250 mM PPi
6 U/mL RAMA, 3 U/ml PhoN-Sf,
(50 U/mL GPO, 2.4 U/mL catalase)
pH 6, 20 °C, 24 h14100 mM
29
O2N
OH
Scheme 7 — Aldol reaction of 4-nitrobutanal 14.
Nitrobutanal 14 was readily accepted by RAMA (Scheme 7), which was also predicted by 
the computational studies on RAMA described in Chapter 2. The conversion of nitrobu-
tanal into the corresponding aldol product 29 occurred at a rate that was more than twice 
as high as for propanal in the four-enzyme cascade. In six hours, most of the aldehyde was 
consumed and the reaction was incubated overnight for optimal conversion (Figure 3).
Figure 3 — HPLC chromatogram of four-enzyme cascade with 4-nitrobutanal.
However, no traces of nitroaldol product 29 were observed after work-up, instead forma-
tion of a single diastereoisomer of nitrocyclohexitol 30 was observed (Scheme 8).8
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HO NO2
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30
H+ H+
-H+-HB
Scheme 8 — Intramolecular Henry reaction.
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The slightly acidic conditions of the cascade reaction were sufficient for the Henry reac-
tion to take place in 81% conversion to provide nitrocyclohexitol 30 as a single diastereo-
isomer in 45% isolated yield.
N
H OH
OH
OH
O
HX OHX
OH
O
OH
500 mM glycerol or DHA,
250 mM PPi
6 U/mL RAMA, 3 U/ml PhoN-Sf,
(50 U/mL GPO, 2.4 U/mL catalase)
pH 6, 20 °C, 24 h21 (X = N3)
25 (X = NO2)
31 (X = N3) 15%
     d.r. >19:1
32 (X = NO2) 0%
X = N3
TES, Pd/C
MeOH,
16 h, 70%
33
100 mM
Scheme 9 — Synthesis of an aryl-substituted azepane.
Finally, the phenacetaldehydes 21 and 25 were submitted to the cascade reaction condi-
tions (Scheme 9). The two-enzyme cascade reaction with DHA and nitro analogue 25 
did not result in any product formation. Upon analyzing the HPLC results, we concluded 
that no phosphorylation had occurred, indicating that aldehyde 25 inhibited the PhoN-Sf 
activity and blocked the synthesis of DHAP. This inhibition was not observed with azido-
substituted aldehyde 21. Product formation was observed on analytical scale with the 
two-enzyme cascade reaction and DHA, however, the reaction required extra addition of 
DMSO to solubilize the aldehyde. With the four enzyme cascade reaction on preparative 
scale, 15% of aldol product 31 was isolated as a single diastereoisomer. The poor solubil-
ity thwarted accurate determination of the conversion, as no adequate calibration curve 
could be obtained. Next, the reductive amination was performed to produce azepane 
33. Subjection of aldol product 31 to standard hydrogenation conditions (H2 and Pd/C 
in MeOH) did not result in the formation of the azepane. Therefore, the reaction was 
repeated in the presence of triethylsilane (TES) and Pd/C as catalyst to generate H2 in 
situ, which produced azepane 33 in an isolated yield of 70%.9 Again, no selectivity was 
observed at the C-2 carbon so that the product was isolated as a 1:1 mixture of diastereo-
isomers.
6.3 — Conclusion
Two trihydroxyazepane derivatives were synthesized using the four-enzyme cascade 
reaction. The examples involved an aliphatic aldehyde and 2-azidophenylacetaldehyde, 
which afforded the desired azepane derivatives in four to six steps. This route offers an 
alternative strategy towards azepanes in significantly less steps compared to the classical 
protecting group strategy synthesis from sugars.4
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6.5 — Experimental
6.5.1 — General information
The general information is described in Section 2.5.1
6.5.2 — Enzymes
The information of the enzymes is described in Section 3.5.2.
6.5.3 — Analytical methods and product characterization
The HPLC method is described in Section 5.5.3.
6.5.4 — 4-Nitrobutanal (14)
To a solution of methyl 4-nitrobutanoate (11, 0.401 g, 2.71 mmol) 
in anhydrous DCM (30 mL, –78 °C) was added DIBAL-H (3.0 mL, 
3.0 mmol, 1M solution in hexanes) and the reaction was stirred for 
1 hour. The temperature was increased to –40 °C and 10% aqueous potassium sodium 
tartrate (2 mL) was added. After stirring for 30 min, the temperature was increased to RT, 
and the aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers 
were washed with water (3 × 50 mL), dried over Na2SO4, filtrated and concentrated in 
vacuo. The crude product was purified by column chromatography (heptane:EtOAc 9:1 
→ 2:1) to afford 14 (204 mg, 64%) as a yellow liquid. Rf: 0.35 (heptane: EtOAc 3:1); 
1H NMR 
(300 MHz, CDCl3) δ 9.80 (s, 1H), 4.45 (t, J = 6.6 Hz, 2H), 2.67 (t, J = 6.9 Hz, 1H), 2.31 (t, J = 
6.7 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 198.8, 73.8, 39.2, 19.1; ʋmax(film) cm
-1 2840, 2734, 
1720, 1435, 1383, 1277, 816, 677. The analytical data were in accordance with previously 
reported results.10
O
H
O2N
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6.5.5 — 2-(3-Azidopropyl)-1,3-dioxolane (18)
A solution of 2-(3-chloropropyl)-1,3-dioxolane (17, 0.810 g, 5.38 
mmol) in DMF (40 mL) was treated with sodium azide (0.55 g, 8.34 
mmol) and stirred for 3 days at 40 °C. The conversion was analyzed 
by GC. 10 Equiv. of H2O were added to the reaction mixture and the aqueous layer was 
extracted with EtOAc (3 × 50 mL). The combined organic fractions were dried and con-
centrated at 500 mbar to afford 18 as a colorless liquid (0.79 g, 93%). Rf: 0.35 (heptane: 
EtOAc 3:1); 1H NMR (300 MHz, CDCl3) δ 4.89 (t, J = 4.1 Hz, 1H), 4.02-3.79 (m, 4H), 3.33 (t, 
J = 6.7 Hz, 2H), 1.80-1.68 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 104.3, 65.5, 51.8, 31.4, 24.0; 
ʋmax(neat) cm
-1 2932, 2094, 1673, 1449, 1091, 609.
6.5.6 — 4-Azidobutanal (16)
Method 1: A solution of 2-(3-azidopropyl)-1,3-dioxolane (18, 0.11 g, 
0.68 mmol) in 0.1 M aqueous HCl (20 mL) was stirred at RT for 2 
days. The deprotection was analyzed by TLC and GC. H2O (5 mL) 
was added and the reaction mixture was extracted thoroughly with Et2O (3 × 50 mL). The 
organic phase was washed with brine (75 mL), dried with Na2SO4 and concentrated under 
reduced pressure (650 mbar). The crude product was purified over a small silica plug and 
eluted with DCM. The pure fractions were combined and concentrated in vacuo (100 
mbar, 40 °C) to obtain 16 as a colourless liquid in quantitative yield (78 mg, 100%). The 
sample was stored at –80°C under argon.
Method 2: 2-(3-Azidopropyl)-1,3-dioxolane (18, 0.25 g, 1.6 mmol) was dissolved in 0.1M 
HCl as a 0.5 M solution and stirred for 16 h. Quantitative deprotection to 16 was observed 
by HPLC. Rf: 0.4 (heptane: EtOAc 3:1); 
1H NMR (400 MHz, CDCl3) δ 9.81 (t, J = 1.2 Hz, 1H), 
3.36 (t, J = 6.6 Hz, 2H), 2.58 (td, J = 7.1, 1.2 Hz, 2H), 2.10-1.90 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 200.6, 50.3, 40.5, 21.2; ʋmax(film) cm
-1 3441, 2936, 2874, 2087, 1721. The analytical 
data were in accordance with previously reported results.11
6.5.7 — 4-Chlorobutanal (19)
This compound was synthesized via method 1 for 4-azidobutanal (16).
1H NMR (300 MHz, CDCl3) δ 9.82 (t, J = 1.0 Hz, 1H), 3.60 (t, J = 6.3 
Hz, 2H), 2.67 (td, J = 7.0, 1.0 Hz, 2H), 2.17-2.05 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 200.4, 43.6, 40.4, 24.4; ʋmax(film) cm
-1: 3441, 2961, 2832, 2727, 1720, 790, 
732. The analytical data were in accordance with previously reported results.12
N3
O
O
N3
O
H
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6.5.8 — 2-(2-Nitrophenyl)acetaldehyde (21)
Dess-Martin periodinane (0.26 g, 0.61 mmol) was added in one 
portion to a stirred solution of 2-(2-nitrophenyl)ethanol (20, 0.51 g, 
3.0 mmol) in DCM (20 mL) at RT. The reaction mixture was stirred 
at RT under an inert atmosphere for 2 days and two additional por-
tions of DMP (2 × 0.26 g, 2 × 0.61 mmol) were added after 18 h and 40 h. The mixture 
was poured into a 1:1 mixture of saturated aqueous NaHCO3 and a saturated aqueous 
Na2S2O3 and was stirred vigorously for 30 min. The layers were separated and the aque-
ous layer was extracted with DCM (3 × 40 mL). The combined organic layers were dried 
over MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (heptane:EtOAc 4:1 → 2:1) to afford 21 (0.27 g, 55%) as a yellow solid. Rf: 
0.54 (heptane:EtOAc 3:1); 1H NMR (300 MHz, CDCl3) δ 9.83 (t, J = 0.9 Hz, 1H), 8.12 (dd, J 
= 8.1, 1.5 Hz, 1H), 7.62 (td, J = 7.5, 1.4 Hz, 1H), 7.49 (td, J = 8.1, 1.5 Hz, 1H), 7.31 (d, J = 9.0 Hz, 
1H), 4.11 (s, 2H); 13C NMR (75 MHz, CDCl3) δ 196.3, 148.0, 133.4, 133.0, 128.4, 128.0, 124.9, 
48.0; ʋmax(neat) cm
-1: 2850, 1723, 1610, 1520, 787. The analytical data were in accordance 
with previously reported results.7
6.5.9 — O-t-Butyldimethylsilane-2-(2-nitrophenyl)ethanol (22)
An excess of pyridine (5 mL) was slowly added to an ice-cooled 
mixture of 2-(2-nitrophenyl)ethanol (20, 0.501 g, 3.01 mmol) and 
tert-butyldimethylsilyl chloride (0.451 g, 2.99 mmol). The reaction 
mixture was stirred overnight, quenched by the addition of ice and extracted with 
Et2O (3 × 20 mL). The combined organic layers were washed with brine (50 mL), dried 
(Na2SO4) and concentrated in vacuo. The yellow residue was purified by silica column 
chromatography (heptane:EtOAc 3:1) to afford 22 as a yellow liquid (2.74 g, 84%). Rf: 0.81 
(heptane:EtOAc 3:1); 1H NMR (300 MHz, CDCl3) δ 7.90 (dd, J = 8.1, 1.4 Hz, 1H), 7.54-7.47 
(m, 1H), 7.39 (t, J = 13.8 Hz, 2H), 3.89 (t, J = 6.4 Hz, 2H), 3.12 (t, J = 6.3 Hz, 2H), 0.83 (s, 9H), 
–0.05 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 149.7, 134.4, 133.5, 132.6, 127.5, 124.7, 63.2, 36.5, 
26.0, –5.4; ʋmax(neat) cm
-1: 2928, 2856, 1610, 1577, 1525, 1471, 1254, 776. The analytical data 
were in accordance with previously reported results.7
6.5.10 — 2- O-t-Butyldimethylsilane-2-(2-aminophenyl)ethanol (23)
Nitro compound 22 (2.74 g, 9.71 mmol) in methanol (15 mL) was 
sirred in the presence of Pd/C (0.1 g (10% Pd/C), 94 mmol) under a 
H2 atmosphere and stirred overnight. The crude product was filtered 
over a Celite plug and concentrated in vacuo to afford 23 as a red oil (0.29 g, 80%). Rf: 
NO2
O
H
OTBDMS
NO2
OTBDMS
NH2
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0.58 (heptane:EtOAc 3:1); 1H NMR (CDCl3, 300 MHz) δ 7.02 (m, 2H), 6.69 (m, 2H), 3.88 (t, 
J = 6.0 Hz, 2H), 2.76 (t, J = 6.0 Hz, 2H), 0.90-0.83 (m, 9H), –0.02 (s, 6H); 13C NMR (CDCl3, 
75 MHz) δ 146.0, 130.9, 127.7, 119.0, 116,2, 64.8, 35.6, 30.0, 26.2, 18.1, –5.2; ʋmax(neat) cm
-1: 
3442, 3352, 3021, 2927, 2883, 1622, 1587, 1254, 776. LRMS (EI+) m/z calcd for C14H25NOSi: 
251.17 found 252.20 [M+H]+. The analytical data were in accordance with previously re-
ported results.7
6.5.11 — 2-(2-Azidophenyl)ethanol (24)
Amine 23 (1.67 g, 6.61 mmol) was dissolved in ethanol (50 mL). Con-
centrated HCl (1.3 mL) was added, and the mixture was cooled on an 
ice bath. Isopentyl nitrite (1.0 mL, 7.4 mmol) was added dropwise at 
T <5 °C. After diazotization the mixture was stirred at 0 °C for 45 min. 
A 0.6 M aqueous solution of sodium azide (0.59 g, 9.13 mmol) was slowly added and 
evolution of N2 was observed. The solution was slowly heated to ambient temperature, 
and MTBE and water (1:1, 50 mL) were added. To facilitate proper phase separation, NaCl 
was added. The aqueous phase was extracted with MTBE (2 × 50 mL) and the combined 
organic layers were washed with aqueous saturated NaHCO3 (50 mL), water (50 mL) and 
dried over anhydrous Na2SO4. After filtration the mixture was concentrated in vacuo. The 
residue was purified by column chromatography (heptane:EtOAc 3:1 → 1:1) to obtain 24 
as a yellow liquid (0.92 g, 85%). Rf: 0.6 (heptane:EtOAc 3:1); 
1H NMR (300 MHz, CDCl3) δ 
7.33-7.08 (m, 4H), 3.81 (dd, J = 6.5, 5.2 Hz, 2H), 2.87 (t, J = 6.7 Hz, 2H), 2.03 (t, J = 5.1 Hz, 1H); 
13C NMR (75 MHz, CDCl3) δ 138.6, 131.6, 130.3, 128.2, 125.0, 118.4, 62.8, 34.9; ʋmax(neat) 
cm-1 3322, 2928, 2124, 1581, 1489, 1283, 749; LRMS (EI+) m/z calcd for C8H9N3O: 163.07 
found 164.07 [M+H]+. The analytical data were in accordance with previously reported 
results.7
6.5.12 — 2-(2-Azidophenyl)acetaldehyde (25)
2-(2-Azidophenyl)ethanol (24, 0.84 g, 5.1 mmol) and DMP (1.5 g, 7.7 
mmol) were dissolved in DCM (50 mL) and stirred at RT for 48 h. 
The reaction mixture was washed with a 1:1 mixture of 0.9 M sodium 
thiosulfate and saturated aqueous sodium bicarbonate (2 × 50 mL) 
and the resulting mixture was stirred for ca. 10-15 min. The organic phase was separated, 
washed thoroughly with water (3 × 50 mL), brine (50 mL), dried with Na2SO4 and con-
centrated in vacuo. The residue was purified using silica gel column chromatography 
(heptane:EtOAc 3:1) to afford 25 (0.72 g, 87%) as a brownish oil. Rf: 0.55 (heptane:EtOAc 
3:1); 1H NMR (300 MHz, CDCl3) δ 9.70 (t, J = 1.9 Hz, 1H), 7.40-7.33 (m, 1H), 7.20-7.05 (m, 
3H), 3.67 (d, J = 1.9 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 198.5, 138.1, 131.2, 128.4, 124.4, 
OH
N3
O
N3
H
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123.3, 117.9, 45.5; ʋmax(neat) cm
-1 2930, 2121, 1722, 1582, 1489, 1285, 751; LRMS (EI+) m/z 
calcd for C8H7N3O: 161.06 found 162.06 [M+H]
+.
6.5.13 — General procedure A for the one-pot two-enzyme cascade
To a solution of 500 mM dihydroxyacetone, 250 mM PPi (3:2 Na2PPi/Na4PPi),
13 and 100 
mM aldehyde in water, 6 U/mL RAMA was added. The reactions were initiated by adding 
3 U/mL PhoNSf and incubated at 20 °C under mild shaking (350 RPM) until completion. 
Dephosphorylation to the end product was completed after 24 h.
6.5.14 — General procedure B for the one-pot four-enzyme cascade
To a solution of 500 mM glycerol, 250 mM PPi (3:2 Na2PPi/Na4PPi),
13 and 100 mM alde-
hyde in water 2.4 U/mL catalase from bovine liver, 6 U/mL RAMA, and 100 U/mL GPO 
were added. The reactions were initiated by adding 3 U/mL PhoN-Sf and incubated at 
20 °C under mild shaking until completion. Dephosphorylation to the end product was 
completed after 24 h.
6.5.15 — General procedure C for the preparative scale one-pot four-enzyme 
cascade
To a solution of aldehyde (1.00 mmol) in water (total volume 10 mL) were added glycerol 
(2.00 mL, 2.5 M, 5.0 mmol) and PPi (591 mg, 2.5 mmol),
13 followed by GPO (1.00 mL, 50 
U/mL), catalase from bovine liver (20 μL, 10 U/mL) and RAMA (161 μL, 6 U/mL). The reac-
tions were initiated by adding PhoN-Sf (600 μL, 3 U/mL) and incubated until completion 
at 20 °C under mild shaking. Silica gel (2 g) was added to the reaction mixture and it was 
concentrated under reduced pressure. The product was obtained by flash chromatogra-
phy (EtOAc:MeOH 19:1).
6.5.16 — (3S,4R)-7-Azido-1,3,4-trihydroxyheptan-2-one (26)
This compound was synthesized via method 6.5.15 from 16 (130 mg, 1.0 
mmol) and resulted in 26 (26 mg, 0.13 mmol) in 13% isolated yield.
Rf 0.2 (DCM:MeOH 9:1); 
1H NMR (300 MHz, CD3OD) δ 4.48 (q, J = 2.4 
Hz, 2H), 4.12 (d, J = 2.4 Hz, 1H), 3.90 (td, J = 6.9, 2.4 Hz, 1H), 3.34(t, J = 5.9 Hz, 2H), 1.82-1.55 
(m, 2H); 13C NMR (75 MHz, CD3OD) δ 213.6, 79.4, 73.0, 67.9, 52.4, 31.4, 26.5; ʋmax(film) 
cm-1: 3369, 2924, 2359, 2097, 1722, 1407, 1353, 1253, 1072, 959, 907, 668, 605, 555; [α]20D : 
–3.2 (c = 0.05, H2O); LRMS (FAB
+) m/z calcd for C7H13N3O4: 203.09 found 204.20 [M+H]
+, 
226.09 [M+Na]+, 242.09 [M+K]+.
OH
O
OHN3
OH
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6.5.17 — (3S,4R)-7-Chloro-1,3,4-trihydroxyheptan-2-one (27)
This compound was synthesized via method 6.5.15 from 19 (106 mg, 1.0 
mmol) and resulted in 26 (69 mg, 0.35 mmol) in 35% isolated yield.
Rf: 0.45 (DCM:MeOH 9:1); 
1H NMR (500 MHz, CD3OD) δ 4.53 (d, J = 
2.6 Hz, 1H), 4.43 (d, J = 2.6 Hz, 1H), 4.03 (d, J = 2.4 Hz, 1H), 3.82 (td, 1H, J = 6.9, 2.4 Hz), 3.51 
(t, J = 6.6 Hz, 2H),1.90-1.68 (m, 4H); 13C NMR (75 MHz, MeOD) δ 212.2, 78.0, 71.5, 66.5, 
44.3, 30.3, 28.9; ʋmax(film)cm
-1: 3331, 2924, 2853, 1722, 1661, 1611, 1509, 1395, 1257,1068, 
876, 644, 619, 575, 456; [α]20D : –3.4 (c = 0.011, MeOH).
6.5.18 — (3R,4R)-2-(Hydroxymethyl)azepane-3,4-diol (28)
 (3S,4R)-7-Azido-1,3,4-trihydroxyheptan-2-one (26, 11.7 mg, 0.058 mmol) 
was dissolved in MeOH (15 ml). Pd/C (10 mg, 0.058 μmol) was added 
and the mixture was placed under a H2 atmosphere and stirred at RT 
overnight. The reaction mixture was concentrated, the crude product 
was purified over a sulfonic acid column and concentrated to afford 28 (12.4 mg, 0.077 
mmol, 100%) as a 1:1 diastereomeric mixture. Rf: 0.20 (DCM:MeOH 9:1); 
1H NMR (500 
MHz, CD3OD) δ 3.95-3.60 (m, 4.5H), 3.4-3.1 (m, 2.5H), 2.1-1.7 (m, 4H); 
13C NMR (125 MHz, 
CD3OD) δ 74.21, 72.59, 70.95, 70.75, 64.56, 62.32, 61.27, 57.01, 47.53, 47.53, 30.49, 29.22, 
20.81, 18.68; ʋmax(film) cm
-1: 3129, 3042, 2815, 1753, 1628, 1402, 778, 742; HRMS (ESI+) m/z: 
Calcd for C7H15NO3: 161.1052, found 162.1142 [M+H]
+.
6.5.19 — (1S,2S,3R,6R)-1-(Hydroxymethyl)-6-nitrocyclohexane-1,2,3-triol (30)
This compound was synthesized via method 6.5.15 from 14 (117 mg, 1.0 
mmol) and resulted in 30 (93 mg, 0.45 mmol) in 45% isolated yield.
Rf: 0.15 (DCM:MeOH 9:1); 
1H NMR (500 MHz, CD3OD) δ 4.80 (dd, J 
= 12.9, 4.0 Hz, 1H), 3.82 (d, J = 11.0 Hz, 1H), 3.73 (ddd, J = 11.6, 9.4, 4.7 
Hz, 1H), 3.37 (d, J = 9.4 Hz, 1H), 3.35 (d, J = 11.0 Hz, 1H), 2.47-2.37 (m, 1H), 2.00 (m, 1H), 1.98 
(m, 1H), 1.33 (m, 1H); 13C NMR (75 MHz, CD3OD) δ 86.33, 77.03, 75.05, 70.90, 61.78, 29.49, 
24.63; ʋmax(neat) cm
-1: 3448, 3290, 2931, 1550, 1468, 1364, 788; [α]20D : 3.7 (c = 0.042, H2O); 
LRMS (FAB+) m/z calcd for C7H13NO6: 207.07 found 208.08 [M+H]
+, 230.07 [M+Na]+.
6.5.20 — 5-(2-Azidophenyl)-1,3,4-trihydroxypentan-2-one (31)
This compound was synthesized via method 6.5.15 from 21 (161 mg, 1.0 
mmol) and resulted in 31 (38 mg, 0.15 mmol) in 15% isolated yield.
OH
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Rf: 0.5 (EtOAc:MeOH 9:1); 
1H NMR (500 MHz, CD3OD) δ 7.24-7.16 (m, 2H), 7.13-7.08 (dd, 
J = 8.0, 1.0 Hz, 1H), 7.02-6.97 (td, J = 7.5, 1.1 Hz, 1H), 4.42 (d, J = 19.5 Hz, 1H), 4.34 (d, J = 
19.5 Hz, 1H), 4.10 (td, J = 7.3, 2.0 Hz, 1H), 3.91 (d, J = 2.0 Hz, 1H), 2.85-2.71 (m, 2H); 13C NMR 
(75 MHz, CD3OD) δ 214.0, 138.7, 133.0, 130.8, 129.2, 125.8, 119.1, 78.5, 73.2, 67.9, 36.3; 
ʋmax(film)cm
-1: 3392, 2923, 2123, 1722, 1581, 1490, 1451, 1285, 753; [α]20D   :+2.4 (c = 0.010, 
MeOH).
6.5.21 — (3R,4R)-2-(Hydroxymethyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-
3,4-diol (33)
 (3S,4R)-5-(2-Azidophenyl)-1,3,4-trihydroxy-2-pentanone (31, 2.67 
mL, 0.040 mmol) was dissolved in methanol (20 mL), followed by 
the addition of Pd/C (13 mg, 0.125 μmol). TES (0.20 mL, 1.25 mmol) 
was added dropwise to the mixture and it was stirred overnight. After 
completion (TLC) the reaction mixture was filtered through a Celite plug, concentrated 
in vacuo and purified with silica gel column chromatography (EtOAc:MeOH 16:1→10:1) 
to afford azepane 33 (10.6 mg, 0.051 mmol, 41%) as a 1:1 mixture of diastereoisomers. Rf: 
0.65 (DCM:MeOH 9:1); 1H NMR (500 MHz, CD3CN) δ 7.06-6.95 (m, 2H), 6.79-6.73 (m, 
2H), 3.97 (dd, J = 10, 5 Hz, 1H, C6-1), 3.72 (t, J = 5 Hz, 1H, C6-2), 3.57-3.37 (m, 3H), 3.21-3.17 
(m, 0.5H), 3.11-3.07 (m, 1H), 2.98 (d, 1H, J = 20 Hz), 2.73-2.68 (m, 1.5H), 2.52 (dt, 0.5H); 13C 
NMR (125 MHz, CD3CN) δ 148.98, 132.09, 130.76, 129.33, 128.49, 127.37, 127.01, 121.55, 
121.13, 119.90, 119.37, 109.97, 77.83, 73.89, 72.73, 69.39, 62.98, 62.45, 62.36, 58.09, 38.85, 
36.17; ʋmax(film) cm
-1: 3120, 3050, 2850, 1605, 1407, 1181, 760; HRMS (ESI+) m/z Calcd. for 
C11H15NO3: 209.1052, found 210.1139 [M+H]
+.
N
H OH
OH
OH
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Perspective Enzymatic cascade 
reactions:past, present and future
“Human beings make mistakes. They’re supposed to. That’s how they learn.” 
– Harry Palmer
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Abstract
Herein I give my view on the past four years of research by comparison of the initial goal 
with the final results and encountered bottlenecks in search of novel enzymatic cascade 
reactions. This also results in a personal outlook on future chemoenzymatic cascade 
processes.
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7.1 — Past: the initial concept
After million years of evolution, the diversity of functions of enzymes has reached an 
enormous level creating numerous applications in different scientific fields. The efficiency 
of sequential reactions catalyzed by enzymes in Nature is striking, especially compared 
to classical chemical reactions, which usually require multiple separate steps including 
work-up procedures and a multitude of chemical reagents. The motivation of the NWO/
ACTS IBOS (Integration of Bio- and Organic Synthesis) program was to integrate both 
fields and use the combined knowledge of biochemists and synthetic chemists to pursue 
new undiscovered reaction pathways to highly functionalized molecules. Especially the 
idea of integrating multiple strategies in one approach appealed to me as this required a 
broader perspective from an organic chemist and an open mind to solutions offered by 
the field of biochemistry. Our project mainly focused on exploring the scope and limita-
tions of enzymatic cascade reactions with the aim to synthesize enantiomerically pure 
multifunctional heterocycles via efficient and sustainable processes. Key in our research 
was the formation of C-C bonds using the well-known aldol reaction to prepare polyhy-
droxylated carbohydrate fragments. Classically, this approach requires protecting group 
strategies, expensive catalysts and multiple steps. Enzymes, however, are able to perform 
these reactions stereoselectively in water without protecting groups in a single step, thus 
resulting in a greener approach.
7.2 — Present: the results after four years of research
7.2.1 — The accomplishments
The research in this manuscript was focused on creating more sustainable chemistry 
routes using biocatalysis as a substitute for laborious multistep procedures containing 
multiple (de)protection steps and resulted in a one-pot four-enzyme cascade reaction al-
lowing us to synthesize non-natural carbohydrate fragments in high enantio- and diaste-
reoselectivities with RAMA as aldolase. With this procedure we were able to synthesize 
various iminosugars from natural resources.
7.2.2 — The bottlenecks encountered
Enzymes are limited with respect to their specific mode of action and substrate specificity, 
which was demonstrated with the synthesis of diastereoisomeric precursors of fagomine 
using the stereocomplementary aldolases. The results with these aldolases were on the 
one hand encouraging in the sense that reactions did proceed, but on the other hand 
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also disappointing due to the generally moderate diastereoselectivity and yields. The 
diastereoselectivity could be tuned with the synthesis of more suitable acceptor alde-
hydes, however chemical synthesis of these aldehydes remains challenging. Previously 
reported results demonstrated that α-branching may lead to higher diastereoselectivities 
in case of RhuA and FucA.1 Our research also demonstrated that β-branching positively 
influenced the diastereoselectivity of RhuA in the synthesis of a batzellaside precursor us-
ing the four-enzyme cascade strategy. These results certainly imply that in case a specific 
diastereoisomer needs to be produced on larger scale, the enzyme specificity could be 
optimized by using genetic engineering techniques such as directed evolution2 and gene 
shuffling.3 The development optimized enzymes might however require a significant 
investment in research.
Another drawback we encountered was the larger scale availability of enzymes in or-
der to be able to produce sufficient amounts of carbohydrate building blocks for follow-
up chemistry. This was required given the aim of the IBOS project use the enzymatic 
cascades for the synthesis of libraries of functionalized heterocycles of interest to the 
pharmaceutical and fine chemical industry. To realize this goal the enzymes had to be 
expressed in large quantities and preferably should be recycled. One bottleneck in the 
scaling up process was the availability of RAMA. This enzyme is commercially available, 
but extracted from rabbits. An effective recombinant system from bacteria would greatly 
reduce the amount of waste, but current alternative expression systems have not been 
efficient up to now.4 PhoN-Sf and the other aldolases were available via recombinant sys-
tems, but even then it would require too much effort to produce the amounts of enzymes 
needed to synthesize grams of the required building blocks. As an example, as much as 
60 U were required to synthesize 1 mmol of aldol product via the four-enzyme cascade, 
meaning that scaling up is laborious and expensive. This, and the bottleneck of recycling 
the enzymes, was elegantly tackled by the group of Wever. They initially showed that 
by immobilization of PhoN-Sf on beads and carrying out the phosphorylation step in 
a continuous flow system led to preparative amounts of the corresponding phosphate 
products.5 In a later stage, they also demonstrated that by combining immobilized PhoN-
Sf and inmmobilized RAMA in a flow reactor, the two-enzyme cascade strategy could be 
applied on larger scale to produce the carbohydrate building blocks in gram amounts.6 
Hence, the continuous flow strategy might provide an excellent opportunity to realize 
the scaling up process.
The last bottleneck was the timing. For a successful synthetic strategy, the optimization 
and modification of enzymes was preferred on forehand, but these routes were pursued 
simultaneously. It would have been favorable to have the enzymes optimized and in bulk 
available to optimize the results in the time span of the IBOS project. Nevertheless we 
were able to combine the two scientific fields, organic chemistry and biochemistry, into 
a fruitful collaboration between our university, the University of Amsterdam (Lara Babich, 
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MSc.), Wageningen University (Pierpaolo Falcicchio, MSc.) and in the case of synthesis of 
batzellaside, Catalonia Institute for Advanced Chemistry, Barcelona (Prof. Dr. Clapés). As 
a result the four-enzyme catalyzed cascade reaction was developed, which combines the 
perspectives of both research fields in an aligned fashion that resulted in a publication in 
Green Chemistry and three poster prizes at conferences.
7.3 — Future: outlook
From my perspective, the biggest challenge we face in the field of multiple enzyme 
catalysis is the availability of enzymes with a broad substrate specificity and selectivity. 
As mentioned in the previous paragraph, this problem could be tackled with directed 
evolution of the enzyme to enhance the selectivity and specificity, however optimiz-
ing these parameters might come at the expense of other parameters, such as reaction 
rate and stability. Clapés et al. have already demonstrated the effect of mutations on 
RhuA that allowed non-phosphorylated donor substrates such as dihydroxyacetone to 
give the same products with similar efficiency and selectivity.7 It would be interesting 
to extend the effect of mutations towards other donor substrates such as halogen- or 
cyanide-containing hydroxyacetone derivatives to modify the functionality of the final 
heterocycles. In addition, the aldolase could also be tuned to enhance the stereoselec-
tivity of the acceptor aldehydes to create a larger variety of functionalized heterocycles. 
The synthesis of modified acceptor aldehydes was challenging and we were unable to 
induce successful cascades with e.g. fluoride in the acceptor aldehyde. On the other 
hand, we were able to functionalize these heterocycles in a later stage. As demonstrated 
in Section 4.2.3, the introduction of fluoride on DNJ greatly enhances the activity against 
α-glucosidase. The group of Overkleeft demonstrated that N-alkylation also positively 
affects the activity.8 We have made a first attempt to combine the enzymatic cascade re-
action with the functionalization of the heterocycles to gain more insight in the structure 
activity relationship of these iminosugars for their glycosidase inhibiting properties, but 
further research is required.
The highly efficient acid phosphatase PhoN-Sf could be applied in cascade reactions 
combined with other homo- or heterogeneous catalysts that operate in acidic aqueous 
media. PhoN-Sf provides easy access to phosphorylated compounds that are challeng-
ing to synthesize with classic synthetic strategies that generally require multiple steps. 
As an example, with PhoN-Sf phosphorylated allylic alcohols can be readily produced 
generated that in situ in aqueous media can undergo palladium-catalyzed cross coupling 
reactions. This is a topic that is currently pursued in our research group.
With the immobilization of PhoN-Sf and RAMA and the development of a continuous 
flow system, the scaling up process has become successful.6 The large scale synthesis 
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with immobilized enzymes was first demonstrated with PhoN-Sf and 0.5 gram phos-
phorylated inosine was isolated.5 With the immobilization of RAMA, the two-enzyme 
cascade could be performed in a continuous system as well and the aldol products could 
be synthesized on gram scale.6 Another advantage of immobilization was suppression 
of the retro-aldol activity and only the aldol reaction was observed. Bottleneck of this 
approach is the use of DHA (Section 3.2), which makes the purification more difficult 
and it would be interesting to investigate the opportunities to immobilize GPO as well 
and perform the four-enzyme catalyzed cascade reaction in a continuous system starting 
from glycerol. The immobilization strategy greatly enhances the scaling up process and 
brings it one step closer to industrial application.
In the past four years we gained significantly more insight in enzymatic cascade reac-
tions with the stereoselective aldol reaction as key step. In my opinion is it an elegant al-
ternative for the classical approach, but to be industrial feasible, it requires more research 
in the optimization and expression of the enzymes, as well as the development of large 
scale immobilized enzymes to produce the aldol product on larger scale.
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“Unity can only be manifested by the Binary. Unity itself and the idea of Unity are already two.” 
- Buddha
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Iminosugars, cyclic sugar derivatives in which the ring oxygen atom has been replaced by 
nitrogen, are biologically active compounds that play an important role in the metabolic 
pathway. They are potent glucosidase and glycosyltransferase inhibitors and therefore may 
have pharmaceutical applications. In fact, two iminosugars are currently marketed as 
drugs. Over the years, many synthetic pathways have been developed to synthesize these 
types of molecules. In the search for efficient and sustainable synthetic strategies, chemists 
increasingly pursue approaches that are inspired by Nature. The ultimate goal is to mimic 
biosynthetic pathways and construct complex products via ingenious sequences of multiple 
enzymatic conversions in one pot, preferably with both high chemo- and stereoselectivity.
Chapter 1 provides an overview of chemoenzymatic routes towards polyhydroxylated 
piperidines focusing on chemoenzymatic strategies involving C–C bond formation cata-
lyzed by aldolases (Scheme 1). Nature provides four complementary aldolases to access 
all four diastereoisomers at the C3 and C4 positions.
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Scheme 1 — Retrosynthetic approach towards iminosugars.
The use of aldolases provides direct stereoselective access to carbohydrate structures 
without going through protecting group manipulations. The potential of existing aldolases in 
C–C bond formation, in particular the fructose-1,6-bisphosphate aldolase from rabbit muscle 
(RAMA), was extensively investigated in Chapter 2. With computational studies more insight 
was gained in the mechanistic properties of RAMA as well as its substrate specificity (Figure 1).
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OPO32- PO3H2 : no substrate
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the gamma position 
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Figure 1 — Structure activity relationships of donor and acceptor substrates for RAMA.
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Previously reported research shows that RAMA is highly specific towards its donor sub-
strate, while many varieties on the acceptor substrate are allowed. Computational studies 
predicted which variations were allowed, based on RAMAs natural acceptor aldehyde D-
glyceraldehyde-3-phosphate (D-G-3-P). These results were experimentally verified and from 
the resulting data we concluded that α-branching on the aldehyde resulted in a lower Vrel, 
which is in accordance with previously reported results. A small electron-withdrawing group 
(EWG), however, on the α-carbon resulted in a higher Vrel due to enhancement of the electro-
philicity of the carbonyl group. Double substitution with an EWG at the α-carbon, however, 
lowered the Vrel, probably due to steric hindrance or hydration of the carbonyl group. These 
results led us to conclude that the high Vrel of D-G-3-P was caused by the stabilizing effect of 
the phosphate group on the γ-position of the aldehyde with the phosphate pocket of the 
enzyme. This effect was also demonstrated by nitro- and carboxylic acid groups. According 
to the computational studies, these groups could mimic the hydrogen bond interactions with 
the enzyme. This was also demonstrated in the experimental verification as both aldehydes 
showed an increased Vrel.
RAMA requires dihydroxyacetone phopsphate (DHAP, Scheme 1) as a donor. Chapter 
3 describes a convenient procedure that was developed for the production of carbo-
hydrates in a highly enantio- and diastereoselective manner using an efficient one-pot 
four-enzyme-catalytic cascade that in situ generates DHAP, followed by the aldol reaction 
(Scheme 2).
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PPi
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DHAP
Scheme 2 — The catalytic cycle of the one pot four enzyme cascade reaction.
This cascade starts from inexpensive glycerol and the acceptor aldehyde, and proceeds 
without the need for protecting groups. The primary step is chemoenzymatic phosphory-
lation of glycerol by the phosphatase PhoN-Sf and subsequent oxidation by glycerol 
phosphate oxidase (GPO) to the energy rich phosphate ester DHAP at the expense of PPi. 
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In the same pot, the formed DHAP is coupled to a variety of aldehydes by DHAP-depen-
dent aldolases, such as RAMA, allowing the synthesis of all four possible stereoisomers.
Based on the four-enzyme-catalytic cascade, a two-step strategy to yield iminosugars 
was successfully demonstrated in Chapter 4. Upon optimization, the natural product 
D-fagomine was obtained in an overall yield of 69% (Scheme 3).
a) R1 = F; R2 = H
b) R1 = R2 = F
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Scheme 3 — Retrosynthesis of 6-membered ring iminosugars via the biocatalytic cascade.
A chemoenzymatic synthesis of deoxynojirimycin (DNJ) was also realized with this 
strategy and derivatization afterwards resulted in the corresponding C-3 (di)fluorinated 
iminosugars. The four-enzyme-catalytic cascade was also conducted using the comple-
mentary aldolases RhuA, TagA and FucA to synthesize epimeric precursors of D-fagomine. 
The results, however, demonstrated that the synthesis of the diastereoisomers is strongly 
dependent on the substrate specificity and stereoselectivity of the aldolases.
Chapter 5 describes an approach towards the synthesis of the so-called batzellasides, 
naturally occurring iminosugars (Scheme 4). The required precursor aldehyde was ob-
tained via a straightforward synthesis starting from commercially available (S)-allylglycine 
using a cyanide substitution to introduce the aldehyde carbon atom in an overall yield 
of 18%.
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O
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O
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N
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Scheme 4 — Synthetic approach towards batzellasides A–C.
The four-enzyme cascade was performed on the aldehyde at pH 6.5 using RhuA WT to 
provide the desired aldol product as the corresponding cyclic hemiaminal in 51% isolated 
yield. Unfortunately, attempts to convert the hemiaminal via reductive amination into 
the desired cyclic derivative were unsuccessful. To probe the feasibility of the final steps, 
S
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2-piperidylacetaldehyde was used as a model compound, on which the side chain via 
indium-catalyzed allylation and subsequent cross-metathesis was introduced in excel-
lent yields.
Chapter 6 describes the application of the four-enzyme cascade in the synthesis of 
azepane derivatives (Scheme 5). Trihydroxy-substituted azepanes were obtained in a 
four- to six-step synthesis via intramolecular reductive amination of the aldol product, 
which in turn was obtained in the enzymatic cascade reaction. Starting materials were 
aminoaldehydes, of which the nitrogen atom was typically protected as an azido or nitro 
group.
N
H
OH
OH
OH
R1
R2
H2N
OH
OH
O
OH
R2
R1 H
N
O
R2
R1
H
reductive amination enzymatic cascade
PG
Scheme 5 — Restrosynthesis of azepanes using the cascade reaction.
Finally Chapter 7 places this thesis in perspective and starts with the comparison of the 
initial goal with the final results and encountered bottlenecks in search of novel enzy-
matic cascade reactions. The research in this manuscript was focused on creating more 
sustainable chemistry routes using biocatalysis as a substitute for laborious multistep pro-
cedures containing multiple (de)protection steps and resulted in a one-pot four-enzyme 
cascade reaction allowing us to synthesize non-natural carbohydrate fragments in high 
enantio- and diastereoselectivities with RAMA as aldolase. With this procedure we 
were able to synthesize various iminosugars from natural resources. But to be industrial 
feasible, it requires more research in the optimization and expression of the enzymes, 
as well as the development of large scale immobilized enzymes to produce the aldol 
products on industrial scale.
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“Simplicity is the ultimate sophistication.”
 - Leonardo da Vinci
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Iminosuikers zijn suikerderivaten waarbij de zuurstof in de ring vervangen is door een 
stikstofatoom. Deze verbindingen hebben interessante biologische activiteiten, zo worden 
ze bijvoorbeeld gebruikt als remmers van de enzymen glucosidase en glycosyltransferase, 
die weer een belangrijke rol spelen bij het metabolisme. De farmaceutische industrie heeft 
dit type verbindingen nader onderzocht en momenteel zijn er zelfs twee iminosuikers als 
medicijn verkrijgbaar tegen diabetes en de ziekte van Gaucher. In de afgelopen jaren zijn 
er vele syntheseroutes ontwikkeld om deze verbindingen te maken. Ons doel was om een 
duurzame route te ontwikkelen waarbij we gebruik wilden maken van een biosynthetische 
route om deze complexe verbindingen te maken met de natuur als inspiratie. Uiteindelijk zou 
dit moeten leiden tot een éénpotssynthese met meerdere enzymen die chemo-, enantio-en 
diastereoselectief deze verbindingen kunnen produceren.
In Hoofdstuk 1 staat een overzicht van chemoenzymatische routes waarbij piperidines met 
een of meerdere hydroxylgroepen gesynthetiseerd worden, in het bijzonder de chemoen-
zymatische aanpak waarbij een van de de C–C bindingen gevormd wordt met behulp van 
aldolases (Schema 1). Er komen vier complementaire aldolases in de natuur voor, waarmee 
alle vier de diastereoisomeren op de C3- en C4-positie gevormd kunnen worden.
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Schema 1 — Retrosynthese van iminosuikers.
In Hoofdstuk 2 wordt dieper ingegaan op de werking van de aldolases waarbij in het 
bijzonder fructose-1,6-bisfosfaat aldolase RAMA nader onderzocht is. Met behulp van 
computergestuurde 3D simulatie werd een model verkregen waarmee we meer inzicht 
kregen in de werking van de acceptor en donor (Figuur 1).
S
Lieke BW CP v2.indd   157 12-09-12   13:33
158
Samenvatting
O
O
H H
P
O
OOHO
H H
O CH2 or S : slecht substraat
NH  : niet stabiel
PO32- H or SO3
- : geen
                  substraat
OPO32- PO3H2 : geen substraat
H Me : slecht substraat
H Me : geen substraat
C(3)H2 NH : inhibitor
OH H, CH3, N3 of NHAc : geen substraat
I, Br, Cl : inhibitor
F : slecht substraat
H
OH
O
Een kleine electronenzuigende groep op de alfa positie 
is toegestaan en heeft een gunstig effect op de Vrel.
O P
O
O O
Vorming van waterstofbruggen
op de gamma positie verhoogt
de Vrel enorm.
Substitutie op de alfa positie verlaagt Vrel.
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Figuur 1 — Structuur-activiteitsrelaties van donor en acceptor met RAMA.
RAMA is zeer specifiek voor het donorsubstraat, terwijl er meer mogelijkheden zijn voor 
het acceptorsubstraat. Deze werden met de computersimulatie voorspeld aan de hand 
van het natuurlijke substraat D-glyceraldehyde-3-fosfaat (D-G-3-P). Ter controle werd 
een aantal substraten experimenteel getest om zo de simulatie te kunnen toetsen. Dit 
leidde tot de conclusies vermeld in Figuur 1.
Het beste donorsubstraat is dihydroxyacetonfosfaat (DHAP, Schema 1) wat in Hoofd-
stuk 3 samen met het aldolproduct in één pot gesynthetiseerd wordt. Hierdoor ontstaat 
er een cascade aan reacties waarbij in totaal vier enzymen betrokken zijn (Schema 2).
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Schema 2 — De enzymatische cyclus van de éénpotsreactie met vier enzymen.
In de eerste stap wordt glycerol gefosforyleerd met pyrofosfaat door het fosfatase PhoN-
Sf, waarna het gevormde product geoxideerd wordt tot DHAP door het enzym glycerol 
fosfaat oxidase (GPO). Bij deze stap ontstaat tevens waterstofperoxide dat door catalase 
wordt omgezet in zuurstof en water. Het gevormde DHAP wordt vervolgens met het aan-
wezige aldehyde gekoppeld door het aldolase (bijvoorbeeld RAMA), waarna PhoN-Sf 
het gefosforyleerde aldolproduct hydrolyseert en het gewenste aldolproduct ontstaat.
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Hoofdstuk 4 laat zien dat met behulp van deze cascadereactie de gewenste iminosui-
kers in twee stappen gesynthetiseerd kunnen worden (Schema 3). Een van de voorbeel-
den is D-fagomine, dat geïsoleerd werd in een totale opbrengst van 69%. Verder werd 
deoxynojirimycin (DNJ) met de cascadereactie gesynthetiseerd.
a) R1 = F; R2 = H
b) R1 = R2 = F
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Schema 3 — Retrosynthese van iminosuikers met behulp van de cascadereactie.
Naast RAMA is de cascade ook uitgevoerd met de stereocomplementaire aldolases 
Rhamnulose (RhuA), Fuculose (FucA)en Tagatose aldolase (TagA) om epimeren van fago-
mine te maken, maar hierbij bleek dat de diastereoselectiviteit erg afhankelijk is van het 
acceptorsubstraat.
In Hoofdstuk 5 is een start gemaakt met de synthese van batzellaside, ook een na-
tuurlijk voorkomende iminosuiker (Schema 4). Het gewenste acceptoraldehyde werd 
gesynthetiseerd uit (S)-allylglycine in een totale opbrengst van 18%, waarna het werd 
gekoppeld in de cascadereactie en een cyclisch hemiacetaal gevormd werd.
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Schema 4 — Synthetisch plan voor de synthese van batzellasiden A–C.
In de cascadereactie werd gebruik gemaakt van RhuA om het gewenste diastereoiso-
meer te krijgen, dat geïsoleerd werd als hemiacetaal in een opbrengst van 51%. Helaas 
verliepen de vervolgstappen minder succesvol, zodat deze uiteindelijk gedaan zijn met 
de modelverbinding 2-piperidylacetaldehyde. De zijketen werd ingevoerd met behulp 
van een indium gekatalyseerde allylering en vervolgens werd met alkeenmetathese de 
gewenste keten ingevoerd.
De laatste toepassing van de cascadereactie staat beschreven in Hoofdstuk 6, waarbij 
uitvoerig wordt ingegaan op de synthese van trihydroxyazepanen (Schema 5). Deze 
azepanen werden verkregen door het reductief amineren van de overeenkomstige aldol-
S
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producten uit de cascadereactie. De stikstof in de acceptoraldehyden werd beschermd 
als azido- of nitro-groep.
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Scheme 5 — Restrosynthese van azepanen.
Ten slotte wordt in Hoofdstuk 7 het vierjarige promotieonderzoek in perspectief ge-
plaatst. Het doel van dit onderzoek was het ontwikkelen van een duurzame synthese-
route met behulp van enzymatische katalyse dat als vervangende methode gebruikt kan 
worden voor de klassieke aanpak waarbij meerdere bescherm- en ontschermstappen 
vereist waren. Met dit onderzoek is de cascadereactie ontwikkeld waarmee suikerderi-
vaten gesynthetiseerd kunnen worden met hoge enantio- en diastereoselectiviteit in één 
pot met vier enzymen. Hoewel dit op labschaal een uitstekend alternatief is, zal voor de 
industriële toepasbaarheid meer onderzoek nodig zijn waarbij het grootste knelpunt de 
beschikbaarheid van de enzymen is. Voor industriële toepassingen zou een methode 
ontwikkeld moeten worden waarbij de enzymen op grote schaal tot expressie gebracht 
kunnen worden, evenals het immobiliseren van deze enzymen op industriële schaal.
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“Our deepest fear is not that we are inadequate. Our deepest fear is that we are 
powerful beyond measure. It is our light, not our darkness that most frightens us. We 
ask ourselves, Who am I to be brilliant, gorgeous, talented, fabulous? Actually, who 
are you not to be? You are a child of God. Your playing small does not serve the world. 
There is nothing enlightened about shrinking so that other people won’t feel insecure 
around you. We are all meant to shine, as children do. We were born to make 
manifest the glory of God that is within us. It’s not just in some of us; it’s in everyone. 
And as we let our own light shine, we unconsciously give other people permission 
to do the same. As we are liberated from our own fear, our presence automatically 
liberates others.”1
1            A Return To Love: Refl ections on the Principles of A Course in Miracles 
- Marianne Williamson, quoted in Nelson Mandela’s inaugural speech.
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Hier staat het dan ineens allemaal op papier, mijn proefschrift. Vier jaar onderzoek, groei, 
ontmoediging, levenslessen, ontmoetingen en perspectieven. Dit had ik niet alleen kun-
nen en willen doen. Ik geloof niet dat de taal toereikend is om mijn waardering in woor-
den uit te drukken, maar ik zal een poging wagen ;-) Ik ben ontzettend dankbaar voor 
iedereen die op welke wijze ook een steentje heeft bijgedragen aan dit werk. Dat kan ‘m 
zitten in experimenten en wetenschap, maar ook in de kopjes thee of tedere schopjes 
onder mijn kont. Ik bedank jullie allemaal voor elke bijdrage hieraan!
Toch is er een aantal mensen dat ik graag nog even in de spotlights wil zetten en ja dat 
zijn er veel ;-) Allereerst Floris en Floris! Floris, bedankt voor de plaats die je me hebt 
aangeboden in je groep. Eerst als masterstudent bij Jorge, daarna als promovendus 
zelfstandig. Ook wil ik je bedanken voor je steun en perspectieven. Het was af en toe 
niet gemakkelijk, maar na een gesprek met jou waren er altijd weer nieuwe ideeën en 
mogelijkheden en konden we weer verder. Zelfs de tijdschriften hebben ons niet weten 
tegen te houden en mede dankzij jouw vertrouwen in ons werk is het toch gepubliceerd!
Floris, mijn co-promotor, jou wil ik ook graag bedanken voor de sparpartijtjes en nut-
tige tips. Jouw kennis over de (suiker)chemie is vaak zeer nuttig gebleken als we weer een 
uitdaging tegenkwamen! Daarnaast wil ik jou, Alide, Maxim, Jolijn en Lauke ook ontzet-
tend bedanken voor de leuke avondjes bij jullie thuis. Ik heb ervan genoten! Dit was vaak 
een welkome afleiding in de afgelopen jaren!
Dan misschien wel de belangrijkste personen die dit boekje tot stand gebracht hebben: 
de studenten die zich met hart en ziel gestort hebben op het onderzoek. Bram, jij mocht 
het spits afbijten. En meteen kreeg je een pittige klus. Je werk met nitrilhydratase is helaas 
niet in dit boekje verschenen, maar je inspanningen voor batzellaside wel! Het was een 
feest om met je te werken en ik wens je heel veel succes en vooral plezier met je promo-
tieonderzoek!
Daarna nam Danny het stokje van je over. Danny, jouw zelfstandigheid en kunde op 
het lab maakten de begeleiding voor mij erg gemakkelijk. Je hebt uitstekend werk gele-
verd, wat zich ook uitte in je eindpunt. Ik wens je heel veel plezier bij Avantium en wie 
weet kruisen onze wegen elkaar nog wel eens.
Luuk, jij hebt het misschien van alle studenten wel het lastigst gehad. Wat op papier 
zo simpel leek, bleek in de praktijk heel wat uitdagender. Ik ben enorm trots op wat we 
uiteindelijk samen hebben weten te creëren. Ik denk dat onze samenwerking wel bewijst 
dat we beiden niet vies waren van een uitdaging ;-) Bedankt voor jouw bijdrage aan dit 
boekje in de vorm van hoofdstuk 7!
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In deze periode werd mijn groepje ineens uitgebreid met Freek, Sybrin en later Sander 
en toen was het hek van de dam ;-) Oké jongens ik heb echt ontzettend veel lol met jullie 
gehad! De foute muziekkeuzes, rare uitspraken en grapjes op het lab hebben regelmatig 
voor hilarische momenten gezorgd! Freek(alicious), jij hebt het batzellaside hoofdstuk 
mogen afronden en ook dit bleek niet zo simpel als het eruit zag. Maar met een beetje 
hulp uit het buitenland is het uiteindelijk een heel mooi hoofdstuk geworden, dankjewel! 
Veel succes in Leiden, ik kom graag over vier jaar naar je verdediging ;-)
Sybrin, jij werd eerst opgezadeld met een chemisch vraagstuk dat helaas op geen enkele 
manier op te lossen was. Gelukkig hadden we nog een alternatief in de koelkast staan en 
lag deze chemische uitdaging je heel wat beter. Je kon weer lachen en produceerde echt 
de strakste NMR spectra die ik in tijden gezien had! En hoeveel mensen kunnen nu zeg-
gen dat een ton in handen hebben gehad en ook rustig een stufie aan reacties verspilden, 
Bz ≠ Cbz ;-) Zonder jouw bijdrage was hoofdstuk 4 heel wat korter, thanx!
Sander G., ook bij jou wilde het maar niet van een leien dakje gaan. De computational 
studies gingen heerlijk vlot, maar ook hier bleek het gebruik van aldehyden in de praktijk 
ingewikkelder. Gelukkig heb je een mooie methode ontwikkeld om het toch allemaal in 
beeld te brengen en is dankzij jouw bijdrage hoofdstuk 2 ontstaan. Bedankt voor je inzet 
en aanwezigheid op het lab! En samen met Sander hoort er ook nog een dikke vette dank 
naar Sander N. uit te gaan! Voor je begeleiding van Sander en mij tijdens ons 3D RAMA 
avontuur, maar ook voor je input in de hoofdstukken en artikelen.
Stefan, ik wil jou heel erg bedanken voor je scriptie! Dankzij jouw kunde heb ik duide-
lijk inzicht gekregen in de wereld van chemoenzymatische piperidine synthese. Ik wens 
je waanzinnig veel succes met je promotie!
Ook heb ik nog Saskia en Frank voor een aantal weken bij me gehad. Saskia, jij kreeg de 
lastige taak van de fluorchemie, mede dankzij jouw werk heeft Sybrin dit later met succes 
af kunnen ronden, bedankt! En dan Frank, ook jij mocht worstelen met aldehyden ;-) En 
dankzij jouw werk hebben we nu een reproduceerbare route, thanx!
Naast de Nijmeegse inbreng was dit werk ook nooit tot stand gekomen zonder de 
hulp van de Wever groep! Allereerst jij Ron, bedankt voor de mogelijkheid om op de 
UvA kennis op te komen doen van de enzymen. Ook wil ik je bedanken voor het vele 
correctiewerk dat je hebt gedaan, zowel voor de artikelen als mijn manuscript. Louis, 
dankzij jouw kennis en jarenlange ervaring heb ik in de afgelopen jaren heel veel geleerd 
op biochemisch/microbiologisch vlak! Daarnaast heb je me kennis laten maken met 
Amsterdam tijdens de lunchwandelingen en hebben we Mexico verkend! Samen met 
Lara heb ik genoten van ons avontuur met de cocktails, tequila, Tulum en uiteraard ons 
tropische congres. Lara, we had a blast these past four years! I loved working together 
with you and creating our green chemistry masterpiece ;-) Thank you for your help and 
company in the lab! Good luck with finalizing your thesis and I am looking forward to 
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your defense! Teunie hoort ook bij dit rijtje uiteraard, want zonder jouw onderzoek was 
dat van ons niet eens mogelijk geweest! Ook wil ik je bedanken voor het plaatsnemen in 
de corona! En dan zijn er uiteraard nog Aleksandra, Michael en Rokus, thank you for your 
contributions! Han en Jan, jullie bedankt voor de moeite die jullie hebben gestoken op 
mijn massa en NMR spectra interpreteerbaar te krijgen. En uiteraard de Hiemstra-groep 
bedankt voor alle gezellige koffiepauzes!
Dat brengt me bij het IBOS team, Pierpaolo, John en Maurice van de WUR, Bernard en 
Martin van DSM, Prof. Kellogg van Syncom (een bijzonder dank voor uw deelname in 
de oppositie) en Gerjan van MSD, allen bedankt voor de input en discussie tijdens de 
meetings! In het bijzonder Pedro, allereerst bedankt voor het corrigeren en lezen van 
mijn manuscript, maar ook voor de overleguurtjes waarbij ik en mijn studenten al onze 
problemen op tafel konden gooien, dat gaf ons altijd weer mogelijkheden om verder te 
gaan!
Hans Scheeren, ook u wil ik nog even speciaal bedanken voor het lezen van mijn manus-
cript en deelname bij de verdediging, dankuwel!
I had a great opportunity to visit Barcelona and do some serious research, while staying in 
this awesome city. Prof. Clapés thank you so much for your hospitality! Without your help 
and that of Xavi, we would have never been able to create chapter 5. I learned a lot and 
really enjoyed the two weeks and I have you and your group to thank for that!
Dan is er nog een select groepje bijzondere mensen op de afdeling die ook zeker een 
speciale benoeming verdienen! Allereerst Jacky, wat zou ik (zouden we!) zonder je 
moeten! Met alles (maar dan ook echt alles!) kon ik bij je terecht, dankjewel. En dit geldt 
ook zeker voor Peter vD. Jouw kantoor stond altijd open voor een praatje of om leeg 
te roven qua glaswerk en andere benodigdheden ;-) Ook heb ik altijd erg genoten van 
onze filosofische gesprekken. En dan zijn er natuurlijk Peter vG. Ad, Paul en Helene, het 
powerteam dat ervoor gezorgd heeft dat mijn experimentelen compleet zijn. En om 
het lijstje volledig te maken: Marieke, Paula en Desiree, dankjulliewel voor alle hulp bij 
organisatorische problemen! Ook de heren van Chiralix, Richard en Peter, wil ik graag 
bedanken voor alle goede tips en adviezen als ik weer eens hun koelkast leeg kwam 
plukken!
Roseri, jou wil ik ook bijzonder bedanken voor al je steun tijdens de afgelopen jaren. Het 
was heel fijn om tegelijk met jou dit traject te doorlopen. Ook heb ik genoten van onze 
nachtelijke babbelsessies tijdens congressen en uiteraard ook voor de suikertoevoer 
tijdens de lezingen ;-) Je eerlijkheid en directheid vond ik heerlijk verfrissend. Bedankt 
D
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voor je taalpurisme tijdens het lezen van mijn manuscript. Egoïstisch gezien hoop ik dat 
je een baan als klinisch chemicus vindt in Amsterdam e.o., maar zo niet, dan weet ik 
zeker dat er ergens hier in Nederland een machtig mooi plekje op je wacht! Ook jou 
Jorge wil ik bedanken voor je kritische oog tijdens het lezen van de hoofdstukken. En 
daarnaast voor je humor en geweldige kookkunsten! Ik kijk er naar uit om je te feliciteren 
als Dr. Verkade, het zal je goed staan ;-) Uiteraard kan Marloes hierin niet ontbreken. Ook 
jij was er altijd voor een goed advies of om even mijn hart te luchten. Je bent samen met 
Jorge een heel fijn referentiepunt geweest tijdens mijn gehele RU tijd. Ik wens je samen 
met Sander heel veel plezier en geluk, waar jullie uiteindelijk ook terecht komen! En 
ook Britzen en Martijn verdienen een benoeming. Britzen voor de vunzige taal en uhm 
Limburgse meningen tijdens onze dinertjes met Roseri, Jorge en Marloes en Martijn voor 
zijn muzikale afleiding met Solid.
Dan wil ik iedereen van Lab 03.130 heel erg bedanken. En in het bijzonder Mariëlle, 
Nanda, Ahne, Mark, Sander vB, Berry, Moniek, Tim, Zaskia en Sophie voor alle heerlijke 
labpicknicks en fantaaastische muziek! En iedereen van de Rutjes-groep van 2005 tot nu.
En zijn er naast de labgenoten nog een aantal anderen die ik wil benoemen. Om te begin-
nen Patrick, onze avondjes NAC waren legendarisch! Er is maar één club in Brabant ;-) 
En de rest van mijn Breda posse: Kim, Monique, Margot, Yves, Marnix, Mike, Chris en 
Denise. En ook de Groene Sael cq Staalmeesters (of moet het inmiddels gewoon breed 
Rembrandtpark) posse: Kelly, Mauz, Sindy, Clemens, Lilian, Stephen, Ruud en Gertjan, 
ik ben zo blij met jullie afleiding (lees theeleutsessies, wijnproeverij, eindeloze BBQs, 
parkhangsessies) geweest! Heerlijk!
Poffer, Marieke jij verdient uiteraard ook een dikke vette dankjewel! Sinds 2004 ben je 
een humoristisch, geduldig en wijze vriendin in Nijmegen geweest! Uren kletsen met 
heel veel thee, kickfitten, spelletjes spelen en ooit nog een legendarische avond met 
chopstick Rik ;-)
En dan zijn er nog mijn lieve (Avatar)vriendinnetjes Carolien, Ellen, Marieke, Nathalie en 
Jos. Jullie hebben me van mijn zuiverste kant mogen zien. Bedankt dat jullie er voor me 
waren, altijd! En dan mijn skypemaatjes in de ochtend: Erma, Joke, Annemieke, Marieke, 
Natasja, Betina, Betty, Arienne en Paulien, jullie zorgen ervoor dat ik ’s ochtends weer fris 
en gemotiveerd mijn dag kon beginnen! Ook wil ik Marieke, Tonny en Pieta bedanken 
voor hun steun en wijsheid. And Harry thank you for the tools, they were mighty useful ;-)
Marc, ik ben jou heel erg dankbaar voor je liefde in de afgelopen jaren. Ik heb heel veel 
van jou en ons geleerd en ben heel blij dat je er tijdens mijn promotietijd als een rots in 
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de branding was. Onze wegen scheidden zich net voor het afronden hiervan en ik wens 
je heel veel liefde en een waanzinnig leven in de toekomst!
Ten slotte mijn familie, uiteraard wil ik jullie ook bedanken voor de steun in de afge-
lopen jaren. En in het bijzonder mijn broeders Janton en Lennar, tevens ook mijn para-
nimfen. Op Wikipedia (ja wetenschappers ik durf deze in mijn dankwoord wel als bron 
te gebruiken ;-)) staat het volgende vermeld bij paranimf: “Honderden jaren geleden, 
toen academische disputen bij een promotie nog wel eens hoog wilden oplaaien en de 
gemoederen danig verhit konden raken, dienden paranimfen als lijfelijke beschermers.” 
Ik kan me geen betere beschermers bedenken dan mijn twee (letterlijk!) grote broers. 
Inger en Nova, jullie verdienen ook een bijzonder plekje als de twee grote liefdes van 
mijn broertje, jullie zijn een hele waardevolle aanvulling op ons gezinnetje!
En dan mama, wat had ik zonder jou gemoeten. Soms was het niet eens nodig om te 
bellen, maar wist je al op afstand hoe het met me ging. Onze band is niet in woorden te 
vatten, altijd ben je eerlijk en wind je er geen doekjes om. Ik kon nog wel eens struisvogel 
spelen met mezelf, maar bij jou lukte dit nooit ;-) Dankjewel voor je onvoorwaardelijke 
liefde!
Zo het is een hele lap geworden, hoe kon het ook anders. Luitjes hiermee zet ik er echt 
een punt achter.
Veel liefs,
Het begin…..
D
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Abbreviations
Ac acetyl
AcOH acetic acid
AIBN 2,2’-azobisisobutyronitrile
All allyl
Alloc allyloxycarbonyl
aq. aqueous
Ar aryl
arom aromatic
ATP adenosine triphosphate
ax axial
Bn benzyl
Boc tert-butoxycarbonyl
br broad
Bu butyl
Bz benzoyl
Cbz benzyloxycarbonyl
CSA camphorsulfonic acid
d days
d (NMR) doublet
DAST diethylaminosulfur trifluoride
dd (NMR) doublet of doublets
d.e. diastereomeric excess
DCM dichloromethane
D-G-3-P D-glycerol-3-phosphate
DHA dihydroxyacetone
DHAP dihydroxyacetone phosphate
DIBAL diisobutylaluminum hydride
DIPEA diisopropylethylamine
DMAP 4-dimethylaminopyridine
DMF N,N-dimethylformamide
DMP dess-martin periodane
DMSO dimethyl sulfoxide
DNJ deoxynojirimycin
DMJ deoxymannojirimycin
dt (NMR) doublet of triplets
e.e. enantiomeric excess
e.g. exempli gratia (for example)
A
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EI electron impact
eq equatorial
equiv. equivalents
ESI electrospray ionization
Et ethyl
et al. et alia (and others)
EWG electron withdrawing group
FBP D-fructose-1,6-bisphosphate
FHAP fluorohydroxyacetone phosphate
Fmoc 9-fluorenylmethoxycarbonyl
GC gas chromatography
h hours
HPLC high performance liquid chromatography
HRMS high resolution mass spectrometry
i.e. id est (that is)
IR infrared
Km Michaelis constant
LRMS low resolution mass spectrometry
m (NMR) multiplet
M molar
m-CPBA meta-chloroperoxybenzoic acid
Me methyl
MeCN acetonitrile
MIC minimum inhibitory concentration
min minutes
MOE molecular operating environment
MS mass spectrometry
m/z mass to charge ratio
NAD(H) nicotinamide adenine dinucleotide
NMR nuclear magnetic resonance
NOESY nuclear overhauser effect spectroscopy
o ortho
p para
PDB protein database
pHTX perhydrohistrionicotoxin
PG protecting group
Ph phenyl
PPi pyrophosphate
q quartet
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quant. quantitatively
RCM ring-closing metathesis
Rf retention factor
RT room temperature
s singlet (NMR)
SAR structure activity relationship
sat. saturated
sp. species
t (NMR) triplet
TBDMS tert-butyldimethylsilyl
t-Bu tert-butyl
TEA triethylamine
TES triethylsilyl
TFA trifluoroacetic acid
THF tetrahydrofuran
TLC thin layer chromatography
TMS trimethylsilyl
TsOH p-toluenesulfonyl acid
U units
UV ultraviolet
Vrel relative reaction rate
Amino acids
Arg arginine (R)
Asn asparagine (N)
Asp aspartate (D)
Glu glutamate (E)
Lys lysine (K)
Ser serine (S)
Tyr tyrosine (Y)
Enzymes
AA-1 aspergillus acylase 1
Cal Candida antarctica lipase
CRL Candida rugosa lipase
A
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Abbreviations
FruA fructose-1,6-bisphosphate aldolase
FSA D-fructose-6-phosphate aldolase
FucA fucose-1-phosphate aldolase
GPDH glycerol-3-phosphate dehydrogenase
GPO L-glycerol-3-phosphate oxidase
HNL hydroxynitrile lyase
PCL Pseudomonas cepacia lipase
PhoN-Sf recombinant Shigella flexneri acid phosphatase
PLE pig liver esterase
RAMA rabbit muscle aldolase
RhuA rhamnulose-1-phosphate aldolase
ROL Rhizopus oryzae lipase
SPH Sphingomonas sp. HXN-200
TagA tagatose-1,6-bisphosphate aldolase
WT wild type
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Synthesis of carbohydrate fragments through biocatalytic cascades – presentation at 
the NWO KNCV meeting in Wageningen, April 8th 2011.
One-Pot Four-Enzyme Cascade Catalysis: Two-Step Synthesis of D-Fagomine – presen-
tation at the Zing Biocatalysis conference in Puerto Morelos, Mexico, December 10th – 13th 
2010.
Toward a Cascade Catalysis-based Synthesis of Batzellaside – poster presentation at 
NWO studygroup meeting in Lunteren, October 25 th– 27th 2010.
Synthesis of industrially relevant heterocycles through biocatalytic cascades – presen-
tation at sIMMposium in Nijmegen, May 17th 2010
Four-enzyme-catalytic cascade to synthesize carbohydrate fragments – poster presen-
tation at NWO study group meeting in Lunteren, October 19th – 21th 2009.
This poster was awarded the first poster prize.
Facile synthesis of D-Fagomine via a stereo-selective one pot cascade reaction – poster 
presentation at Tetrahedron conference in Paris, June 23th – 26th 2009.
Industrially relevant heterocycles through biocatalytic cascades – presentation at the 
NCCC conference in Noordwijkerhout, March 1st – 3rd 2009.
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This poster was awarded the first poster prize.
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CV
Curriculum Vitae
Lieke is op 19 april 1980 in Middelburg geboren. Haar middelbare schooltijd op het 
atheneum is begonnen in 1992 op Colegio Arubano te Aruba en voltooid aan het Mencia 
de Mendoza Lyceum in Breda. Haar chemische carrière begon met de opleiding Chemie 
aan de Hogeschool West-Brabant (nu Avans) in 1998. In het laatste jaar (2001-2002) heeft 
ze met veel plezier een stage voltooid bij Janssen Pharmaceutica op de afdeling Johnson 
& Johnson Pharmaceutical Research and Development. Dit beviel haar zo goed dat ze 
er nog twee jaar werkzaam is geweest. De honger naar kennis was sterker en in 2004 is 
ze gestart met de master opleiding Scheikunde aan de Radboud Universiteit Nijmegen. 
Tijdens haar vrije uurtjes kluste ze als vakantiekracht bij MercaChem. In 2005 is ze be-
gonnen met haar hoofdvakstage onder begeleiding van prof. dr. Floris Rutjes en Jorge 
Verkade, waarbij ze onderzoek heeft gedaan naar de enzymatische ontscherming van de 
paramethoxyfenyl beschermgroep. Nadat ze cum laude haar master diploma behaalde in 
2007 wachtte het promotieavontuur. Dit werd even op pauze gezet door een korte stop 
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I see trees of green, red roses too. 
I see them bloom, for me and you.  
And I think to myself, what a wonderful world.   
I see skies of blue, and clouds of white.  
The bright blessed day, the dark sacred night.  
And I think to myself, what a wonderful world.  
The colors of the rainbow, so pretty in the sky.  
Are also on the faces of people going by. 
I see friends shaking hands saying, “How do you do?” 
They’re really saying “I love you”. 
I hear babies cry, I watch them grow. 
They’ll learn much more than I’ll ever know. 
And I think to myself what a wonderful world.   
Oh yeah.
 
What a wonderful world – Bob Thiele and George David Weiss
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